Stephen R. Bloom

Q: What Schools Are Affiliated With Stephen R. Bloom

Stephen R. Bloom is affiliated with the following schools: Imperial College London, University of Oxford, Royal Postgraduate Medical School, University of Toronto, Dokkyo University, University of Adelaide, University of Texas Southwestern Medical Center, University of Cambridge

Stephen R. Bloom's AcademicInfluence.com Rankings

Stephen R. Bloom

Philosophy

#1173

World Rank

#2191

Historical Rank

Logic

#152

World Rank

#349

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Stephen R. Bloom Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Stephen Robert Bloom FRS is a British Professor of Medicine at Imperial College London where he leads the Diabetes, Endocrinology and Metabolism division. Education Bloom was educated at Queens' College, Cambridge, where he was awarded a Master of Arts degree in 1968 and a Doctor of Medicine degree in 1979. He received his Doctor of Science degree from the University of London in 1982. Bloom completed appointments as a house officer, senior house officer and specialist registrar at Middlesex Hospital, University College London, where he also received his Medical Research Council Clinical Research Fellowship training.

(See a Problem?)

Stephen R. Bloom's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Ghrelin enhances appetite and increases food intake in humans. (2001) (2453)
Gut hormone PYY3-36 physiologically inhibits food intake (2002) (2237)
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression (1998) (2177)
A role for glucagon-like peptide-1 in the central regulation of feeding (1996) (1842)
GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN (1987) (1740)
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. (2000) (1580)
Inhibition of food intake in obese subjects by peptide YY3-36. (2003) (1577)
Ghrelin causes hyperphagia and obesity in rats. (2001) (1153)
Human distribution and release of a putative new gut hormone, peptide YY. (1985) (1110)
Neuropeptide Y distribution in the rat brain. (1983) (1100)
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. (1979) (844)
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults (2014) (837)
Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters (2006) (746)
AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* (2004) (736)
Gut hormones and the regulation of energy homeostasis (2006) (736)
Gut Hormones as Mediators of Appetite and Weight Loss After Roux-en-Y Gastric Bypass (2007) (683)
Neuropeptide Y distribution in human brain (1983) (665)
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. (1998) (600)
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. (2005) (599)
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. (1989) (591)
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. (1999) (566)
The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway (2005) (555)
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. (1974) (555)
Food fails to suppress ghrelin levels in obese humans. (2002) (549)
Attenuated peptide YY release in obese subjects is associated with reduced satiety. (2006) (541)
GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN GASTROINTESTINAL AND PANCREATIC D CELLS (1975) (516)
Pancreatic polypeptide reduces appetite and food intake in humans. (2003) (481)
The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents (2014) (480)
POSSIBLE DUAL ROLE FOR VASOACTIVE INTESTINAL PEPTIDE AS GASTROINTESTINAL HORMONE AND NEUROTRANSMITTER SUBSTANCE (1976) (468)
Central and Peripheral Administration of Kisspeptin‐10 Stimulates the Hypothalamic‐Pituitary‐Gonadal Axis (2004) (464)
Oxyntomodulin suppresses appetite and reduces food intake in humans. (2003) (462)
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. (2004) (461)
The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. (1999) (459)
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. (2001) (456)
NEURON-SPECIFIC ENOLASE IS PRODUCED BY NEUROENDOCRINE TUMOURS (1981) (451)
Gut hormones and appetite control. (2007) (448)
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. (1984) (439)
ENKEPHALIN-LIKE IMMUNOREACTIVITY IN THE HUMAN GASTROINTESTINAL TRACT (1977) (438)
Glucagon-like peptide 1 (GLP-1) (2019) (438)
Distribution of galanin immunoreactivity in the central nervous system and the responses of galanin-containing neuronal pathways to injury (1985) (435)
Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. (1997) (427)
Metabolic surgery profoundly influences gut microbial–host metabolic cross-talk (2011) (421)
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. (2005) (386)
Ghrelin increases food intake in obese as well as lean subjects (2004) (385)
VASOACTIVE INTESTINAL PEPTIDE AND WATERY-DIARRHŒA SYNDROME (1973) (366)
HORMONAL AND METABOLIC RESPONSES TO AN ENKEPHALIN ANALOGUE IN NORMAL MAN (1978) (362)
The distribution of nine peptides in rat spinal cord with special emphasis on the substantia gelatinosa and on the area around the central canal (laminaX) (1981) (361)
Effects of exercise on gut peptides, energy intake and appetite. (2007) (361)
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. (2012) (359)
Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function 1 (1971) (359)
Requirement for Leptin in the Induction and Progression of Autoimmune Encephalomyelitis1 (2001) (355)
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. (1999) (346)
Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. (1989) (346)
Peripheral oxyntomodulin reduces food intake and body weight gain in rats. (2004) (336)
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. (1987) (336)
Calcitonin gene-related peptide in cardiovascular tissues of the rat (1985) (334)
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. (2005) (330)
Progressive rise in gut hormone levels after Roux‐en‐Y gastric bypass suggests gut adaptation and explains altered satiety (2006) (330)
Distribution and release of human pancreatic polypeptide. (1976) (320)
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study (2005) (320)
Calcitonin gene related peptide. (1991) (317)
The Gut Hormone Peptide YY Regulates Appetite (2003) (315)
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial (2006) (311)
An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. (1995) (309)
Effect of peptide YY on gastric, pancreatic, and biliary function in humans. (1985) (304)
The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. (2002) (304)
The role of gut hormones and the hypothalamus in appetite regulation. (2010) (303)
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. (1997) (302)
Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. (1993) (300)
The Gut Hormones PYY3-36 and GLP-17-36 amide Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans (2011) (291)
Gastrointestinal satiety signals. (2008) (291)
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. (2005) (283)
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. (1990) (283)
Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. (2005) (282)
Differential expression of α-CGRP and β-CGRP by primary sensory neurons and enteric autonomic neurons of the rat (1988) (281)
Oxyntomodulin inhibits food intake in the rat. (2001) (280)
Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry (1977) (276)
Elevated plasma endothelin in patients with diabetes mellitus (1990) (276)
HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MAN (1983) (270)
MECHANISM OF PANCREATIC POLYPEPTIDE RELEASE IN MAN (1977) (270)
Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. (2007) (269)
The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin‐releasing hormone and neurokinin B neurons (2010) (268)
Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. (2005) (266)
The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. (2000) (265)
A glucagonoma syndrome. (1974) (262)
Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. (1984) (262)
An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. (2008) (261)
Neuroendocrine tumours. (2004) (261)
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity (2012) (258)
Slow release dietary carbohydrate improves second meal tolerance. (1982) (252)
BREAST vs BOTTLE: ENDOCRINE RESPONSES ARE DIFFERENT WITH FORMULA FEEDING (1980) (252)
Further characterisation of the 'ileal brake' reflex in man--effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. (1988) (252)
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. (1974) (247)
Differences in the metabolic and hormonal response to exercise between racing cyclists and untrained individuals. (1976) (243)
Occurrence, distribution and ontogeny of CGRP immunoreactivity in the rat lower respiratory tract: Effect of capsaicin treatment and surgical denervations (1986) (241)
Can the human neonate mount an endocrine and metabolic response to surgery? (1985) (241)
Calcitonin gene-related peptide immunoreactivity in afferent neurons supplying the urinary tract: Combined retrograde tracing and immunohistochemistry (1986) (237)
Gut peptides in the regulation of food intake and energy homeostasis. (2006) (236)
Postembryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype (2005) (234)
Gastric bypass reduces fat intake and preference. (2011) (225)
Remission of Type 2 Diabetes After Gastric Bypass and Banding: Mechanisms and 2 Year Outcomes (2010) (224)
A gastrin releasing peptide from the porcine nonantral gastric tissue. (1978) (220)
Neuropeptides in Alzheimer type dementia (1983) (218)
Effect of peripheral nerve section and nerve crush on spinal cord neuropeptides in the rat; increased VIP and PHI in the dorsal horn (1984) (218)
Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. (1993) (217)
Glucagon-like peptide-1 is a physiological incretin in rat. (1995) (215)
Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. (2005) (215)
Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. (1999) (213)
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. (1981) (212)
Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. (2000) (210)
Gastric bypass increases energy expenditure in rats. (2010) (209)
Gut Hormones and ‘Minimal Enteral Feeding’ (1986) (208)
Appetite regulation: from the gut to the hypothalamus (2004) (208)
Hypothalamic neuropeptides and the regulation of appetite (2012) (206)
Bombesin: action on gut hormones and calcium in man. (1982) (206)
Galanin regulates prolactin release and lactotroph proliferation. (1998) (202)
Obesity and Appetite Control (2012) (201)
Neuropeptide tyrosine (NPY) immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland. (1984) (199)
CORONARY ARTERY INFUSION OF NEUROPEPTIDE Y IN PATIENTS WITH ANGINA PECTORIS (1987) (199)
Increased Neuropeptide Y Concentrations in Specific Hypothalamic Regions of Streptozocin-Induced Diabetic Rats (1989) (196)
Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo–pituitary axes in vitro and in vivo in male rats (2001) (196)
Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon (1984) (195)
PANCREATIC POLYPEPTIDE IN INSULINOMAS, GASTRINOMAS, VIPOMAS, AND GLUCAGONOMAS (1976) (193)
The newer gut hormones. Cellular sources, physiology, pathology, and clinical aspects. (1977) (192)
NEUROPEPTIDE TYROSINE (NPY)—A MAJOR CARDIAC NEUROPEPTIDE (1983) (191)
The Hypothalamic Mechanisms of the Hypophysiotropic Action of Ghrelin (2002) (190)
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin (2010) (190)
Peptide YY abnormalities in gastrointestinal diseases. (1986) (189)
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3–36) on food intake (2005) (189)
GUT-HORMONE PROFILE IN CŒLIAC DISEASE (1978) (186)
Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma. (1981) (184)
An enteroglucagon tumour (1972) (184)
Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. (2009) (181)
Bowels control brain: gut hormones and obesity (2010) (180)
INHIBITION OF PANCREAS AND GALLBLADDER BY PANCREATIC POLYPEPTIDE (1978) (180)
Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. (1997) (180)
Minireview: Gut peptides regulating satiety. (2004) (180)
Peptides, the limbic lobe and schizophrenia (1983) (180)
Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia (2013) (179)
Capsaicin induces a depletion of calcitonin gene-related peptide (CGRP)-immunoreactive nerves in the cardiovascular system of the guinea pig and rat. (1986) (178)
Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. (1998) (178)
Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects (2011) (177)
Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system (2000) (175)
Organization of galanin‐immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents (1987) (175)
DISTRIBUTION OF A BOMBESIN-LIKE PEPTIDE IN HUMAN GASTROINTESTINAL TRACT (1976) (175)
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. (2006) (174)
EFFECT OF NEUROTENSIN ON GASTRIC FUNCTION IN MAN (1980) (173)
Alterations of sucrose preference after Roux-en-Y gastric bypass (2011) (172)
Measurement of fasting and postprandial plasma VIP in man. (1978) (172)
Enkephalin-, VIP- and substance P-like immunoreactivity in the carotid body (1980) (172)
Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. (2001) (172)
The regulation of food intake by the gut-brain axis: implications for obesity (2013) (172)
Calcitonin gene-related peptide immunoreactive sensory and motor nerves of the rat, cat, and monkey esophagus. (1985) (171)
High concentrations of a novel peptide, neuropeptide Y, in the innervation of mouse and rat heart. (1984) (170)
Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones (1985) (170)
Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart (1983) (170)
Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. (1981) (169)
Central relaxin-3 administration causes hyperphagia in male Wistar rats. (2005) (168)
Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. (2005) (167)
Characterization of ghrelin-like immunoreactivity in human plasma. (2005) (167)
Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract. (1983) (166)
Effects of peptide YY and neuropeptide Y on gastric emptying in man. (1984) (166)
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. (1996) (165)
Leptin inhibits the anti‐CD3‐driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines (2002) (165)
Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double‐blind, placebo‐controlled study (2000) (165)
Gut Hypertrophy After Gastric Bypass Is Associated With Increased Glucagon-Like Peptide 2 and Intestinal Crypt Cell Proliferation (2010) (164)
Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. (2001) (163)
Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia. (1983) (162)
Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. (2001) (162)
Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum (1973) (159)
Motilin and the interdigestive migrating motor complex in man (1979) (159)
Scope and Specificity of Acarbose in Slowing Carbohydrate Absorption in Man (1981) (158)
Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells (1996) (158)
Peptidergic innervation of the human male genital tract. (1983) (158)
Distribution and quantification of immunoreactive orexin A in rat tissues (1999) (158)
Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. (2004) (158)
Developmental changes in bombesin, substance P, somatostatin and vasoactive intestinal polypeptide in the rat brain (1982) (158)
Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas). (1981) (156)
Hypothalamic actions of neuromedin U. (2002) (156)
Immunohistochemical analysis of the early ontogeny of the neuropeptide Y system in rat brain (1985) (155)
Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7-36) Amide or Exendin-(9-39) Alters Body Weight in the Rat* *This work was supported by the United Kingdom Medical Research Council. (1999) (155)
Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. (1985) (154)
Bromocriptine treatment of acromegaly. (1975) (154)
Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males (2001) (153)
Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat. (1980) (153)
Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. (1991) (150)
Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety (2016) (150)
A qualitative comparison of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide (GRP) (1981) (149)
Endoscopic Duodenal–Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes (2013) (149)
Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung. (1990) (148)
Hypothalamic regulation of food intake and clinical therapeutic applications. (2009) (147)
Cellular localization of a vasoactive intestinal peptide in the mammalian and avian gastrointestinal tract (1974) (147)
A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men (2003) (146)
Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. (2006) (145)
The plasma release of atrial natriuretic peptide in man. (1986) (145)
Enterochromaffin cells of the mammalian small intestine as the source of motilin (1974) (143)
The distribution of substance p-like immunoreactive nerves in the guinea-pig heart (1981) (142)
NEUROPEPTIDE Y IN PHAEOCHROMOCYTOMAS AND GANGLIONEUROBLASTOMAS (1983) (142)
Leptin interacts with glucagon‐like peptide‐1 neurons to reduce food intake and body weight in rodents (1997) (142)
Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats. (2002) (141)
Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. (1987) (140)
IDENTIFICATION OF CHOLECYSTOKININ-SECRETING CELLS (1975) (140)
The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal (2003) (139)
VIPERGIC NERVES IN THE PENIS (1981) (138)
Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. (1985) (137)
Neuropeptide Y (NPY) in the adrenal gland. (1983) (137)
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. (2000) (136)
Effects of stimulation of the chorda tympani in bursts on submaxillary responses in the cat (1982) (135)
Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel (1983) (134)
Orexin A interactions in the hypothalamo-pituitary gonadal axis. (2001) (133)
Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial (2017) (133)
Investigation of the melanocyte stimulating hormones on food intake Lack of evidence to support a role for the melanocortin-3-receptor (2000) (131)
Neuropeptide Y Induced Feeding in the Rat Is Mediated by a Novel Receptor1. (1997) (130)
PANCREATECTOMISED MAN: A MODEL FOR DIABETES WITHOUT GLUCAGON (1976) (130)
Regulatory peptides in the mammalian respiratory tract. (1982) (130)
Endothelin in the gastrointestinal tract. Presence of endothelinlike immunoreactivity, endothelin-1 messenger RNA, endothelin receptors, and pharmacological effect. (1990) (130)
Increased Hypothalamic Neuropeptide Y Concentrations in Diabetic Rat (1988) (129)
Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk (1998) (129)
Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. (2003) (129)
Distribution and chromatographic characterisation of CGRP-like immunoreactivity in the brain and gut of the rat (1985) (129)
Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption. (1992) (128)
CGRP and adrenomedullin binding correlates with transcript levels for Calcitonin Receptor‐Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) in rat tissues (2000) (127)
Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. (2007) (127)
The Central Effects of Orexin‐A in the Hypothalamic‐Pituitary‐Adrenal Axis In Vivo and In Vitro in Male Rats (2001) (126)
Immunofluorescent localization of enteroglucagon cells in the gastrointestinal tract of the dog (1971) (126)
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. (2009) (126)
Radioimmunoassay of neuropeptide Y (1984) (125)
A VIP-containing system concentrated in the lumbosacral region of human spinal cord (1983) (125)
DIRECT INHIBITION OF GASTRIC ACID BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN DOGS (1975) (124)
Glucagon control of fasting glucose in man. (1974) (123)
Occurrence, distribution and origin of peptide-containing nerves of guinea-pig and rat male genitalia and the effects of denervation on sperm characteristics. (1986) (123)
Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease (1980) (122)
Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food. (2014) (122)
Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. (1993) (122)
Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the intestinal epithelium to refeeding in the rat and relationship to plasma gastrin, enteroglucagon, and PYY concentrations. (1987) (122)
Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. (1978) (122)
Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat (1988) (122)
Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung (1988) (121)
Galanin regulates basal and oestrogen-stimulated lactotroph function (1993) (121)
Vasoactive intestinal peptide and watery-diarrhoea syndrome. (1973) (121)
Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf. (1984) (120)
A radioimmunoassay for neurotensin in human plasma. (1979) (120)
Expression of the rat amylin (IAPP/DAP) gene. (1989) (120)
NEUROTENSIN SECRETION BY FIBROLAMELLAR CARCINOMA OF THE LIVER (1984) (119)
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. (2014) (119)
Targeting GLP-1 receptor trafficking to improve agonist efficacy (2018) (118)
Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats (2006) (118)
Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. (2004) (118)
Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. (1987) (118)
Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. (2002) (116)
Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. (1995) (116)
Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus (1989) (116)
Coinfusion of Low-Dose GLP-1 and Glucagon in Man Results in a Reduction in Food Intake (2014) (115)
Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man. (1984) (115)
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. (2005) (115)
Autoradiographic Localization of Endothelin‐1 Binding Sites in the Cardiovascular and Respiratory Systems (1989) (115)
A role for arcuate cocaine and amphetamine regulated transcript in hyperphagia, thermogenesis, and cold adaptation (2003) (114)
Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. (2010) (113)
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. (2009) (113)
Twice‐Weekly Administration of Kisspeptin‐54 for 8 Weeks Stimulates Release of Reproductive Hormones in Women With Hypothalamic Amenorrhea (2010) (113)
In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. (1989) (113)
The regulation of appetite (2005) (113)
Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers (2006) (112)
Calcitonin gene-related peptide-immunoreactive nerves in the tongue, epiglottis and pharynx of the rat: Occurrence, distribution and origin (1986) (112)
DIARRHOEA IN VIPOMA PATIENTS ASSOCIATED WITH COSECRETION OF A SECOND ACTIVE PEPTIDE (PEPTIDE HISTIDINE ISOLEUCINE) EXPLAINED BY SINGLE CODING GENE (1983) (112)
The future role of gut hormones in the treatment of obesity (2014) (112)
Studies on the hormonal regulation of fuel metabolism in the human newborn infant undergoing anaesthesia and surgery. (1985) (111)
The release of pancreatic glucagon and inhibition of insulin in response to stimulation of the sympathetic innervation. (1975) (111)
PYY3–36 and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans (2010) (110)
Glucagon increases energy expenditure independently of brown adipose tissue activation in humans (2015) (110)
Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors. (1988) (110)
Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study (2005) (110)
Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy (2015) (110)
Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. (1998) (109)
Calcitonin gene-related peptide messenger RNA is expressed in sensory neurones of the dorsal root ganglia and also in spinal motoneurones in man and rat (1988) (109)
Peptide YY, appetite and food intake (2005) (109)
The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf (1973) (109)
Electron immunocytochemical localization of enkephalin-like material in catecholamine-containing cells of the carotid body, the adrenal medulla, and in pheochromocytomas of man and other mammals. (1982) (108)
Increasing LH Pulsatility in Women With Hypothalamic Amenorrhoea Using Intravenous Infusion of Kisspeptin-54 (2014) (108)
Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. (1987) (108)
Minireview: Glucagon in stress and energy homeostasis. (2012) (108)
Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping. (1990) (107)
Occurrence and distribution of a newly discovered peptide, galanin, in the mammalian enteric nervous system. (1986) (107)
Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. (1986) (106)
Effect of motilin on the rate of gastric emptying and gut hormone release during breakfast. (1979) (106)
Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide. (1984) (106)
Regulatory Peptides (1989) (105)
Regulation of neuroendocrine gene expression by alternative RNA processing. Colocalization of calcitonin and calcitonin gene-related peptide in thyroid C-cells. (1985) (105)
Effect of total parenteral nutrition on gut hormone release in humans. (1981) (105)
Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. (2006) (105)
The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. (2011) (104)
Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. (1990) (104)
The glucagonoma syndrome. (1978) (104)
Influence of Islet Amyloid Polypeptide and the 8–37 Fragment of Islet Amyloid Polypeptide on Insulin Release From Perifused Rat Islets (1993) (104)
Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas (2004) (104)
Regulation of hepatic enzymes and insulin levels in offspring of rat dams fed a reduced-protein diet. (1997) (104)
Neuropeptide tyrosine (NPY): a newly discovered peptide is present in the mammalian respiratory tract. (1984) (103)
Peptide-containing neurones connect the two ganglionated plexuses of the enteric nervous system (1980) (102)
Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. (1980) (102)
Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure (2002) (102)
Failure of Glucagon Release in Infants of Diabetic Mothers (1972) (102)
Evidence for neuropeptide Y synthesis in the rat anterior pituitary and the influence of thyroid hormone status: comparison with vasoactive intestinal peptide, substance P, and neurotensin. (1989) (101)
Central orexin A has site-specific effects on luteinizing hormone release in female rats. (2003) (100)
SUPPRESSION OF PANCREATIC ENDOCRINE TUMOUR SECRETION BY LONG-ACTING SOMATOSTATIN ANALOGUE (1979) (100)
Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. (1989) (100)
Decreased plasma motilin concentrations in pregnancy. (1982) (99)
Neurokinin B Administration Induces Hot Flushes in Women (2015) (99)
Gut hormone release after intestinal resection. (1982) (98)
Glucagon‐like peptide‐1 (GLP‐1): a trial of treatment in non‐insulin‐dependent diabetes mellitus (1997) (98)
The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf (1974) (98)
Vasoactive intestinal polypeptide in the normal and unstable bladder. (1983) (97)
Gut hormones and the control of appetite (2004) (97)
Low degree of overlap between kisspeptin, neurokinin B, and dynorphin immunoreactivities in the infundibular nucleus of young male human subjects challenges the KNDy neuron concept. (2012) (97)
Cardiovascular, biochemical and hormonal changes during food-induced hypotension in chronic autonomic failure (1989) (97)
Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia (1984) (97)
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. (1983) (97)
Peptide-containing nerves in human urinary bladder. (1984) (97)
Proceedings: Effect of somatostatin on motilin levels and gastric emptying. (1975) (96)
Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. (2002) (96)
Peripheral and Central Administration of Xenin and Neurotensin Suppress Food Intake in Rodents (2009) (96)
Ontogeny of a novel peptide, neuropeptide Y (NPY) in rat brain (1984) (96)
Production of Endothelin 1 by Cultured Bovine Retinal Endothelial Cells and Presence of Endothelin Receptors on Associated Pericytes (1989) (96)
Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene-related peptide receptors. (1996) (96)
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. (1981) (96)
Hormones of the gastrointestinal tract. (1974) (95)
Interdiestive Motor Activity in Patients with Systemic Sclerosis (1982) (95)
Distribution and molecular heterogeneity of galanin in human, pig, guinea pig, and rat gastrointestinal tracts. (1986) (94)
Substance P-like immunoreactive nerves in mammalian lung. (1979) (94)
Investigation of the feeding effects of melanin concentrating hormone on food intake — action independent of galanin and the melanocortin receptors (1999) (94)
Pituitary adenylate cyclase-activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxant. (1991) (94)
The distributions of PHI and VIP in porcine gut and their co-localisation to a proportion of intrinsic ganglion cells (1984) (94)
Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. (1984) (94)
Co-localization of neuropeptide tyrosine (NPY) and its C-terminal flanking peptide (C-PON) (1985) (93)
Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding. (1991) (93)
Studies on cardiac distribution and function of neuropeptide Y. (1986) (93)
Cytokine stimulated endothelin release from endothelial cells. (1991) (93)
Gut hormones in tropical malabsorption. (1979) (93)
Bombesin production by human small cell carcinoma of the lung (1982) (93)
Characterization of an avian gastric (proventricular) peptide having sequence homology with the porcine gastrin‐releasing peptide and the amphibian peptides bombesin and alytesin (1980) (92)
Ketoacidosis in pancreatectomized man. (1977) (91)
Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man. (1990) (91)
The Gut Hormones in Appetite Regulation (2011) (91)
DECREASE OF VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN THE PENISES FROM IMPOTENT MEN (1984) (91)
A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. (1993) (91)
Release of motilin by oral and intravenous nutrients in man. (1979) (91)
Ghrelin for the gastroenterologist: history and potential. (2003) (91)
Calcitonin gene-related polypeptide as a mediator of the neurogenic ocular injury response. (1985) (91)
A radioimmunoassay of gastric inhibitory polypeptide in human plasma. (1980) (91)
The effect of a 72-h fast on plasma levels of pituitary, adrenal, thyroid, pancreatic and gastrointestinal hormones in healthy men and women. (1989) (90)
Regulatory peptides and neuron-specific enolase in the respiratory tract of man and other mammals. (1982) (90)
Is bombesin a tumour marker for small-cell carcinoma? (1982) (90)
Immunofluorescent localization of secretin and enteroglucagon in human intestinal mucosa. (1971) (90)
Agouti related peptide (Agrp) stimulates the hypothalamo pituitary gonadal axis in vivo & in vitro in male rats. (1999) (89)
Metabolic studies in subjects following thermal injury, Intermediary metabolites, hormones and tissue oxygenation (1976) (89)
Neuropeptide Y in the human male genital tract. (1984) (89)
Ghrelin stimulates insulin-induced glucose uptake in adipocytes (2006) (89)
Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging. (2006) (89)
Endothelin in renal failure. (1990) (88)
Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men (2006) (88)
Administration of Kisspeptin‐54 into Discrete Regions of the Hypothalamus Potently Increases Plasma Luteinising Hormone and Testosterone in Male Adult Rats (2006) (88)
Long term treatment of acromegaly with a long acting analogue of somatostatin. (1985) (88)
Distribution of immunoreactive growth hormone-releasing hormone in the human brain and intestine and its production by tumors. (1984) (88)
Chromaffin, Enterochromaffin and Related Cells (1977) (88)
Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. (2007) (88)
Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala (2013) (87)
Effect of endocrine manipulation on anterior pituitary galanin in the rat. (1990) (87)
Immunofluorescent localization of secretin in the canine duodenum (1971) (87)
Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection. (1992) (87)
Immunogold staining procedure for the localisation of regulatory peptides (1982) (87)
Neuropeptide Y innervation of the rodent pineal gland and cerebral blood vessels (1985) (86)
Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells (1998) (86)
Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in salivary glands. (1979) (86)
Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogs. (2009) (86)
Radioimmunoassay of substance P and its stability in tissue. (1983) (85)
Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male rats. (2000) (85)
Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats. (1992) (85)
The Gut Hormone Response Following Roux-en-Y Gastric Bypass: Cross-sectional and Prospective Study (2010) (85)
Vagal control of glucagon release in man. (1974) (84)
Evidence for a humoral mechanism after small intestinal resection: Exclusion of gastrin but not enteroglucagon (1983) (84)
Calcitonin gene-related peptide (CGRP) in the female rat urogenital tract (1985) (84)
Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance (2009) (84)
Pancreatic endocrine responses to stimulation of the peripheral ends of the vagus nerves in conscious calves. (1981) (83)
Peptides as drugs. (1999) (83)
Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI) (2009) (83)
Distribution of galanin immunoreactivity in the genitourinary tract of man and rat (1986) (83)
Morphologic patterns and diagnostic criteria of VIP‐producing endocrine tumors. A histologic, histochemical, ultrastructural, and biochemical study of 32 cases (1983) (82)
Topical capsaicin pretreatment inhibits axon reflex vasodilatation caused by somatostatin and vasoactive intestinal polypeptide in human skin (1983) (82)
Substance P, vasoactive intestinal polypeptide (VIP) and somatostatin levels in ocular tissue of normal and sensorily denervated rabbit eyes. (1981) (82)
Atrial natriuretic peptide: physiological release associated with natriuresis during water immersion in man. (1986) (82)
Distribution and postprandial release of porcine peptide YY. (1987) (81)
Vagal Sparing Surgical Technique but Not Stoma Size Affects Body Weight Loss in Rodent Model of Gastric Bypass (2010) (81)
l-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodents (2017) (81)
Carcinoid tumours. (1997) (81)
Distribution of galanin immunoreactivity in the respiratory tract of pig, guinea pig, rat, and dog. (1985) (81)
Bombesin and vasoactive intestinal polypeptide in the developing lung: marked changes in acute respiratory distress syndrome. (1983) (81)
Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis (2008) (81)
Pancreatic cholera due to production of gastric inhibitory polypeptide. (1972) (80)
Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide. (1979) (80)
Effect of neurotensin on pancreatic function in man. (1981) (79)
A comparison of the distributions of eight peptides in spinal cord from normal controls and cases of motor neurone disease with special reference to Onuf's nucleus (1988) (79)
The role of the autonomic nervous system in the control of glucagon, insulin and pancreatic polypeptide release from the pancreas. (1978) (79)
Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes. (1992) (79)
PRESENCE OF NEUROPEPTIDE Y IN HUMAN CIRCLE OF WILLIS AND ITS POSSIBLE ROLE IN CEREBRAL VASOSPASM (1984) (79)
Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. (2011) (79)
Effect of Direct Injection of Melanin‐Concentrating Hormone into the Paraventricular Nucleus: Further Evidence for a Stimulatory Role in the Adrenal Axis via SLC‐1 (2003) (79)
Pituitary Adenylate Cyclase Activating Polypeptide is a Potent Vasodilator in Humans (1992) (78)
Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. (1985) (78)
Diurnal rhythm in the plasma concentration of atrial natriuretic peptide. (1986) (77)
Decreased gastric acid secretion and bacterial colonization of the stomach in severely malnourished Bangladeshi children. (1988) (77)
Neuropeptide Y and drug development (1997) (77)
Release of glucagon, induced by stress. (1973) (77)
The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat (1982) (77)
Metabolic surgery: an evolution through bariatric animal models (2010) (77)
Increase in SP-like immunoreactivity in nerve fibres of rabbit iris and ciliary body one to four months following sympathetic denervation. (1983) (77)
The consequences of long-term topical capsaicin application in the rat (1991) (77)
Low-dose pancreatic polypeptide inhibits food intake in man (2007) (77)
Metabolic Effects of Reducing Rate of Glucose Ingestion by Single Bolus Versus Continuous Sipping (1990) (77)
Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. (2008) (77)
Development of gut hormone responses to feeding in neonates. (1980) (76)
Kisspeptin modulates sexual and emotional brain processing in humans (2017) (76)
Evidence of a paracrine role of neuropeptide-Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone-treated rats. (1994) (76)
The effect of sympathectomy on calcitonin gene-related peptide levels in the rat trigeminovascular system (1985) (75)
The Hypothalamic Melanocortin System Stimulates the Hypothalamo-Pituitary-Adrenal Axis in vitro and in vivo in Male Rats (2002) (74)
PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. (2001) (74)
Sexual Dimorphism of Kisspeptin and Neurokinin B Immunoreactive Neurons in the Infundibular Nucleus of Aged Men and Women (2011) (74)
Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release. (1976) (74)
Development of intestinal regulatory peptides in the human fetus. (1982) (74)
Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract. (1995) (73)
Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3. (1992) (73)
Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders. (1985) (73)
Expression of adrenomedullin (ADM) and its binding sites in the rat uterus: increased number of binding sites and ADM messenger ribonucleic acid in 20-day pregnant rats compared with nonpregnant rats. (1997) (73)
Plasma immunoreactive leptin concentration in end-stage renal disease. (1997) (73)
Enteroglucagon release in the dumping syndrome. (1972) (73)
Neuropeptide Y in the stria terminalis: evidence for an amygdalofugal projection (1984) (73)
Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal. (1988) (72)
Interdigestive biliary output in man: relationship to fluctuations in plasma motilin and effect of atropine. (1982) (72)
Cell proliferation, plasma enteroglucagon and plasma gastrin levels in starved and refed rats (1983) (72)
Gastrointestinal satiety signals (2008) (72)
Localization and molecular forms of galanin in human adrenals: elevated levels in pheochromocytomas. (1986) (72)
The role of oxyntomodulin and peptide tyrosine–tyrosine (PYY) in appetite control (2006) (71)
Regulatory peptides—The distribution of two newly discovered peptides: PHI and NPY (1984) (71)
Cardiovascular and endocrine responses to feeding in the young calf. (1975) (71)
Peptide YY and appetite control. (2004) (71)
Measurement of human plasma motilin. (1976) (71)
Distribution of the gut hormones in the primate intestinal tract. (1979) (70)
Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. (2006) (70)
Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. (1997) (70)
The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats (1984) (70)
Neurotensin infusion in man: pharmacokinetics and effect on gastrointestinal and pituitary hormones. (1980) (70)
Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin. (1993) (69)
The distribution and origin of VIP in the spinal cord of six mammalian species (1984) (69)
Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. (2007) (69)
Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer. (1986) (69)
Comparison of the expression of calcitonin receptor‐like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines (2002) (69)
RELEASE OF MOTILIN AFTER DUODENAL ACIDIFICATION (1976) (69)
The hormonal responses to repetitive brief maximal exercise in humans (2004) (68)
Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach (1989) (68)
Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. (2001) (68)
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. (1983) (68)
A new universal technique for the immunocytochemical localization of peptidergic innervation [proceedings]. (1978) (68)
Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects. (1976) (68)
Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. (1996) (68)
Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. (1997) (67)
Hepcidin levels in diabetes mellitus and polycystic ovary syndrome (2013) (67)
Regional Cerebral Glucose Transport in Insulin-Dependent Diabetic Patients Studied Using [11C]3-O-Methyl-D-Glucose and Positron Emission Tomography (1986) (67)
Hypothalamic Interactions Between Neuropeptide Y, Agouti‐Related Protein, Cocaine‐ and Amphetamine‐Regulated Transcript and Alpha‐Melanocyte‐Stimulating Hormone In Vitro in Male Rats (2002) (67)
Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA. (2000) (67)
Optical Control of Insulin Secretion Using an Incretin Switch (2015) (67)
The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat (2006) (67)
Quantification and synthesis of cocaine- and amphetamine-regulated transcript peptide (79-102)-like immunoreactivity and mRNA in rat tissues. (2000) (67)
Preliminary report: role of peptide YY in defence against diarrhoea (1990) (67)
Long-term Infusion of Growth Hormone Release Inhibiting Hormone in Acromegaly: Effects on Pituitary and Pancreatic Hormones (1974) (67)
Ghrelin and appetite control in humans—Potential application in the treatment of obesity (2011) (67)
Mice With Hyperghrelinemia Are Hyperphagic and Glucose Intolerant and Have Reduced Leptin Sensitivity (2009) (67)
Localisation and measurement of VIP in the genitourinary system of man and animals (1984) (66)
Regional distribution of bombesin and seven other regulatory peptides in the human brain (1984) (66)
The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers (2017) (66)
Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors. (1986) (66)
The obesity epidemic: pharmacological challenges. (2008) (66)
Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes. (1989) (66)
Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study (2019) (66)
Influence of somatostatin and bombesin on plasma enteroglucagon and cell proliferation after intestinal resection in the rat. (1985) (66)
Effects of Galanin-Like Peptide on Food Intake and the Hypothalamo-Pituitary-Thyroid Axis (2003) (66)
Reduced adrenal cortical sensitivity to ACTH in lambs with cut splanchnic nerves. (1986) (66)
Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis. (1983) (65)
The In Vitro Role of Tumour Necrosis Factor‐Alpha and Interleukin‐6 in the Hypothalamic‐Pituitary Gonadal Axis (2001) (65)
Effect of pectin on gastric emptying and gut hormone release in the dumping syndrome. (1983) (65)
Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? (1985) (64)
Obesity treatment: novel peripheral targets. (2009) (64)
Neuropeptide Y in human spinal cord (1984) (64)
Gut hormones in inflammatory bowel disease. (1983) (64)
Orexin A immunoreactivity and prepro-orexin mRNA in the brain of Zucker and WKY rats (2001) (64)
Reduction of neuropeptide Y (NPY) in the rabbit iris-ciliary body after chronic sympathectomy. (1983) (64)
Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. (2019) (64)
Kisspeptin signaling in the amygdala modulates reproductive hormone secretion (2015) (64)
Studies on the distribution of PHI in mammals (1984) (63)
Neuropeptide y-immunoreactive nerves in the uvea of guinea pig and rat (1983) (63)
Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. (1980) (63)
Somatostatin in the human heart and comparison with guinea pig and rat heart. (1985) (63)
The effect of the mammalian neuropeptide, gastrin-releasing peptide (GRP), on gastrointestinal and pancreatic hormone secretion in man. (1983) (63)
Autoradiographic localisation of endothelin binding sites in human and porcine coronary arteries. (1989) (63)
Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. (1989) (62)
Postnatal surges in plasma gut hormones in term and preterm infants. (1982) (62)
Selective ablation of peptide YY cells in adult mice reveals their role in beta cell survival. (2012) (62)
Prokineticin 2 Is a Hypothalamic Neuropeptide That Potently Inhibits Food Intake (2009) (61)
Local application of capsaicin to one sciatic nerve of the adult rat induces a marked depletion in the peptide content of the lumbar dorsal horn (1982) (61)
Pancreatic cholera. Sudies on tumoral secretions and pathophysiology of diarrhea. (1975) (61)
Improved glucose tolerance four hours after taking guar with glucose (1980) (61)
Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes. (1998) (61)
Hyperglucagonaemia in the surgical patient. (1975) (61)
Pyroglutamylated RFamide peptide 43 stimulates the hypothalamic-pituitary-gonadal axis via gonadotropin-releasing hormone in rats. (2008) (61)
Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP and inhibit mitogen-activated protein kinase activity. (1999) (61)
ARE PEPTIDE HISTIDINE ISOLEUCINE AND VASOACTIVE INTESTINAL PEPTIDE CO-SYNTHESISED IN THE SAME PRO-HORMONE? (1982) (60)
Galanin is a paracrine inhibitor of gonadotroph function in the female rat. (1998) (60)
Elevation of plasma neurotensin in the dumping syndrome. (1980) (60)
Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake (2008) (60)
Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201-995. (1986) (60)
RELEASE OF ATRIAL NATRIURETIC PEPTIDE DURING PREGNANCY AND IMMEDIATE PUERPERIUM (1987) (60)
Effects of VIIth (facial) nerve degeneration on vasoactive intestinal polypeptide and substance P levels in ocular and orbital tissues of the rabbit. (1984) (59)
Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY3–36 but resistant to ghrelin (2004) (59)
The hormonal regulation of food intake, digestion, and absorption. (1985) (59)
Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects. (1998) (59)
Production of pituitary protein 7B2 immunoreactivity by endocrine tumors and its possible diagnostic value. (1986) (59)
The role of pancreatico‐biliary secretions in intestinal adaptation after resection, and its relationship to plasma enteroglucagon (1983) (58)
Certain pharmacological characteristics of the release of pancreatic glucagon in response to stimulation of the splanchnic nerves. (1978) (58)
Plasma Kisspeptin Levels in Pregnancies with Diabetes and Hypertensive Disease as a Potential Marker of Placental Dysfunction and Adverse Perinatal Outcome (2012) (58)
Pharmacokinetics of pancreatic polypeptide in man. (1978) (58)
Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia. (1981) (58)
Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans. (1991) (58)
Circulating somatostatin. Physiological regulator of pancreatic function? (1987) (58)
Bile acids and the metabolic syndrome (2019) (57)
Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man. (1992) (57)
The location of VIP in the pancreas of man and rat (2005) (57)
Prolactin-Releasing Peptide Releases Corticotropin-Releasing Hormone and Increases Plasma Adrenocorticotropin via the Paraventricular Nucleus of the Hypothalamus (2002) (57)
Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels (2007) (57)
Effect of inhibition of acid secretion on the regulatory peptides in the rat stomach. (1986) (57)
Pancreatic tumours produce neurotensin. (1981) (57)
Peptide immunoreactive nerves and cells of the guinea pig gall bladder and biliary pathways. (1983) (57)
Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea. (1979) (57)
Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking. (1991) (57)
Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat (2000) (56)
Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome (1978) (56)
Peptide containing nerves in the ureter of the guinea-pig and cat (1981) (56)
Neurotensin-like immunoreactivity in a subpopulation of noradrenaline-containing cells of the cat adrenal gland. (1983) (55)
Galanin-like peptide stimulates the release of gonadotropin-releasing hormone in vitro and may mediate the effects of leptin on the hypothalamo-pituitary-gonadal axis. (2004) (55)
Release of vasoactive intestinal peptide in the dumping syndrome. (1981) (55)
Gut and mind (2003) (55)
c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y (1995) (55)
Plasma trypsin in chronic pancreatitis and pancreatic adenocarcinoma. (1979) (55)
Reduced Levels of Plasma Kisspeptin During the Antenatal Booking Visit Are Associated With Increased Risk of Miscarriage (2014) (55)
Atrial natriuretic peptide is released by dynamic exercise in man. (1986) (55)
Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem (2001) (55)
Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacology. (1984) (55)
The regulation of neuropeptide expression in rat anterior pituitary following chronic manipulation of estrogen status: a comparison between substance P, neuropeptide Y, neurotensin, and vasoactive intestinal peptide. (1990) (55)
Gastrointestinal endocrine tumours (1996) (54)
Targeted Disruption of the Murine Galanin Gene a (1998) (54)
Adrenal cortical responses to vasoactive intestinal peptide in conscious hypophysectomized calves. (1987) (54)
AAV mediated expression of anti-sense neuropeptide Y cRNA in the arcuate nucleus of rats results in decreased weight gain and food intake. (2005) (54)
Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas (1978) (54)
Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure. (1986) (54)
Release of substance P from rat hypothalamus and pituitary by endothelin. (1990) (54)
Hormonal and metabolic responses to intravenous glucose in children on regular hemodialysis. (1978) (54)
Regulation of rat pituitary cocaine- and amphetamine-regulated transcript (CART) by CRH and glucocorticoids. (2004) (54)
A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10 (2009) (54)
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. (1984) (54)
Secretin cells in coeliac disease (1973) (54)
Intramural distribution of regulatory peptides in the sigmoid-recto-anal region of the human gut. (1988) (54)
Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase. (2000) (53)
The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism (1998) (53)
G cell population of the gastric antrum, plasma gastrin, and gastric acid secretion in patients with and without duodenal ulcer. (1978) (53)
Dissociation of neuropeptide Y and somatostatin in Parkinson's disease (1985) (53)
Thermal Imaging Is a Noninvasive Alternative to PET/CT for Measurement of Brown Adipose Tissue Activity in Humans (2017) (53)
Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas. (1983) (52)
Physiology: Does gut hormone PYY3–36 decrease food intake in rodents? (reply) (2004) (52)
Regulation of food intake by gastrointestinal hormones (2006) (52)
Endothelin binding sites in porcine aortic and rat lung membranes. (1989) (52)
Localisation of neuropeptide Y in nerves of the rat cardiovascular system and the effect of 6-hydroxydopamine. (1985) (52)
A role for central glucagon‐like peptide‐1 in temperature regulation (1996) (52)
Plasma secretin and pancreatic bicarbonate response to exogenous secretin in man. (1977) (52)
Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells. (1991) (52)
Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy (2009) (51)
Control of insulin secretion by GLP-1 (2018) (51)
A single injection of kisspeptin‐54 temporarily increases luteinizing hormone pulsatility in healthy women (2013) (51)
Relative Importance of the Arcuate and Anteroventral Periventricular Kisspeptin Neurons in Control of Puberty and Reproductive Function in Female Rats (2015) (51)
Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass (2012) (51)
Proliferative effects of 'fibre' on the intestinal epithelium: relationship to gastrin, enteroglucagon and PYY. (1987) (51)
Localization of immunoreactivity for calcitonin gene-related peptide in the rat anterior pituitary during ontogeny and gonadal steroid manipulations and detection of its messenger ribonucleic acid. (1990) (50)
Neuron specific enolase: a marker for the early development of nerves and endocrine cells in the human lung. (1984) (50)
Presence of the predicted C-flanking peptide of neuropeptide Y (CPON) in tissue extracts (1985) (50)
Substance P Immunoreactivity Exhibits Frequent Colocalization with Kisspeptin and Neurokinin B in the Human Infundibular Region (2013) (50)
Isolation and characterisation of GLP‐1 7–36 amide from rat intestine Elevated levels in diabetic rats (1988) (50)
The New Era of Drug Therapy for Obesity: The Evidence and the Expectations (2015) (50)
Epidermal growth factor in blood (1986) (50)
Overexpression of CART in the PVN Increases Food Intake and Weight Gain in Rats (2008) (50)
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis.[see comment] (2000) (50)
Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis. (2003) (50)
Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist. (1987) (50)
The Pharmacological Treatment and Management of Obesity (2011) (50)
Regional hemodynamic effects of neuromedin U in conscious rats. (1990) (50)
SUBCUTANEOUS GLUCAGON AS A TEST OF THE ABILITY OF THE PITUITARY TO SECRETE GH AND ACTH (1974) (50)
Adrenal and pancreatic endocrine responses to hypoxia and hypercapnia in the calf. (1977) (49)
Immunoreactive endothelin in human plasma, urine, milk, and saliva. (1991) (49)
The hormonal pattern of intestinal adaptation. A major role for enteroglucagon. (1982) (49)
Colonic motor and vascular responses to pelvic nerve stimulation and their relation to local peptide release in the cat. (1983) (49)
Neurone-specific enolase and S-100: new markers for delineating the innervation of the respiratory tract in man and other mammals. (1983) (49)
Leptin prevents the fall in plasma osteocalcin during starvation in male mice. (2002) (49)
Gastrointestinal hormones and regulation of food intake. (2004) (49)
Amylin and amylin-amide lack an acute effect on blood glucose and insulin. (1990) (49)
Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells (2019) (49)
GASTROINTESTINAL MEDIATOR OF INSULIN ACTION (1980) (49)
Interdigestive motor activity in patients with systemic sclerosis. (1982) (49)
Delayed mouth-caecum transit of a lactulose labelled liquid test meal in patients with steatorrhoea caused by partially treated coeliac disease. (1987) (49)
Atrial natriuretic peptide: what is the excitement all about? (1986) (49)
Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas. (1985) (49)
The physiological role of arcuate kisspeptin neurons in the control of reproductive function in female rats. (2014) (48)
Acute stimulation of glucose uptake by leptin in l6 muscle cells. (2002) (48)
Endocrine and metabolic response in the human newborn to first feed of breast milk. (1977) (48)
Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. (1988) (48)
Effect of hypothalamic neuropeptides on corticotrophin release from quarters of rat anterior pituitary gland in vitro. (1984) (48)
Effect of pancreatic polypeptide on gallbladder pressure and hepatic bile secretion. (1982) (48)
The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. (1986) (48)
Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in rats. (1997) (48)
Endocrine responses to exogenous bombesin and gastrin releasing peptide in conscious calves. (1983) (48)
The regional distribution of NPY-, PHM-, and VIP-containing nerves in the human female genital tract. (1986) (48)
Quantitative analysis of peptide levels and neurogenic extravasation following regeneration of afferents to appropriate and inappropriate targets (1989) (47)
Central regulators of food intake. (2003) (47)
MECHANISM OF PANCREATIC-POLYPEPTIDE RELEASE (1977) (47)
Gut hormones and regulatory peptides in relation to enteral feeding, gastroenteritis, and necrotizing enterocolitis in infancy. (1990) (47)
The actions of tuberoinfundibular peptide on the hypothalamo-pituitary axes. (2001) (47)
Gut hormones as therapeutic agents in treatment of diabetes and obesity. (2013) (47)
NEURAL AND HORMONAL PEPTIDES IN RECTAL BIOPSY SPECIMENS FROM PATIENTS WITH CHAGAS' DISEASE AND CHRONIC AUTONOMIC FAILURE (1980) (47)
Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines. (1991) (47)
Oxidation/reduction of methionine residues in CCK: A study by radioimmunoassay and isocratic reverse phase high pressure liquid chromatography (1985) (47)
Distribution of PHI in the rat brain (1982) (47)
Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor (2002) (47)
Content and release of neurotensin in PC12 pheochromocytoma cell cultures: modulation by dexamethasone and nerve growth factor (1982) (47)
Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer. (1983) (47)
A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptors. (1996) (47)
Somatostatin and the dumping syndrome. (1985) (46)
Molecular identification of binding sites for calcitonin gene-related peptide (CGRP) and islet amyloid polypeptide (IAPP) in mammalian lung: species variation and binding of truncated CGRP and IAPP. (1993) (46)
Islet amyloid polypeptide: production by an osteoblast cell line and possible role as a paracrine regulator of osteoclast function in man. (1991) (46)
Plasma release of atrial natriuretic peptide in response to blood volume expansion. (1986) (46)
Hormonal interactions between gut and brain. (2010) (46)
Somatostatin and the gut. (1978) (46)
Plasma glucagon-like peptide-1 (7-36) amide (GLP-1) response to liquid phase, solid phase, and meals of differing lipid composition. (1998) (46)
Cytochemical relationships in the paracervical ganglion (Frankenhäuser) of rat studied by immunocytochemistry (1985) (46)
Lithium dramatically potentiates neurotensin/neuromedin N gene expression. (1988) (46)
The neuroendocrine design of the gut. (1979) (46)
Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland. (2003) (46)
Measurement of gut hormonal peptides in biopsies from human stomach and proximal small intestine. (1983) (46)
Hypothalamic cocaine- and amphetamine-regulated transcript (CART) and agouti-related protein (AgRP) neurons coexpress the NOP1 receptor and nociceptin alters CART and AgRP release. (2005) (46)
Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents (2010) (45)
Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma. (1987) (45)
Hyperenteroglucagonaemia and small intestinal mucosal growth after colonic perfusion of glucose in rats. (1985) (45)
Depletion of neuropeptides during wound healing in rat skin (1986) (45)
Morphological evidence for enhanced kisspeptin and neurokinin B signaling in the infundibular nucleus of the aging man. (2012) (45)
The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency (2004) (45)
Production of endothelin by vascular smooth muscle cells. (1991) (45)
Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma (1988) (45)
Hormonal abnormalities of the pancreas and gut in cystic fibrosis (1980) (44)
Cloning and molecular characterization of complementary deoxyribonucleic acid corresponding to a novel form of pituitary adenylate cyclase-activating polypeptide messenger ribonucleic acid in the rat testis. (1995) (44)
Gastrointestinal Regulatory Peptide Responses in Long-Distance Runners (1984) (44)
ENKEPHALIN IN PERIPHERAL NEUROENDOCRINE TUMOURS (1978) (44)
Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats. (1989) (44)
Adrenomedullin activity in chronically hypoxic rat lungs. (1996) (44)
Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man. (1986) (44)
Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II? (1994) (44)
Somatostatin localization in tissues. (1986) (43)
LATROGENIC HYPERINSULINISM AT BIRTH (1980) (43)
Presence of neuromedin B-like immunoreactivity in the brain and gut of rat and guinea-pig (1985) (43)
Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. (2000) (43)
PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones. (2008) (43)
Epithelially derived endothelin and nitric oxide in asthma. (1995) (43)
Molecular forms of motilin in the mammalian and human gut and human plasma (1981) (43)
Decrease of Pancreatic Somatostatin in Neonatal Nesidiobiastosis (1981) (43)
The neuroendocrine physiology of kisspeptin in the human (2007) (43)
Specific adrenomedullin binding sites and hypotension in the rat systemic vascular bed (1996) (42)
Circulating Gastrointestinal Hormone Abnormalities in Patients With Severe Idiopathic Constipation (1998) (42)
Qualitative and quantitative studies of antral and fundic G cells in pernicious anaemia. (1973) (42)
Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass (2017) (42)
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial (2017) (42)
Distribution of bombesin, somatostatin, substance-P and vasoactive intestinal polypeptide in feline and porcine skin. (1983) (42)
Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma. (1987) (42)
The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. (1988) (42)
Regulatory peptides: key factors in the control of bodily functions. (1983) (42)
Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression. (2000) (42)
The relationship between food, gastro-intestinal hormones and calcitonin secretion. (1973) (42)
Identification of the D1-cell as the source of human pancreatic polypeptide (HPP). (1976) (42)
Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. (2001) (42)
Gastrointestinal responses to a panel of lectins in rats maintained on total parenteral nutrition. (1999) (42)
Glucagon-like peptide-1 and satiety (1997) (42)
Localization of pancreatic endocrine tumours (1994) (42)
Neuropeptide Y (NPY) in pc12 phaeochromocytoma cultures: Responses to dexamethasone and nerve growth factor (1984) (41)
Effects of Feeding Regimen on Blood Glucose Levels and Plasma Concentrations of Pancreatic Hormones and Gut Regulatory Peptides at 9 Months of Age: Comparison Between Infants Fed with Milk Formula and Infants Exclusively Breast‐Fed from Birth (1988) (41)
Does resection enhance the response of the intestine to urogastrone-epidermal growth factor in the rat? (1988) (41)
Peptides and their potential role in the treatment of diabetes and obesity. (2011) (41)
Demonstration of paracervical ganglion origin for the vasoactive intestinal peptide-containing nerves of the rat uterus using retrograde tracing techniques combined with immunocytochemistry and denervation procedures (1984) (41)
Production of "ectopic" vasoactive intestinal peptide-like and neurotensin-like immunoreactivity in human pheochromocytoma cell cultures (1984) (41)
Endocrine responses to insulin hypoglycaemia in the young calf. (1975) (41)
Proglucagon-Derived Peptides in Intestinal Epithelial Proliferation (2001) (41)
Effect of graded amounts of acid instilled into the duodenum on pancreatic bicarbonate secretion and plasma secretin in duodenal ulcer patients and normal subjects. (1977) (41)
Failure of secretin release in patients with duodenal ulcer. (1975) (41)
The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension (2005) (41)
The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma. (1984) (41)
Endothelin-like immunoreactivity in rat models of diabetes mellitus (1990) (40)
Gastrointestinal endocrine tumours. Glucagonomas. (1996) (40)
Why do patients lose weight after Roux-en-Y gastric bypass? (2005) (40)
Hypothalamic Localization of the Feeding E ffect of Agouti-Related Peptide and-Melanocyte – Stimulating Hormone (2000) (40)
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome. (1981) (40)
Cooperative regulation of neurotensin content in PC12 pheochromocytoma cell cultures: effects of nerve growth factor, dexamethasone, and activators of adenylate cyclase (1986) (40)
Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule. (1985) (40)
Pharmacokinetics of motilin in man. (1977) (40)
Effect of Motilin on the Gastric Emptying of Glucose and Fat in Humans (1981) (40)
24-hour variation in content and release of hypothalamic neuropeptides in the rat (1983) (39)
Glucagon levels in normal and diabetic subjects: Use of a specific immunoabsorbent for glucagon radioimmunoassay (2004) (39)
Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue (2002) (39)
Glucose-dependent Insulinotropic Polypeptide Augmentation of Insulin Physiology or Pharmacology? (1984) (39)
The influence of thyroid hormone status on the hypothalamo-hypophyseal growth hormone axis. (1990) (39)
Randomised clinical study: inulin short‐chain fatty acid esters for targeted delivery of short‐chain fatty acids to the human colon (2016) (39)
Localization of insulinomas by selective intraarterial calcium injection. (1996) (39)
Problem or solution: The strange story of glucagon (2018) (39)
The role of secretin in the inhibition of gastric secretion by intraduodenal acid (1974) (39)
L‐arginine promotes gut hormone release and reduces food intake in rodents (2016) (39)
The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat. (2010) (38)
Diazepam binding inhibitor-like immunoreactivity(51–70): distribution in human brain, spinal cord and peripheral tissues (1989) (38)
Plasma enteroglucagon and plasma volume change after gastric surgery. (1976) (38)
Hypothalamic regulation of appetite (2008) (38)
Glucagonomas, VIPomas and somatostatinomas. (1980) (38)
A novel substance P pathway linking the dorsal and ventral horn in the upper lumbar segments of the rat spinal cord (1984) (38)
Distribution and localization of neuromedin B-like immunoreactivity in pig, cat and rat spinal cord (1985) (38)
Evidence for a humoral mechanism after small intestinal resection. Exclusion of gastrin but not enteroglucagon. (1983) (38)
Detection of human probombesin mrna in neuroendocrine (small cell) carcinoma of the lung. In situ hybridization with crna probe (1989) (38)
Effects of gastrointestinal hormones on fasting gallbladder storage patterns in man (1979) (38)
Vagal origin of substance P-containing nerves in the guinea pig lung (1983) (37)
Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value. (1989) (37)
Trifluoperazine reversal of secretory diarrhea in pancreatic cholera. (1980) (37)
Neural regulation of pancreatic polypeptide release. (1983) (37)
Electrophysiological actions of somatostatin on the atrioventricular junction in sinus rhythm and reentry tachycardia. (1986) (37)
Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome. (1987) (37)
Fentanyl and the beta-endorphin, ACTH and glucoregulatory hormonal response to surgery. (1987) (37)
Emerging therapies in the treatment of 'diabesity': beyond GLP-1. (2011) (37)
Plasma glucagon levels in the term human infant and effect of hypoxia (1973) (37)
Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men (2015) (37)
AUTOIMMUNITY IN DIABETICS INDUCED BY HORMONAL CONTAMINANTS OF INSULIN (1979) (37)
Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain (1992) (36)
Gut hormones in adaptation. (1987) (36)
Preanalytical factors affecting RIA measurement of plasma kisspeptin. (2008) (36)
No evidence of an additive inhibitory feeding effect following PP and PYY3−36 administration (2008) (36)
Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. (2004) (36)
Neuroendocrine responses to stimulation of the vagus nerves in bursts in conscious calves. (1983) (36)
Cerebellin-like peptide: TIssue distribution in rat and guinea-pig and its release from rat cerebellum, hypothalamus and cerebellar synaptosomes in vitro (1988) (36)
Pectin and complications after gastric surgery: normalisation of postprandial glucose and endocrine responses. (1980) (36)
Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses. (1976) (36)
VIP-, substance P- and met-enkephalin-immunoreactive innervation of the human gastroduodenal mucosa and Brunner's glands. (1984) (36)
Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. (1981) (36)
The diffuse neuroendocrine system. Studies of this newly discovered controlling system in health and disease. (1979) (36)
Effect of food deprivation and streptozotocin-induced diabetes on hypothalamic neuropeptide Y release as measured by a radioimmunoassay-linked microdialysis procedure (1994) (36)
Effect of gut regulatory peptides of intestinal luminal fluid in the rat. (1981) (35)
Characteristics of the neuroendocrine responses to stimulation of the splanchnic nerves in bursts in the conscious calf. (1984) (35)
Release of VIP, secretin and motilin after duodenal acidification in man. (1978) (35)
Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide. (1981) (35)
Specific appetite, energetic and metabolomics responses to fat overfeeding in resistant-to-bodyweight-gain constitutional thinness (2014) (35)
Gastrointestinal peptides and the adaptation to extrauterine nutrition. (1985) (35)
Gut hormone responses in the irritable bowel syndrome. (1981) (35)
D cell pathology in duodenal ulcers and achlorhydria. (1978) (35)
The importance of cholinergic tone in the release of pancreatic polypeptide by gut hormones in man. (1979) (35)
The peripheral substance P-ergic system (1981) (35)
Effects of Neurokinin B Administration on Reproductive Hormone Secretion in Healthy Men and Women (2013) (35)
Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes (2007) (35)
Hypophysiotropic Gonadotropin-Releasing Hormone Projections Are Exposed to Dense Plexuses of Kisspeptin, Neurokinin B and Substance P Immunoreactive Fibers in the Human: A Study on Tissues from Postmenopausal Women (2014) (35)
A role for GLP-1(7-36)NH2 in the central control of feeding behaviour (1993) (35)
Effects of vasoactive intestinal peptide on resting and pentagastrin-stimulated lower esophageal sphincter pressure. (1978) (35)
The effects of anabolic steroids on growth, body composition, and metabolism in boys with chronic renal failure on regular hemodialysis. (1980) (35)
The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients. (2006) (35)
Starvation, Leptin and Epithelial Cell Proliferation in the Gastrointestinal Tract of the Mouse (2000) (34)
CAN INHIBITION OF HORMONE SECRETION BE ASSOCIATED WITH ENDOCRINE TUMOUR SHRINKAGE? (1983) (34)
Role of neuromedin B in the control of the release of thyrotropin in the rat. (1989) (34)
Localisation of endothelin like immunoreactivity in adult and developing human gut. (1992) (34)
The purification and sequence analysis of an avian neuromedin U (1992) (34)
Role of gut hormones in obesity. (2008) (34)
Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript. (2012) (34)
A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells (2017) (34)
ACTH, GLUCAGON AND GASTRIN PRODUCTION BY A PANCREATIC ISLET CELL CARCINOMA AND ITS TREATMENT (1973) (34)
The effects of kisspeptin-54 on blood pressure in humans and plasma kisspeptin concentrations in hypertensive diseases of pregnancy. (2010) (34)
Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy. (2008) (34)
Growth hormone secretion dynamics in a patient with ectopic growth hormone-releasing factor production. (1985) (34)
Allosteric Optical Control of a Class B G‐Protein‐Coupled Receptor (2016) (34)
Presence of neuropeptide Y and its messenger ribonucleic acid in human islets: evidence for a possible paracrine role. (1996) (33)
Gut hormones in acute diarrhoea. (1983) (33)
Vasoactive intestinal polypeptide in relation to penile erection in the cat evoked by pelvic and hypogastric nerve stimulation. (1987) (33)
Peptidergic innervation of the gastrointestinal tract. (1978) (33)
Orexins/hypocretins: waking up the scientific world (2001) (33)
Investigating the KNDy Hypothesis in Humans by Coadministration of Kisspeptin, Neurokinin B, and Naltrexone in Men (2016) (33)
Elevated Plasma Peptide YY in Human Neonates and Infants (1986) (33)
Effects of tactile and electrical stimuli upon release of vasoactive intestinal polypeptide in the mammalian penis. (1984) (33)
Neural vasodilator control in the rectum of the cat and its possible mediation by vasoactive intestinal polypeptide. (1983) (33)
Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420. (2012) (33)
Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. (2005) (33)
Evidence for a Stimulatory Action of Melanin‐Concentrating Hormone on Luteinising Hormone Release Involving MCH1 and Melanocortin‐5 Receptors (2006) (33)
Oxyntomodulin analogue increases energy expenditure via the glucagon receptor (2018) (33)
Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma. (1974) (33)
Isolation, Structural Characterization, and Bioactivity of a Novel Neuromedin U Analog from the Defensive Skin Secretion of the Australasian Tree Frog, Litoria caerulea * 210 (2000) (33)
Endothelin in human brain and pituitary gland: comparison with rat. (1991) (33)
New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides (1991) (33)
DEVELOPMENTAL ASPECTS OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) AND ITS POSSIBLE ROLE IN THE ENTEROINSULAR AXIS IN NEONATES (1980) (33)
Signalling, trafficking and glucoregulatory properties of glucagon‐like peptide‐1 receptor agonists exendin‐4 and lixisenatide (2019) (33)
Relaxin-3 stimulates the neuro-endocrine stress axis via corticotrophin-releasing hormone. (2014) (33)
Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen. (1989) (32)
Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin. (1990) (32)
Translational studies on PYY as a novel target in obesity. (2011) (32)
Gut hormones and appetite control. (2009) (32)
Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. (2006) (32)
Galanin and vasoactive intestinal polypeptide are colocalised with classical pituitary hormones and show plasticity of expression (2004) (32)
Twice-Daily Subcutaneous Injection of Kisspeptin-54 Does Not Abolish Menstrual Cyclicity in Healthy Female Volunteers (2013) (32)
Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin. (1978) (32)
Chapter 2 – Central effects of neuropeptide Y with emphasis on its role in obesity and diabetes (1997) (32)
Gut hormones as peripheral anti obesity targets. (2004) (32)
Release of vasodilator, but not vasoconstrictor, neuropeptides and of enteroglucagon by intestinal ischaemia/reperfusion in the rat. (1994) (32)
Expression of the atrial natriuretic peptide gene in the cardiac muscle of rat extrapulmonary and intrapulmonary veins. (1988) (32)
Comparison of effects of ingested mediumand long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptides (1987) (32)
Spontaneous proliferative lesions of the adrenal medulla in aging Long-Evans rats. Comparison to PC12 cells, small granule-containing cells, and human adrenal medullary hyperplasia. (1985) (31)
Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations. (2001) (31)
Potent Prearranged Positive Allosteric Modulators of the Glucagon‐like Peptide‐1 Receptor (2017) (31)
l-cysteine suppresses ghrelin and reduces appetite in rodents and humans (2014) (31)
Gastrointestinal hormones and their role in obesity (2016) (31)
The Temporal Sequence of Gut Peptide–CNS Interactions Tracked In Vivo by Magnetic Resonance Imaging (2007) (31)
Glucokinase activity in the arcuate nucleus regulates glucose intake. (2015) (31)
Airway endothelin levels in asthma: influence of endobronchial allergen challenge and maintenance corticosteroid therapy. (1997) (31)
Vasoactive intestinal peptide, but not pituitary adenylate cyclase-activating peptide, modulates the responsiveness of the gonadotroph to LHRH in man. (1993) (31)
IMPORTANCE OF PITUITARY HORMONES IN ÆTIOLOGY OF DIABETIC KETOACIDOSIS (1978) (31)
Peripheral localization of regulatory peptides as a clue to their function. (1980) (31)
Guar in NIDD: Effect of different modes of administration on plasma glucose and insulin responses to a starch meal (1986) (31)
Cellular origin of human pancreatic polypeptide (HPP) in endocrine tumours of the pancreas (1976) (31)
Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. (1983) (31)
Regulatory peptides in the respiratory tract of Macaca fascicularis. (1987) (31)
Comparison of the effects of transforming growth factor alpha and epidermal growth factor on gastrointestinal proliferation and hormone release. (1996) (31)
Cloning, characterization, and sequence of a porcine cDNA encoding a secreted neuronal and endocrine protein. (1988) (31)
FETAL DISTRESS, MECONIUM, AND MOTILIN (1979) (31)
The APUD cells of the alimentary tract in health and disease. (1974) (31)
EFFECTIVENESS OF SMS 201-995, A SYNTHETIC, LONG-ACTING SOMATOSTATIN ANALOGUE, IN TREATMENT OF QUININE-INDUCED HYPERINSULINAEMIA (1986) (31)
Characterization of complementary DNA encoding the rat neuromedin U precursor. (1992) (30)
Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors (2020) (30)
Metabolic and endocrine events at the time of the first feed of human milk in preterm and term infants (1979) (30)
Metabolic and endocrine events at the time of the first feed of human milk in preterm and term infants. (1978) (30)
Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factor. (2005) (30)
Transfection with SV40 gene of human pancreatic endocrine cells. (1991) (30)
The distribution of melanin-concentrating hormone-like immunoreactivity in the central nervous system of rat, guinea-pig, pig and man (1988) (30)
Stimulation of DNA synthesis in cultured small intestine by partially purified enteroglucagon (1982) (30)
The neuropeptide Y-immunoreactive neuronal system: discovery, anatomy and involvement in neurodegenerative disease. (1986) (30)
Interactions between the melanocortin system and the hypothalamo–pituitary–thyroid axis (2006) (30)
Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes (1989) (30)
Gut and Brain - Endocrine Connections (1980) (30)
Pancreatic and gastrointestinal hormones in chronic pancreatitis. (1982) (30)
Amylin in bone conservation current evidence and hypothetical Considerations (1993) (29)
Regulatory peptides of the gastrointestinal and respiratory tracts. (1986) (29)
The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity (2005) (29)
Novel peptide pancreastatin: Its occurrence and codistribution with chromogranin a in the central nervous system of the pig (1989) (29)
Octadecaneuropeptide, benzodiazepine ligand, -like immunoreactivity in rat central nervous system, plasma and peripheral tissues (1986) (29)
Modulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functions (2018) (29)
Insights into the role of neuronal glucokinase (2016) (29)
Presence of immunoreactive endothelin in human milk (1990) (29)
Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man (1990) (29)
Dose-response comparisons of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide (GRP) (1983) (29)
Development of a Rapid and Efficient Magnetic Resonance Imaging Technique for Analysis of Body Fat Distribution (1996) (29)
Changes in vascular resistance in the feline urinary bladder in response to bladder filling. (1985) (29)
A VIP/PHI-containing pathway links urinary bladder and sacral spinal cord (1986) (29)
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics. (1980) (29)
Appetite control and reproduction: leptin and beyond. (2002) (29)
Effect of ketoconazole on adrenocorticotrophic hormone secretion in vitro and in vivo. (1986) (29)
Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome. (1978) (28)
Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines. (1995) (28)
Exendin‐4 treatment enhances L‐DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6‐hydoxydopamine lesioned rat (2012) (28)
Nonpeptidic glucagon-like peptide 1 receptor agonists: A magic bullet for diabetes? (2007) (28)
Hypotrypsinaemia in diabetes mellitus. (1979) (28)
The effect of slow spaced eating on hunger and satiety in overweight and obese patients with type 2 diabetes mellitus (2014) (28)
Comparison of effects of neurotensin and fat on pancreatic stimulation in dogs. (1983) (28)
Acute and chronic effects of kisspeptin‐54 administration on GH, prolactin and TSH secretion in healthy women (2014) (28)
The influence of peptide context on signalling and trafficking of glucagon-like peptide-1 receptor biased agonists (2020) (28)
IS GLUCAGON IMPORTANT IN STABLE INSULIN-DEPENDENT DIABETICS? (1975) (28)
Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. (1980) (28)
Evidence for neuromedin-B synthesis in the rat anterior pituitary gland. (1992) (28)
Acrolein depletes the neuropeptides CGRP and substance P in sensory nerves in rat respiratory tract. (1990) (28)
Impact of Duodenal-Jejunal Exclusion on Satiety Hormones (2016) (27)
Release of motilin in man. (1976) (27)
RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling (2017) (27)
Pancreatic endocrine responses to stimulation of the peripheral ends of the splanchnic nerves in the conscious adrenalectomized calf. (1980) (27)
Adult Cystic stic Fibrosis: Postprandial Response of Gut Regulatory Peptides (1983) (27)
Subcutaneous infusion of kisspeptin‐54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels (2015) (27)
Appetite and hedonism: gut hormones and the brain. (2010) (27)
Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut. (1991) (27)
Central glucagon-like peptide-I in the control of feeding. (1996) (27)
Response of plasma pancreatic and gastrointestinal hormones and growth hormone to oral and intravenous glucose and insulin hypoglycaemia in Chagas's disease. (1980) (27)
Neuroendocrine control of food intake (2005) (27)
Hypothalamic peptides as drug targets for obesity. (2001) (27)
Transgenic over-expression of galanin in injured primary sensory neurons (2002) (27)
The motor effect of neuromedin U on rat stomach in vitro. (1991) (27)
Protein PYY and its role in metabolism. (2014) (27)
Recent progress in PYY research—An update report for 8th NPY meeting (2007) (26)
Motilin cells investigated by the use of region-specific antisera (1981) (26)
Gut-hormone profile in totally pancreatectomised patients. (1981) (26)
Neuropeptides and 5-HT immunoreactivity in the gastric nerves of the dogfish (Scyliorhinus stellaris) (1985) (26)
Bombesin and calcitonin secretion by pulmonary carcinoma is modulated by cholinergic receptors. (1983) (26)
Combination of Peptide YY3–36 with GLP-17–36 amide Causes an Increase in First-Phase Insulin Secretion after IV Glucose (2014) (26)
Neuropeptides of the gut: A newly discovered major control system (1979) (26)
Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones. (1985) (26)
Localization of S-100 protein in Müller cells of the retina--1. Light microscopical immunocytochemistry. (1983) (26)
The effect of 6-hydroxydopamine, reserpine and cold stress on the neuropeptide Y content of the rat central nervous system (1986) (26)
VIP in the rat brain: Evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis (1980) (26)
Effects of Melanocortin Receptor Ligands on Thyrotropin‐Releasing Hormone Release: Evidence for the Differential Roles of Melanocortin 3 and 4 Receptors (2002) (26)
Increased Energy Expenditure in Gastric Bypass Rats Is Not Caused by Activated Brown Adipose Tissue (2012) (25)
Hormonal and metabolic rhythms in Cushing's syndrome. (1980) (25)
PHI-like immunoreactivity co-locates with the VIP-containing system in human lumbosacral spinal cord (1984) (25)
Gut hormones and the first meals. (1981) (25)
Effects of decapeptide of mammalian bombesin and neuromedin B on pancreatic exocrine secretion in the rat. (1986) (25)
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays (2012) (25)
Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man (2005) (25)
Oxyntomodulin : a novel potential treatment for obesity. (2006) (25)
Plasma enteroglucagon, gastrin and peptide YY in conventional and germ-free rats refed with a fibre-free or fibre-supplemented diet. (1989) (25)
PEPTIDERGIC VERSUS PURINERGIC (1978) (25)
Distribution and developmental pattern of neuromedin U expression in the rat gastrointestinal tract. (1994) (25)
The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat (1993) (25)
Characterization and distribution of prolactin releasing peptide (PrRP) binding sites in the rat – evidence for a novel binding site subtype in cardiac and skeletal muscle (2000) (25)
Effect of vagotomy on secretin release in man. (1975) (25)
Microinjection of Galanin‐Like Peptide into the Medial Preoptic Area Stimulates Food Intake in Adult Male Rats (2006) (25)
Gut Hormones as Potential New Targets for Appetite Regulation and the Treatment of Obesity (2012) (25)
Kisspeptin Expression in the Human Infundibular Nucleus in Relation to Sex, Gender Identity, and Sexual Orientation. (2016) (25)
The mechanism of action for oxyntomodulin in the regulation of obesity. (2010) (25)
Neuroendocrine responses to stimulation of the splanchnic nerves in bursts in the conscious adrenalectomized calf. (1984) (25)
Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake (2011) (25)
The presence of islet amyloid polypeptide/calcitonin gene-related peptide/salmon calcitonin binding sites in the rat nucleus accumbens. (1994) (25)
Neuropeptide Y (NPY)-containing nerves in mammalian ureter. (1990) (25)
Disconnect between signalling potency and in vivo efficacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonists (2019) (24)
Bombesin-like immunoreactivity in female rat genito-urinary tract (1985) (24)
The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system. (1988) (24)
Effect of motilin on the gastric emptying of glucose and fat in humans. (1981) (24)
Pleural involvement in the carcinoid syndrome. (1993) (24)
Role of orexins in sleep and arousal mechanisms (2000) (24)
VASOACTIVE INTESTINAL POLYPEPTIDE IN THE PITUITARY PARS NERVOSA (1979) (24)
The effects of pancreatic polypeptide on locomotor activity and food intake in mice (2008) (23)
Immunocytochemistry of Regulatory Peptides (1983) (23)
Lack of effect of pancreatic polypeptide in the rate of gastric emptying and gut hormone release during breakfast. (1981) (23)
5 The neuroendocrine design of the gut (1979) (23)
The relationship of the renin-angiotensin-aldosterone system to atrial natriuretic peptide and the natriuresis of volume expansion in diabetics with and without proteinuria. (1988) (23)
The gut hormone profile of fulminant hepatic failure. (1981) (23)
Bombesin-like immunoreactivity in the avian gut and its localisation to a distinct cell type (1979) (23)
Postprandial ghrelin suppression is exaggerated following major surgery; implications for nutritional recovery (2007) (23)
Changes in circulating gut hormones in the horse during long distance exercise. (1982) (23)
Pancreatic endocrine responses to exogenous neurotensin in the conscious calf. (1981) (23)
The differential distribution of vasoactive intestinal polypeptide in the normal human female genital tract (2004) (23)
Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system. (1984) (23)
A role for metalloendopeptidases in the breakdown of the gut hormone, PYY 3-36. (2011) (23)
Gastrin-releasing peptide-like immunoreactivity in medullary thyroid carcinoma. (1985) (23)
Diabetes and rhabdomyolysis. A rare complication of a common disease. (1993) (23)
Mapping, quantitative distribution and origin of substance P- and VIP-containing nerves in the Uvea of guinea pig eye (2004) (23)
PLASMA SECRETIN IN NEONATES (1980) (23)
Peptide YY3‐36 and Pancreatic Polypeptide Differentially Regulate Hypothalamic Neuronal Activity in Mice In Vivo as Measured by Manganese‐Enhanced Magnetic Resonance Imaging (2011) (23)
Galanin abolishes the inhibitory effect of cholinergic blockade on growth hormone-releasing hormone-induced secretion of growth hormone in man. (1988) (23)
The role of the autonomic nervous system in the control of pancreatic endocrine responses to milk ingestion in the calf. (1978) (22)
How glucagon-like is glucagon-like peptide-1? (1984) (22)
Gut–brain cross-talk in appetite regulation (2010) (22)
Proceedings: Radioimmunoassay of a new gut hormone-human pancreatic polypeptide. (1976) (22)
Colocalization of Cocaine- and Amphetamine-Regulated Transcript with Kisspeptin and Neurokinin B in the Human Infundibular Region (2014) (22)
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells (2020) (22)
Hypergastrinaemia of sheep infected with Haemonchus contortus. (1988) (22)
Impaired circulating glucagon‐like peptide‐1 response to oral glucose in women with previous gestational diabetes (2005) (22)
Characterization of a novel prepro VIP derived peptide. (1986) (21)
Bombesin production by human small cell carcinoma of the lung (1982) (21)
Bladder vasodilatation and release of vasoactive intestinal polypeptide from the urinary bladder of the cat in response to pelvic nerve stimulation. (1987) (21)
Hypersecretion of glucagon and gastrin in severely burnt patients. (1975) (21)
Age-dependent elevations in plasma kisspeptin are observed in boys and girls when compared with adults (2014) (21)
Studies on intracavernosal VIP levels during pharmacologically induced penile erections. (1987) (21)
Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum. (1984) (21)
Neuropeptides in the brain (1985) (21)
Accurate Measurement of Body Weight and Food Intake in Environmentally Enriched Male Wistar Rats (2011) (21)
Effect of reserpine, phenoxybenzamine and cold stress on the neuropeptide Y content of the rat peripheral nervous system (1986) (21)
Feeding premature infants with human milk or preterm milk formula. Effects on postnatal growth and on circulating concentrations of intermediary metabolites, amino acids, and regulatory peptides. (1985) (21)
Extracellular pH monitoring for use in closed-loop vagus nerve stimulation (2018) (21)
Does Enteroglucagon Play a Trophic Role in Intestinal Adaptation (1976) (21)
Studies on the interdigestive (migrating) motor complex in man (1978) (21)
Peptide-immunoreactive nerves in the mammalian female genital tract (1984) (21)
Ontogeny of PHI in the rat brain (1983) (21)
Effect of single dose of omeprazole on the gastrointestinal peptide response to food. (1984) (21)
Ghrelin and peptide YY (PYY) profiles in gastrointestinal tissues and the circulation of the rat during pregnancy and lactation (2009) (21)
CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons (2020) (21)
Calcitonin gene-related peptide (CGRP)-immunoreactive sensory and motor nerves of the mammalian palate (2004) (21)
THE EFFECT OF FEEDS OF DIFFERING COMPOSITION ON ENTERO‐INSULAR HORMONE SECRETION IN THE FIRST HOURS OF LIFE IN HUMAN NEONATES (1979) (21)
Effects of α‐Glucosidase Inhibition and Viscous Fibre on Diabetic Control and Postprandial Gut Hormone Responses (1990) (21)
Gastrin, antral g cells, and gastric acid in secretagogue-induced and antihistamine-inhibited duodenal ulcers. (1977) (21)
Adrenal and pancreatic endocrine responses to hypoxia in the conscious calf. (1976) (21)
Central and peripheral administration of human relaxin‐2 to adult male rats inhibits food intake (2010) (21)
THE EFFECT OF THE INTESTINAL POLYPEPTIDES, IRP AND GIP, ON INSULIN|RELEASE AND GLUCOSE TOLERANCE IN THE BABOON (1974) (20)
Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay (1989) (20)
Role of Central Nervous System and Ovarian Insulin Receptor Substrate 2 Signaling in Female Reproductive Function in the Mouse1 (2007) (20)
Presence, distribution, and pharmacological effects of neuropeptide Y in mammalian gastrointestinal tract (1987) (20)
Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine. (1981) (20)
Gut hormone secreting tumours. (1983) (20)
Relaxin‐3 and Its Role in Neuroendocrine Function (2009) (20)
Is peptide YY trophic to the intestinal epithelium of parenterally fed rats? (1990) (20)
Adult cystic fibrosis: postprandial response of gut regulatory peptides. (1983) (20)
Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides (2005) (20)
Anin vivo13C magnetic resonance spectroscopic study of the relationship between diet and adipose tissue composition (1996) (20)
Proceedings: Studies on gastric D cell pathology. (1976) (20)
Expression of a novel receptor for the calcitonin peptide family and a salmon calcitonin-like peptide in the alpha-thyrotropin thyrotroph cell line. (1995) (20)
Progress report. Radioimmunoassay of intestinal hormones. (1974) (20)
Neuropep tides synthesised in the anterior pituitary: possible paracrine role (1991) (20)
Changes in glucagon level associated with anxiety or stress (1972) (20)
Neuropeptide Y (NPY)-like immunoreactive amacrine cells in retinas of frog and goldfish (2004) (20)
Galanin in the normal human pituitary and brain and in pituitary adenomas. (1991) (20)
Somatostatin analogue treatment for malignant hypercalcaemia. (1990) (20)
Peptide-containing innervation of the human intestinal mucosa (1982) (20)
CORTICOTROPHIN RELEASING FACTOR: EFFECTS ON CIRCULATING GUT AND PANCREATIC PEPTIDES IN MAN (1984) (20)
Occurrence and distribution of regulatory peptides in the respiratory tract. (1985) (20)
Neuropeptide Y in renovascular models of hypertension in the rat. (1986) (20)
γ‐MSH increases intracellular cAMP accumulation and GnRH release in vitro and LH release in vivo (2003) (19)
Intussusception in the Syrian Golden hamster (1990) (19)
An endocrine tumour in kidney affecting small bowel structure, motility, and function. (1970) (19)
Regulation of anterior pituitary galanin and vasoactive intestinal peptide by oestrogen and prolactin status. (1997) (19)
Alpha atrial natriuretic peptide concentrations in plasma in children with congenital heart and pulmonary diseases. (1985) (19)
Gut hormones and obesity: physiology and therapies. (2013) (19)
Effect of secretin on plasma motilin in man. (1977) (19)
Distribution and localization of regulatory peptides. (1985) (19)
Gastric acid regulates the release of plasma secretin in man (1982) (19)
Characterization of the rat uterine neuromedin U receptor. (1993) (19)
Gastrointestinal regulatory peptide storage granule abnormalities in jejunal mucosal diseases. (1984) (19)
Hypothalamic injection of oxyntomodulin suppresses circulating ghrelin-like immunoreactivity. (2009) (19)
Increase of substance P-like immunoreactivity in the peripheral nerve of the axolotl after injury (1987) (19)
The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas (2004) (19)
The differential effects of galanin-(1-30) and -(3-30) on anterior pituitary hormone secretion in vivo in humans. (2000) (19)
Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects (2014) (19)
Co‐administration of SR141716 with peptide YY3–36 or oxyntomodulin has additive effects on food intake in mice (2006) (19)
Somatostatin inhibits neutrophil elastase release in vitro (1990) (19)
EFFECT OF NEUROMEDIN B ON GUT HORMONE SECRETION IN THE RAT (1984) (18)
Neuropeptides in neurological tumours (2004) (18)
Naloxone-induced anorexia increases neuropeptide Y concentrations in the dorsomedial hypothalamus: Evidence for neuropeptide Y-opioid interactions in the control of food intake (1994) (18)
Cerebral activation by fasting induces lactate accumulation in the hypothalamus (2009) (18)
The effect of changes in adrenal blood flow on adrenal cortical responses to adrenocorticotrophin in conscious calves. (1990) (18)
Ileal enteroglucagon cells after ileal-duodenal transposition in the rat. (1983) (18)
Pancreatic polypeptide and calcitonin secretion from a pancreatic tumour-clinical improvement after hepatic artery embolization. (1983) (18)
The role of the parasympathetic system in the control of insulin release in the conscious calf. (1981) (18)
Kisspeptin is released from human prostate cancer cell lines but plasma kisspeptin is not elevated in patients with prostate cancer. (2010) (18)
Resolution of acromegaly after removal of a bronchial carcinoid shown to secrete growth hormone releasing factor. (1987) (18)
Peptidergic nerves. (1982) (18)
Pattern of cell proliferation and enteroglucagon response following small bowel resection in the rat. (1984) (18)
Hormonal and metabolic responses to cholecystectomy: comparison of extradural somatostatin and diamorphine. (1989) (18)
Effects of prepro-vasoactive intestinal peptide-derived peptides on the murine immune response (1990) (18)
Development of a high-throughput UHPLC-MS/MS (SRM) method for the quantitation of endogenous glucagon from human plasma. (2014) (18)
Regional distribution of a novel pituitary protein (7B2) in the rat spinal cord: Effect of neonatal capsaicin treatment and thoracic cord transection (1985) (18)
Effect of 6-hydroxydopamine on neuropeptides in the rat female genitourinary tract (1985) (18)
Pancreatic endocrine responses to substance P and calcitonin gene-related peptide in conscious calves. (1994) (18)
The effects of glutamate receptor agonists and antagonists on mouse hypothalamic and hippocampal neuronal activity shown through manganese enhanced MRI (2012) (18)
Glucose transporter expression and glucose utilization in skeletal muscle and brown adipose tissue during starvation and re-feeding. (1992) (18)
Differential neuropeptide expression after visceral and somatic nerve injury in the cat and rat (1991) (18)
Iatrogenic hyperinsulinism at birth. (1980) (18)
Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling (2021) (18)
Fermentable dietary fibre, intestinal microflora and plasma hormones in the rat. (1997) (17)
Cholecystokinin abnormalities in coeliac disease (1978) (17)
Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary. (1992) (17)
Abnormalities of the somatotrophic axis in the obese agouti mouse (2006) (17)
Rat anterior pituitary neuropeptides following chronic prolactin manipulation: a combined radioimmunoassay and mRNA study. (1991) (17)
Cardiovascular and hormonal responses to a meal in hypertrophic cardiomyopathy: A comparison of patients with and without postprandial exacerbation of symptoms (1996) (17)
Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma (1981) (17)
VASOACTIVE INTESTINAL PEPTIDE IN SHOCK AND HEART FAILURE (1983) (17)
Recent physiological studies of the alimentary autonomic innervation. (1982) (17)
Elevation of a novel pituitary protein (7B2) in the plasma in small cell carcinoma of the lung. (1989) (17)
The distribution of galanin message-associated peptide-like immunoreactivity in the pig (1990) (17)
Gut Hormone Responses to Feeding in Healthy Pony Foals Aged 0 to 7 Days (1995) (17)
Hormonal abnormalities of the pancreas and gut in cystic fibrosis. (1980) (17)
Radioimmunoassay of human peripheral plasma secretin. (1973) (17)
Lack of hepatic inactivation of canine vasoactive intestinal peptide. (1977) (17)
Effect of ACTH on VIP and galanin release from the pituitary. (1990) (17)
The distribution and origin of VIP in the spinal cord of six mammalian species (1983) (17)
Thyroid Hormone Receptor Beta in the Ventromedial Hypothalamus Is Essential for the Physiological Regulation of Food Intake and Body Weight (2017) (17)
Are all fats created equal? (2006) (17)
Analogs of pancreatic polypeptide and peptide YY with a locked PP-fold structure are biologically active (2013) (17)
Serum trypsin concentration and pancreatic trypsin secretion in insulin-dependent diabetes mellitus. (1980) (17)
Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study. (1988) (17)
FLUMAZENIL AND BENZODIAZEPINE WITHDRAWAL (1987) (17)
Visualisation of messenger RNA directing peptide synthesis by in situ hybridisation using a novel single-stranded cDNA probe potential for the investigation of gene expression and endocrine cell activity (2004) (17)
Failure of the human placenta to transfer pancreatic glucagon. (1972) (17)
Co-secretion of calcitonin gene-related peptide, gastrin-releasing peptide and ACTH by a carcinoid tumour metastasizing to the cerebellum. (1987) (17)
Nippostrongylus brasiliensis: changes in plasma levels of gastrointestinal hormones in the infected rat. (1985) (17)
Circulating Pancreatic Polypeptide Concentrations Predict Visceral and Liver Fat Content (2014) (17)
Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide. (1992) (17)
Differential response of neuropeptide Y, substance P and vasoactive intestinal polypeptide in the rat anterior pituitary gland to alterations in thyroid hormone status. (1994) (17)
Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. (1992) (16)
The origin of VIP-containing nerves in the urinary bladder of rat (1984) (16)
Identification of bombesin-immunoreactive cells in rat, human, and other mammalian pituitaries, their ontogeny and the effect of endocrine manipulations in the rat. (1992) (16)
Dexfenfluramine treatment and hypothalamic neuropeptides in diet-induced obesity in rats (1992) (16)
Vipoma: localisation by percutaneous transhepatic portal venous sampling. (1978) (16)
Vasoactive intestinal peptide: Expression of the prohormone in bacterial cells (1985) (16)
Neuropeptides in salivary glands. (1980) (16)
Prostatic cancer: treatment with long-acting LHRH analogue. (1983) (16)
The Distribution and Biological Effects of Neuromedins B and U (1988) (16)
A 67 kDa protein mediates pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated insulin secretion in a hamster clonal beta-cell line. (1995) (16)
Absence of Mutations in the Gsα and Gi2α Genes in Sporadic Parathyroid Adenomas and Insulinomas (1994) (16)
Production of "ectopic" vasoactive intestinal peptide-like immunoreactivity in normal human chromaffin cell cultures. (1985) (16)
Presence of immunoreactive endothelin in human saliva and rat parotid gland (1991) (16)
Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse (2004) (16)
Peptide histidine isoleucine: a secretagogue in human jejunum. (1984) (16)
Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors. (1993) (16)
Fasting plasma peptide-YY concentrations are elevated but do not rise postprandially in type 2 diabetes (2006) (16)
Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion. (1987) (16)
Gut hormone profile in pancreatic disease (1978) (16)
Gonadal steroids regulate rat anterior pituitary levels of TSH-releasing hormone- and pyroglutamyl-glutamyl-proline amide-like immunoreactivity. (1995) (16)
No Guts, No Loss: Toward the Ideal Treatment for Obesity in the Twenty-First Century (2018) (16)
Neuromedin U-like immunoreactivity in the thyroid gland of the rat (1990) (16)
Hormonal responses to cardiac surgery: effects of sufentanil, somatostatin and ganglion block. (1990) (16)
Kisspeptins and the control of gonadotropin secretion in humans (2009) (16)
Studies of the importance of the pattern of autonomic stimulation in relation to alimentary effectors. (1984) (16)
Glibenclamide but not other sulphonylureas stimulates release of neuropeptide Y from perifused rat islets and hamster insulinoma cells. (2000) (16)
Endothelin immunoreactivity in mice with gram-negative bacteraemia: relationship to tumour necrosis factor-alpha. (1990) (16)
Glucagon-like peptide-1 does not have a role in hepatic carbohydrate metabolism (1985) (16)
Campylobacter pylori, duodenal ulcer disease, and gastrin. (1989) (16)
Measurement of cholecystokinin octapeptide using a new specific radioimmunoassay (1985) (16)
Secretion of epidermal growth factor in parotid saliva in diabetic patients: role of autonomic innervation. (1990) (16)
A novel pituitary protein (7B2)-like immunoreactivity is secreted by a rat phaeochromocytoma cell line (PC12). (1986) (16)
Depletion of islet amyloid polypeptide in the spontaneously diabetic (BB) Wistar rat. (1991) (16)
Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia (1978) (16)
Two patients with pancreatic apudomas secreting neurotensin and VIP. (1983) (15)
Glucagonoma Syndrome in a Young Man (1976) (15)
In vitro degradation of neurotensin in human plasma (1986) (15)
Effect of bovine pancreatic polypeptide on gastric acid and pepsin output in man. (1978) (15)
Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells (1991) (15)
Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones (2015) (15)
Normal Distribution and Postprandial Release of Gut Hormones (1975) (15)
Localization of Calcitonin Gene—Related Peptide in the Rat and Human Pituitary Gland Using Immunocytochemistry and in Situ Hybridization (1992) (15)
L‐Arginine Increases Postprandial Circulating GLP‐1 and PYY Levels in Humans (2018) (15)
Gut hormones and gastrointestinal motility in children with cystic fibrosis (1992) (15)
Failure to detect plasma neuropeptide release during trigeminal thermocoagulation. (1987) (15)
Effects of VIP and related peptides and Gila monster venom on genitourinary smooth muscle. (1986) (15)
The influence of adrenal hormone status on neuroendocrine peptides in the rat anterior pituitary gland. (1990) (15)
Effects of carbohydrate type on postprandial blood pressure, neuroendocrine and gastrointestinal hormone changes in the elderly (1991) (15)
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus (2017) (15)
Investigation of the effects of antisense oligodeoxynucleotides to islet amyloid polypeptide mRNA on insulin release, content and expression. (1996) (15)
Studies of the Entero‐insular Axis Following Pancreas Transplantation in Man: Neural or Hormonal Control? (1989) (15)
Studies of vasoactive intestinal polypeptide expression in injured peripheral neurons using capsaicin, sympathectomy and mf mutant rats (1990) (15)
Intestinal Adaptation in Hypothermic Hyperphagia (1975) (15)
The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPY (2004) (15)
Immunocytochemical Localization of Neuropeptide Y-Like Immunoreactivity in Extrinsic Noradrenergic and Intrinsic Gut Neurons (1984) (15)
GIP and insulin release in relation to gastric emptying of a mixed meal in man (1989) (15)
Gastroduodenal mucosal hormone content in duodenal ulcer disease. (1985) (15)
Neuropeptides are selectivemarkers of spinal cord autonomic pathways (1984) (15)
Motilin secretion and the migrating myoelectric complex in the pig. (1987) (14)
Combined use of in situ hybridisation and immunocytochemistry for the investigation of prolactin gene expression in immature, pubertal, pregnant, lactating and ovariectomised rats (2004) (14)
Ghrelin does not orchestrate the metabolic changes seen in fasting but has significant effects on lipid mobilisation and substrate utilisation. (2011) (14)
Plasma kisspeptin: a potential biomarker of tumor metastasis in patients with ovarian carcinoma. (2012) (14)
Immunocytochemical evidence for the presence of gamma 1-MSH-like immunoreactivity in pituitary corticotrophs and ACTH-producing tumours. (1983) (14)
Subcellular fractionation studies of human rectal mucosa: localization of the mucosal peptide hormones. (1980) (14)
Clinical evaluation of SMS 201-995 (1987) (14)
Endothelin an endocrine role (1992) (14)
Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons (2018) (14)
Pancreatic neuroendocrine responses to butyrate in conscious sheep. (1985) (14)
Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression. (2015) (14)
Distribution and heterogeneity of immunoreactive cholecystokinin (CCK) in the mucosa of the porcine gastrointestinal tract (1984) (14)
Effect of pancreatic polypeptide on DNA-synthesis in the pancreas (1977) (14)
Glycoprotein hormone alpha-subunit-producing pituitary adenomas in rats treated for one year with calcitonin. (1992) (14)
Grass sickness of horses: changes in the regulatory peptide system of the bowel (1982) (14)
Persistent metabolic abnormalities in diabetes in the absence of glucagon (2004) (14)
Pancreatic endocrine responses to physiological changes in plasma neurotensin concentration in the calf. (1981) (14)
Duodenal perfusion with sodium taurocholate inhibits biliary but not pancreatic secretion in man. (1982) (14)
The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage in mice (2014) (14)
Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin). (1988) (14)
Neuropeptides in the control of the islets of Langerhans. (1983) (14)
A pilot investigation of a behavioral weight control program with mentally retarded adolescents and adults: Effects on weight, fitness, and knowledge of nutritional and behavioral principles. (1984) (14)
Effect of steroids and the estrous cycle on uterine neuromedin U receptor expression (1999) (14)
Effects of keratinocyte growth factor (KGF) on gut growth and repair. (1998) (14)
Oral water causes emptying of the human gallbladder through actions of vagal stimuli rather than motilin. (1985) (14)
Vascular distribution of neuropeptide Y (NPY) and effect on blood pressure. (1984) (14)
PLASMA-SECRETIN DURING FASTING (1978) (13)
Glucagonoma syndrome. (1987) (13)
Radioimmunoassay and intramural distribution of PHI-IR in human intestine (1983) (13)
Serum molecular signatures of weight change during early breast cancer chemotherapy. (2009) (13)
Ventricular and atrial myocytes of newborn rats synthesise and secrete atrial natriuretic peptide in culture: Light-and electron-microscopical localisation and chromatographic examination of stored and secreted molecular forms (2004) (13)
Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery (2007) (13)
TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERON (1987) (13)
Treating the obese diabetic (2013) (13)
Gut hormones and the treatment of disease cachexia (2008) (13)
Hypothalamic neuropeptides and regulation of fat mass in prader-willi syndrome (2003) (13)
Studies on the pathogenesis of the early dumping syndrome induced by intraduodenal instillation of hypertonic glucose. (1989) (13)
Possible evidence for endogenous production of a novel galanin-like peptide. (1997) (13)
VASOACTIVE INTESTINAL PEPTIDE IN CIRRHOSIS (1975) (13)
Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus (2002) (13)
The effect of cholinergic blockade on the growth hormone response to galanin in humans. (1988) (13)
Life threatening thrombocytopenia in sarcoidosis. (1990) (13)
Does the response of the intestinal epithelium to keratinocyte growth factor vary according to the method of administration? (2000) (13)
Endocrine effects of Haemonchus contortus infection in lambs (1985) (13)
The identification of elevated urinary kisspeptin-immunoreactivity during pregnancy (2015) (13)
Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans (1994) (13)
Gut hormone responses in subjects with a permanent ileostomy. (1982) (13)
Gastrointestinal and pancreatic hormones in the human fetus and mother at 18-21 weeks of gestation. (1995) (13)
Delayed postprandial plasma bile acid response in coeliac patients with slow mouth-caecum transit. (1987) (13)
Peptides and obesity: the PYY3–36 story (2004) (13)
Motilin release in the pig. (1978) (12)
Increased ileal proglucagon expression after jejunectomy is not suppressed by inhibition of bowel growth (1996) (12)
Cure of intractable watery diarrhoea by excision of a vipoma (1978) (12)
The effects of IAPP and CGRP on guinea pig tracheal smooth muscle in vitro (1994) (12)
Changes in gut hormones and leptin in military personnel during operational deployment in Afghanistan (2015) (12)
Effects of certain metabolites on pancreatic endocrine responses to gastrin‐releasing peptide in conscious calves. (1984) (12)
Approaches to the pharmacological treatment of obesity (2010) (12)
Molecular forms of motilin in the mammalian and human gut and human plasma. (1981) (12)
Vipoma of the pancreas: observations on the diarhrhea and circulatory disturbances. (1979) (12)
Hormone profile of coeliac disease (1978) (12)
Regulatory peptides in endocrine cells and autonomic nerves: electron immunocytochemistry. (1981) (12)
Effect of modifying the rate of digestion of a food on the blood glucose, amino acid, and endocrine responses in patients with cirrhosis. (1987) (12)
Neurotensin and the dumping syndrome (1978) (12)
Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study (2020) (12)
Effects of bolus doses of fat on small intestinal structure and on release of gastrin, cholecystokinin, peptide tyrosine-tyrosine, and enteroglucagon. (1992) (12)
Increased content of neuropeptide Y in human pheochromocytoma cell cultures. (1985) (12)
Glucagon 1‐21 reduces intestinal epithelial cell proliferation in parenterally fed rats (1991) (12)
Does the arteriovenous fistula in chronic haemodialysis patients stimulate endothelin-1 release? (1992) (12)
Joint contractures and diabetic retinopathy. (1983) (12)
Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition. (1988) (12)
Distribution of vasoactive intestinal polypeptide binding sites in guinea pig genital tissues (1987) (12)
The anterior pituitary content of neuromedin U-like immunoreactivity is altered by thyrotrophin-releasing hormone and thyroid hormone status in the rat. (1989) (12)
Hyponatremia and Ultramarathons (1986) (12)
Diabetes mellitus in idiopathic haemochromatosis. (1978) (12)
First International Cisapride Investigators’ Meeting (1986) (12)
Effect of enprostil on gastric emptying, intestinal transit time and post-prandial release of gastro-intestinal peptides. (1989) (12)
Elevated plasma enteroglucagon alone fails to alter distal colonic carcinogenesis in rats. (1987) (12)
Relation of Fasting Plasma Glucose Concentration to Plasma Insulin and Glucagon Concentrations: Studies in Latent Diabetics and Women Who Have Produced Large-for-dates Babies (1977) (12)
Effects of Amidated Gastrin and Glycine-Extended Gastrin on Cell Proliferation and Crypt Fission in Parenterally and Orally Fed Rats (2002) (12)
Neuromedin B stimulates the hypothalamic–pituitary–gonadal axis in male rats (2011) (12)
Increased substance P in rabbit iris-ciliary bodies following sympathectomy (1982) (11)
Water content, vasoactive intestinal polypeptide and substance P in intact and crushed sciatic nerves of normal and streptozotocin-diabetic rats (1988) (11)
Occurrence, distribution and nature of neuropeptide Y in the rat pancreas (1985) (11)
Results obtained in the treatment of prostate cancer patients with Zoladex. (1985) (11)
Ontogeny of a novel pituitary protein (7B2) in the human fetal intestine (1985) (11)
Effects of acute and chronic ethanol administration on the gastrointestinal hormones gastrin, enteroglucagon, pancreatic glucagon and peptide YY in the rat. (1989) (11)
The effect of pirenzepine on meal-stimulated gastrointestinal hormones. (1980) (11)
Plasma atrial natriuretic factor and graft function in renal transplant recipients. (1989) (11)
Amylin tonally regulates arginine-stimulated insulin secretion in rats (1994) (11)
Distribution and chromatographic characterization of neuromedin B-like immunoreactivity in the human spinal cord (1985) (11)
The Effects of Ciliary Neurotrophic Factor on the Hypothalamo‐Pituitary Gonadal Axis In Vitro in Female Rats (2000) (11)
Gut hormones and the alpha cell. (1976) (11)
Pancreatic polypeptide, motilin and somatostatin levels during interdigestive motility in man (1980) (11)
Degradation Paradigm of the Gut Hormone, Pancreatic Polypeptide, by Hepatic and Renal Peptidases (2017) (11)
Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in anuran intestine (2004) (11)
Reduced NPY Induced Feeding in Diabetic but not Steroid‐Treated Rats: Lack of Evidence for Changes in Receptor Number or Affinity (1996) (11)
Kinetics of regulation of neurotensin content in PC12 cells. (1983) (11)
The effect of somatostatin on pancreatic endocrine responses mediated via the parasympathetic innervation in the conscious calf. (1980) (11)
Vagotomy and the motor response to feeding. (1980) (11)
GIP and insulin responses to oral glucose in coeliac patients before and after treatment. (1981) (11)
Pro-atrial natriuretic peptide (1–98): The circulating cardiodilatin in man (1989) (11)
Combined use of vasopressin and synthetic hypothalamic releasing factors as a new test of anterior pituitary function. (1986) (11)
Leptin fails to blunt the lipopolysaccharide-induced activation of the hypothalamic–pituitary–adrenal axis in rats (2014) (11)
Pancreatic Polypeptide Meal Response May Predict Gastric Band-Induced Weight Loss (2011) (11)
The Ileal Brake—A Compensatory Slowing of Jejunal Transit following Ileal Fat Infusion in Man (1983) (11)
The effects of the 5‐hydroxytryptamine (5HT3) receptor antagonist ICS 205‐930 in the carcinoid syndrome (1988) (11)
Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy (1989) (11)
Proceedings: Secretin pharmacokinetics and plasma levels for half maximum bicarbonate response in man. (1976) (11)
[Behavior of plasma pancreatic polypeptides and motilin in obese patients subjected to biliopancreatic bypass]. (1980) (10)
Kisspeptin: a novel physiological trigger for oocyte maturation in in-vitro fertilisation treatment (2014) (10)
Ghrelin enhances gastric emptying in diabetic gastroparesis (2005) (10)
Atrial natriuretic peptide: physiological release associated with natriuresis during negative pressure breathing in man. (1989) (10)
Cerebellin1 is a novel orexigenic peptide (2010) (10)
Malnutrition after gastric surgery (1985) (10)
The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study (2020) (10)
Gut hormones in fetal distress (1979) (10)
Impaired secretin release in chronic alcoholic dogs. (1978) (10)
Plasma trypsin in the diagnosis of steatorrhoea due to chronic pancreatitis (1978) (10)
VASOACTIVE INTESTINAL PEPTIDE (VIP) IN PRETERM AND TERM NEONATES (1982) (10)
A NOVEL PITUITARY PROTEIN (7B2) IN THE RAT UROGENITAL TRACT (1985) (10)
The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro (1994) (10)
Subcellular fractionation studies of human gastric antrum: localization of the mucosal peptide hormones. (1980) (10)
Effects of pancreatic polypeptide infusion in man (1978) (10)
Combined use of immunocytochemistry and in situ hybridization to study beta thyroid-stimulating hormone gene expression in pituitaries of hypothyroid rats. (1990) (10)
Marked depletion of dorsal spinal cord substance P and calcitonin gene-related peptide with intact skin flare responses in multiple system atrophy. (1988) (10)
Quantification of Rat Kisspeptin Using a Novel Radioimmunoassay (2014) (10)
Colonic inhibition of gastric secretion in man (1981) (10)
Elevated plasma endothelin in diabetes mellitus (1989) (10)
Proceedings: Inhibition of gastrin and gastric acid by growth hormone release inhibiting hormone. (1975) (10)
Reply to letter by Abraira and Lawrence (1983) (10)
Agouti related protein (AgRP) is upregulated in Cushing's syndrome. (2005) (10)
Neuropeptide Y: a putative neurotransmitter (1986) (10)
The lung contents of endothelin are altered by thyroid hormone status in rat (1993) (10)
Gastric regulatory peptides in rats with reduced acid secretion. (1986) (10)
Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose Tolerance (2016) (10)
Binding sites for islet amyloid polypeptide in mammalian lung: species variation and effects on adenylyl cyclase. (1995) (10)
A pancreatic‐polypeptide‐producing tumor of the stomach (1984) (10)
From Gut to Mind—Hormonal Satiety Signals and Anorexia Nervosa (2006) (10)
Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumors. (1993) (10)
The regulatory peptide system of the large bowel in equine grass sickness (1984) (9)
Blood glucose control by direct islet innervation. (1976) (9)
Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking (2021) (9)
Distribution of Fluorescence following Injection of Recombinant Adeno-Associated Virus Encoding Green Fluorescent Protein into the Paraventricular Nucleus (2003) (9)
The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man (2004) (9)
Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal (1985) (9)
Effects of changes in neonatal thyroid status on the development of neuropeptide systems in the rat brain (1983) (9)
Effect of a long-acting analogue of somatostatin, SMS 201-995, on the development of intestinal tumours in azoxymethane-treated rats. (1987) (9)
Slowly digested carbohydrate food improves impaired carbohydrate tolerance in patients with cirrhosis. (1984) (9)
Effect of synthetic human glucose‐dependent insulinotropic polypeptide (hGIP) on the release of insulin in man (1990) (9)
Separation of the gut hormone endocrine-cell storage granules of human jejunum using analytical subcellular fractionation. (1980) (9)
Effect of low dose secretin and caerulein on pure pancreatic bicarbonate secretion and plasma secretin in man. (1979) (9)
Islet amyloid polypeptide The cause of type-2 diabetes? (1991) (9)
Experience with an LHRH analogue in the management of relapsed progressive prostatic cancer. (1984) (9)
Intravenous calcitonin gene-related peptide stimulates net water secretion in rat colonin Vivo (1989) (9)
The distribution of substrate P-like immunoreactive nerves in the guinea-pig heart. (1981) (9)
Release of gastrointestinal hormones following an oral water load (1979) (9)
Gastrin and somatostatin in the rat antrum. The effect of removal of acid-secreting mucosa (1988) (9)
Men at increased risk of coronary heart disease are not different from age- and weight-matched healthy controls in their postprandial triglyceride, nonesterified fatty acid, or incretin responses to sucrose. (2002) (9)
The effects of naloxone and morphine on postprandial gastrointestinal hormone secretion. (1982) (9)
The presence and molecular forms of cardiodilatin immunoreactivity in the human and rat right atrium. (1988) (9)
Role of adrenoceptors in the hypertensive response to feeding in the conscious calf. (1997) (9)
PROGRESS IN GASTROENTEROLOGY THE NEWER GUT HORMONES Cellular sources, physiology, pathology, and clinical aspects (1977) (9)
Does motilin have a role in eliciting the interdigestive migrating motor complex (MMC) in man (1978) (9)
Pancreatic exocrine and endocrine responses in chronic pancreatitis. (1984) (9)
Proceedings: The relationship between gastric emptying rate and plasma enteroglucagon concentration. (1975) (9)
VASOACTIVE INTESTINAL POLYPEPTIDE (1976) (9)
Comparative studies on the release of vasopressin and 7B2 from isolated hypothalami (1990) (9)
7B2, a possible marker for nonfunctioning pancreatic islet cell tumor. (1991) (9)
The Ileal Brake: a Potent Mechanism for Feedback Control of Gastric Emptying and Small Bowel Transit (1984) (9)
Bombesin-like immunoreactivity in the pancreas of man and other mammalian species (1984) (9)
Intramural distribution of immunoreactive vasoactive intestinal polypeptide (VIP), substance P, somatostatin and mammalian bombesin in the oesophago-gastro-pyloric region of the human gut (1989) (9)
The distribution and significance of the VIPergic system in man and other mammals. (1980) (8)
Are hormonal factors responsible for the intestinal and pancreatic hyperplasia of pancreatico-biliary diversion (PBD)? (1982) (8)
Intracellular topography of immunoreactive gastrin demonstrated using electron immunocytochemistry (1983) (8)
Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF (1–44)] in type 2 (non-insulin-dependent) diabetes (1984) (8)
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist (2021) (8)
The preanalytical stability of glucagon as measured by liquid chromatography tandem mass spectrometry and two commercially available immunoassays (2017) (8)
The distribution of GAWK-like immunoreactivity in neuroendocrine cells of the human gut, pancreas, adrenal and pituitary glands and its co-localisation with chromogranin B (2004) (8)
Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage. (2016) (8)
Measurement and characterisation of human cholecystokinin-like immunoreactivity (CCK-LI) in tissues by radioimmunoassay. (1984) (8)
In vitro autoradiographic localisation of regulatory peptide binding sites in guinea-pig uterus (1985) (8)
AN INVESTI CATION OF THE USE OF HIGH‐AND LOW‐PREFERENCE FOOD AS A REINFORCER FOR INCREASED ACTIVITY OFINDIVIDUALSWITH PRADER‐WILLI SYNDROME (2008) (8)
In vivo assessment of metabolic perturbations following alanine and glucagon administration using 31P-MRS in the rat. (1997) (8)
Clinic biopsies in the diagnosis of gut endocrine disorders (1978) (8)
Clinical aspects of gut hormones and neuropeptides. (1982) (8)
Distribution and effect of calcitonin gene-related peptide in the gastrointestinal tract of the guinea-pig (1984) (8)
Novel therapeutic targets for appetite regulation. (2005) (8)
Plasma neurotensin release and gastric emptying in the dumping syndrome. (1983) (8)
Acute effects of central neuropeptide Y injection on glucose metabolism in fasted rats. (1995) (8)
Endogenous acid releases secretin in man. (1977) (8)
Serum leptin and insulin in paediatric end‐stage liver disease and following successful orthotopic liver transplantation (1998) (8)
Plasma glucagon in diabetes resulting from total pancreatectomy [proceedings]. (1976) (8)
Increased neuropeptide Y messenger RNA and decreased neurotensin messenger RNA in the hypothalamus of the obese (ob/ob) mouse (1992) (8)
The presence of neuropeptides in GABAergic and cholinergic rat cerebrocortical synaptosome sub-populations (1992) (8)
Can Bayliss and Starling gut hormones cure a worldwide pandemic? (2014) (8)
Expression of the C-terminal peptide of human pro-bombesin in 361 lung endocrine tumours, a reliable marker and possible prognostic indicator for small cell carcinoma (2004) (8)
Human and porcine immunoreactive gastric inhibitory polypeptides (IR‐GIP) are not identical (1984) (8)
Measurement of VIP and origin of its innervation in the rat urinary bladder (1983) (8)
Pancreatic α cell function in the fetal and newborn pig (1986) (8)
The effect of insulin-induced hypoglycaemia on gastrointestinal motility in man. (1987) (8)
Effects of certain metabolites on pancreatic endocrine responses to stimulation of the vagus nerves in conscious calves. (1985) (8)
Plasma enteroglucagon and CCK levels and cell proliferation in defunctioned small bowel in the rat (1984) (8)
Coeliac sprue: abnormalities of the hormone profile of gastroduodenal mucosa. (1989) (8)
Endogenous motilin and the LES pressure. (1976) (8)
Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study (2020) (7)
Relaxin-3 stimulates the stress axis (2007) (7)
Nesfatin stimulates the hypothalamic-pituitary-gonadal axis in male rats (2011) (7)
Hormonal Interrelations and Their Clinical Significance (1975) (7)
Intramural distribution of regulatory peptides in the human stomach and duodenum. (1987) (7)
Crow's 'Lateralization Hypothesis' for Schizophrenia-Reply (1991) (7)
Hormonal peptides of the gastrointestinal tract (1979) (7)
Comparative distribution of vasoactive intestinal polypeptide (VIP), substance P and PHI in the enteric sphincters of the cat (1984) (7)
Chromatographic characterisation of neurotensin-like immunoreactivity in plasma and tissue extracts from hepatoma patients. (1985) (7)
A case of somatostatinoma: responses to food and SMS 201-995 administration. (1988) (7)
Cellular energy sensor balances the scales (2004) (7)
Influence of Cholecystokinin-8 on Compound Nerve Action Potentials from Ventral Gastric Vagus in Rats (2018) (7)
Acute Rise of Pancreatic Polypeptide after Electroconvulsive Therapy (1982) (7)
7B2, a new protein secreted by human functionless pituitary tumours, in vitro. (1988) (7)
Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man (1987) (7)
The effect of antral distension in healthy subjects on betazole-stimulated gastric acid secretion and the plasma concentration of immunoreactive neurotensin. (1980) (7)
An infected prosthetic hip. Is there a role for prophylactic antibiotics? (1992) (7)
Reduction by Morphine of Human Postprandial Insulin Release is Secondary to Inhibition of Gastrointestinal Motility (1986) (7)
Optische Kontrolle der Insulinsekretion mit einem Inkretinschalter (2015) (7)
Elevated Motilin Levels in Patients Treated with Antidepressant and Neuroleptic Drugs (1982) (7)
The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction (2021) (7)
How appetite is controlled (2002) (7)
Immunoreactive endothelin, endothelin mRNA and endothelin receptors in human brain and pituitary gland (1990) (7)
Jejunal mucosal enzyme activities, regulatory peptides and organelle pathology of the enteropathy of common variable immunodeficiency. (1986) (7)
Hypergastrinaemia in a peptic ulcer patient with antral gastrin cell hyperplasia. (1975) (7)
Fate and effects of the α-glucosidase inhibitor acarbose in humans (1988) (7)
In vitro production and characterisation of low molecular weight forms of calcitonin gene-related peptide immunoreactivity from rat thyroid. (1987) (7)
Opioid peptides do not modulate atrial natriuretic peptide or aldosterone release under basal conditions in man. (1988) (7)
Assessment of neurological injury due to circulatory arrest during profound hypothermia. An experimental study in vertebrates. (1993) (7)
New specific long-acting somatostatin analogues in the treatment of pancreatic endocrine tumours (1978) (7)
Regulatory peptides as therapeutic agents: Somatostatin in UGI bleeding (1981) (7)
Proceedings: Plasma levels of amino acids and glucagon in patients with pancreatic glucagonomas. (1974) (7)
The effect of ovariectomy and oestrogen replacement on the anterior pituitary peptides 7B2 and galanin in the rat (1988) (7)
Paracrine/autocrine control of the islet and the amylin family. (1995) (7)
CORTICOTROPIN-RELEASING FACTOR IN THE ALIMENTARY TRACT (1983) (7)
Neuropeptide Y (NPY) actions on the corticotroph cell of the anterior pituitary gland are not mediated by a direct effect (1998) (7)
Chromatographic analysis of tumour-produced hormones (1978) (7)
Proceedings: The association of a specific skin lesion with islet-cell tumours of the pancreas. (1973) (7)
Increased food intake with oxyntomodulin analogues (2015) (7)
Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years (2019) (7)
Neuropeptide Y in neuroblastoma X glioma hybrid cells. Response to dexamethasone and nerve growth factor. (1983) (7)
Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2 receptor antagonist therapy (2005) (7)
Peptide-l (GLP-1) Releases Thyrotropin (TSH): Characterization of Binding Sites for GLP-1 on c;u-TSH Cells* (1996) (7)
Proceedings: Pancreatic D cells in normal and pathological human pancreas. (1975) (7)
Establishment of a continuous somatostatin-producing line of medullary thyroid carcinoma cells from BALB/c mice. (1986) (7)
Quantification of endocrine cells in whole intestinal crypts and villi (1982) (7)
Plasma hormone concentrations in gastrointestinal disease. (1980) (6)
A pancreatic-polypeptide-producing tumor of the stomach. (1984) (6)
Glucagon-like peptide-1 (7–36) amide response to low versus high glycaemic index preloads in overweight subjects with and without type II diabetes mellitus (2007) (6)
Peripheral influences on central melanocortin neurons (2005) (6)
Control of appetite--the role of glucagon-like peptide-1 (7-36) amide. (1997) (6)
Allosterische optische Steuerung eines Klasse-B-G-Protein-gekoppelten Rezeptors (2016) (6)
Weight Loss by Low-Calorie Diet Versus Gastric Bypass Surgery in People With Diabetes Results in Divergent Brain Activation Patterns: A Functional MRI Study (2021) (6)
Receptors for pituitary adenylate cyclase activating polypeptide and its effect on cAMP levels in the rat pituitary cell line GH3 (1991) (6)
Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats (2015) (6)
Lymph, pancreatic and gastrointestinal hormones in response to feeding in the conscious pig. (1985) (6)
The influence of modified sham feeding on plasma polypeptide (CCK, gastrin, motilin, neurotensin and somatostatin) concentrations in duodenal ulcer disease. (1984) (6)
Developmental changes in pancreatic endocrine function in the young calf. (1981) (6)
[The vaso-active intestinal polypeptide in Verner-Morrison syndrome]. (1975) (6)
Proceedings: Endocrine quantitation of clinical gastric biopsies. (1975) (6)
Plasma vasoactive intestinal polypeptide and other regulatory peptides in children with neurogenic tumours (1981) (6)
The role of the sympathetic system in the control of insulin release in response to hyperglycaemia in conscious calves. (1985) (6)
[Behavior of plasma enteroglucagon and neurotensin in obese patients subjected to biliopancreatic bypass]. (1980) (6)
Schizophrenia — Peptidergic deficits in the limbic system (1982) (6)
Distribution of three sensory neuropeptides in human skin (1988) (6)
Isotonic Saline Infusion Stimulates Plasma Release of Atrial Natriuretic Peptide (ANP) in Man (1986) (6)
Regulatory peptide distribution in separated layers of the human jejunum. (1987) (6)
Effect of motilin on gastric emptying of solid meals in man (1978) (6)
Specific immunostaining of CCK cells by use of synthetic fragment antisera (1977) (6)
Neuropharmacology: Cheap date (1998) (6)
Molecular Form of Islet Amyloid Polypeptide (Amylin) Released from Isolated Rat Islets of Langerhans (1993) (6)
Continuous subcutaneous administration of ghrelin results in accumulation of adipose tissue, independent of hyperphagia or body weight gain (2004) (6)
Bile exclusion from the duodenum (1985) (6)
In vivo and in vitro effects of dexamethasone on pituitary thyrotrophin-releasing hormone-like peptide concentrations in the rat. (1995) (6)
Physiology of gastrointestinal hormones. (1980) (6)
The presence, characterisation and synthesis of neuromedin B in the human pituitary gland. (1992) (6)
Effect of high dose somatostatin analogue on growth hormone concentrations in acromegaly (1988) (6)
PLASMA-MOTILIN IN CARCINOID TUMOURS (1977) (6)
Plasma enteroglucagon and neurotensin in infantile pyloric stenosis (1983) (6)
Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man (1983) (6)
GUT HORMONES AND GLOMERULAR HYPERFILTRATION (1984) (6)
Distribution, Origin, and Pathology of the Gut Peptidergic Innervation (1981) (6)
Role of Central Nervous System and Ovarian Insulin Receptor Substrate 2 Signaling in Female Reproductive Function in the Mouse 1 (2007) (6)
The new peptide hormones of the gut and their clinical significance. (1978) (6)
Regulatory peptides and the lung. (1985) (6)
Combined carbenicillin and gentamicin for prophylaxis of post-operative infection following major abdominal surgery (1969) (6)
The Localisation, Molecular Forms and in Vivo Release of Atrial Natriuretic Peptide Immunoreactivity (ANP-IR) in the Rat (1985) (6)
The Regulatory Peptides of the Colon (1983) (6)
Postprandial release of motilin in relation to the interdigestive motor complex in man (1981) (5)
Galanin: hydrokinetic action on salivary glands in man (1989) (5)
Peptidergic neurones as the main autonomic innervation of the gut (1978) (5)
Distribution of a novel pituitary protein (7B2) in mammalian gastrointestinal tract and pancreas (1988) (5)
Quantification of secretin release by acid, using immunocytochemistry and radioimmunoassay (1975) (5)
Peptide histidine isoleucine (PHI). A secretagogue in porcine intestine. (1983) (5)
Rat immunoreactive cholecystokinin (CCK): characterization using two chromatographic techniques (1985) (5)
Elevated circulating levels of cocaine- and amphetamine regulated transcript (CART) in anorexia nervosa (2003) (5)
Effects of physiological increases of plasma noradrenaline on gastric acid secretion and gastrointestinal hormones (1987) (5)
Peptidergic (substance P) nerves in the heart (1980) (5)
The control of the adaptation of the human neonate to postnatal nutrition. (1981) (5)
Expression of the C-terminal flanking peptide of human progastrin in human gastroduodenal mucosa, G-cell hyperplasia and islet cell tumours producing gastrin. (1987) (5)
Solubilization of binding sites for IAPP and CGRP from rat lung (1994) (5)
Proceedings: Release of secretin for S cells of porcine duodenum and jejunum by acid. (1975) (5)
Peptide YY: a gut hormone associated with anorexia during infectious diarrhea in children. (2008) (5)
PARALLEL RELEASE OF TWO MOLECULAR FORMS OF MOTILIN IN HUMAN PLASMA AND SUPPRESSION OF BIG MOTILIN BY EXOGENOUS MOTILIN INFUSION (1981) (5)
Bombesin infusion in man, pharmacokinetics and effect on gastro-intestinal and pancreatic hormonal peptides [proceedings]. (1979) (5)
Calcitonin gene-related peptide in the rat urogenital tract (1984) (5)
Changes in the concentration of vasoactive intestinal peptide in intestinal lymph in response to vagal stimulation in the calf (1978) (5)
VIP: the cause of the watery diarrhoea syndrome. (1978) (5)
Co-localisation of VIP and PHI in the human gut (1983) (5)
Kisspeptin: a novel physiological trigger for oocyte maturation in IVF treatment (2014) (5)
localization ofenteroglucagon cells inthegastrointestinal tract ofthedog (1971) (5)
Distribution of CGRP-immunoreactive nerves in the mammalian ureter (1984) (5)
Substance P, vol 2 (1980) (5)
Postnatal development of calcitonin gene-related peptide (CGRP)-, substance P (SP)-, galanin (GAL)- and thyrotrophin releasing hormone (TRH)-like immunoreactivity in the rat lumbar spinal cord (1984) (5)
Unilateral sciatic nerve section induces a significant increase of vasoactive intestinal polypeptide (VIP) in nerves of the ipsilateral dorsal horn of the rat (1983) (5)
Release of motilin in man by oral and intravenous nutriments (1978) (5)
Proceedings: Vasoactive intestinal peptide and the Verner-Morrison syndrome. (1975) (5)
A rapid and sensitive hypercalcaemic assay for parathyroid hormone using the chicken. (1972) (5)
Galanin: A newly recognised peptide in the enteric nervous system (1984) (5)
An investigation of the use of high- and low-preference food as a reinforcer for increased activity of individuals with Prader-Willi syndrome. (1986) (5)
Studies on the release of pancreatic polypeptide and its relationship to pancreatic exocrine function [proceedings]. (1977) (5)
Increase in diazepam binding inhibitor-like immunoreactivity(51–70) in Huntington's disease (1988) (5)
Enteroglucagon and experimental intestinal carcinogenesis in the rat. (1987) (5)
Alterations in thyroid status do not affect plasma peptide YY (PYY) and ghrelin concentrations (2008) (5)
Proceedings: The distribution of vasoactive intestinal peptide (VIP) in the primate gastrointestinal tract and characterization of VIP from human tumours. (1973) (5)
Stimulation of calcitonin secretion by gastro-intestinal hormones. (1972) (5)
Signals for glucagon secretion. (1977) (5)
Neuron specific enolase (NSE) immunostaining a useful tool for the light microscopical detection of endocrine cell hyperplasia in adult rats exposed to asbestos (2004) (5)
Effect of Peptide YY and Neuropeptide Y on the Rate of Gastric Emptying in Man (1985) (5)
Radioimmunoassay of gastric inhibitory polypeptide and its release in morbid obesity and after jejuno-ileal bypass [proceedings]. (1979) (5)
DIABETES WITHOUT GLUCAGON (1976) (5)
Effect of synthetic human glucose‐dependent insulinotropic polypeptide (hGIP) on the release of insulin in man (1990) (5)
Distribution, synthesis and molecular characterization of pituitary adenylate cyclase activating polypeptide (PACAP) in rat brain (1992) (5)
Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma. (1983) (5)
Endothelin-like immunoreactivity in human breast cyst fluid. (1990) (5)
Age-related changes in regulatory peptides in rectal mucosa. (1987) (5)
Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1 (2021) (5)
Weight loss in rats treated with intracerebroventricular cobalt protoporphyrin is not specific to the neuropeptide Y system (1996) (5)
Regulatory peptides of the respiratory tract: a newly discovered control system (1984) (5)
Medical registrar training (1991) (5)
The novel hypothalamic peptide Galanin-Like Peptide (GALP) stimulates food intake in male wistar rats (2001) (5)
Renal function during bovine neurotensin infusion in man (1987) (5)
The relationship between release of vasoactive intestinal peptide in the salivary gland of the cat in response to parasympathetic stimulation and the atropine resistant vasodilatation [proceedings]. (1979) (5)
Isolation Studies of Enteroglucagon-Like Immunoreactive Peptides from a Human Renal Tumour (1972) (4)
Neural Influences on the Endocrine Pancreas1 (1980) (4)
Plasma enteroglucagon, peptide YY and gastrin in rats deprived of luminal nutrition, and after urogastrone-EGF administration. A proliferative role for PYY in the intestinal epithelium? (1989) (4)
DIFFERENTIAL EFFECTS OF BILE ACIDS ON THE POST-PRANDIAL SECRETION OF GUT HORMONES: a randomised crossover study. (2021) (4)
TOP SCORING ABSTRACT SESSION S-11. TX-001HR is Associated with a Clinically Meaningful Effect on Vasomotor Symptoms (2018) (4)
Plasma pancreatic glucagon relationship between mother and foetus at term. (1972) (4)
PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTOR SUBTYPES IN RAT TISSUES: INVESTIGATION OF RECEPTOR BINDING, A NOVEL VIP RECEPTOR ANTAGONIST AND CHEMICAL CROSS-LINKING (1994) (4)
Plasma motilin in infantile pyloric stenosis (1982) (4)
Localisation of receptors using a dimeric ligand and electron immunocytochemistry (2004) (4)
Relationship of plasma motilin response to lower esophageal sphincter pressure in man. (1976) (4)
Neuropeptides in Leprosy: Evidence of a Role for Vip in the Re-Organisation or Regeneration of the Nervous System (1983) (4)
Calcitonin-gene-related peptide (CGRP) in mucosal endocrine cells and in the lung innervation of rat and man (1983) (4)
Proceedings: Investigation and treatment of a recurrent vipoma. (1975) (4)
Changes in Plasma Leptin Levels Relating to Short-Term Thyroid Manipulation in Rats (2002) (4)
NPY localization and distribution in the juxtaglomerular apparatus (1983) (4)
Plasma levels of 7B2 (a novel pituitary polypeptide) and its molecular forms in plasma and urine in patients with chronic renal failure: possible degradation by the kidney (1988) (4)
Effects of elevating colonic propionate on liver fat content in overweight adults with non-alcoholic fatty liver disease: a pilot study (2015) (4)
Peptide histidine valine: its haemodynamic actions and pharmacokinetics in man differ from those of vasoactive intestinal peptide and peptide histidine methionine. (1990) (4)
Bombesin, possible role of a hew gut and brain peptide (1978) (4)
The effect of atrial natriuretic peptide on plasma renin activity, plasma aldosterone, and urinary dopamine in man (2004) (4)
Studies of This Newly Discovered Controlling System in Health and Disease (1979) (4)
Pancreatic glucagon in human foetal stomach (2004) (4)
Glucagonomas and Skin Disease (1977) (4)
Measurement of gut hormones in plasma. (2006) (4)
Binding and degradation of endothelin by porcine aortic membranes (1988) (4)
Proceedings: Distribution of gut hormones. (1975) (4)
Effect of Enprostil on Glucose and Lipid Metabolism in Type 2 Diabetes (1989) (4)
Atrial natriuretic peptide and the natriuresis due to acute beta-blockade in conscious hypertensive rats. (1987) (4)
Isolation and Characterization of Gut Hormone Storage Granules from Human Stomach, Jejunum and Rectum (1979) (4)
HUMORAL ASPECTS OF DUMPING SYNDROME (1981) (4)
CNS Control of Metabolism Insights into the role of neuronal glucokinase (2016) (4)
Evaluation of a proposed technique to assess unscheduled DNA synthesis and genotoxicity. (1993) (4)
The peptidergic system in Chagas's disease [proceedings]. (1980) (4)
Pharmacokinetics and pharmacodynamics of subcutaneously administered PYY3–36 and its analogues in vivo (2015) (4)
Localisation of mRNA and co-expression and molecular forms of GRP gene products in endocrine cells of fetal human lung (2004) (4)
Low‐dose oral tri‐iodothyronine does not directly increase food intake in man (2007) (4)
Distribution and possible dual role of CGRP-containing nerves in the skin of the rat (1984) (4)
Bombesin-like immunoreactivity in the pituitary gland (1983) (4)
EFFECT OF OCTAPEPTIDE SOMATOSTATIN ANALOGUE (SMS 201‐995) ON PLASMA 7B2 (A NEUROENDOCRINE POLYPEPTIDE) LEVELS IN PATIENTS WITH ACROMEGALY (1990) (4)
Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT (2021) (4)
Vasoactive intestinal peptide-secreting tumor appearing as growth failure. (1983) (4)
Gastric stress ulcers and gastrointestinal hormones - response to hydrochloric acid and sodium chloride infused intraduodenally. Preliminary report. (1980) (4)
Gut hormones regulating appetite and metabolism (2007) (4)
Plasma and tissue hormones in the dog after administration of the prostaglandin analogue, misoprostol. (1992) (4)
Significant depletion of NPY in the innervation of the rat mesenteric, renal arteries and kidneys in experimentally (aorta coarctation) induced hypertension (2004) (4)
PYY and decreased appetite following jejunum intestinal bypass in rats (2003) (4)
A glucagon analogue decreases body weight in mice via signalling in the liver (2021) (4)
Clinical application of the atropine test for diagnosis of pancreatic PP'omas (1983) (4)
Acylation of the incretin peptide exendin-4 directly impacts GLP-1 receptor signalling and trafficking (2021) (4)
Pharmacotherapy for obesity: a field in crisis? (2011) (4)
Wirkung von Somatostatin beim Carcinoid- und Verner-Morrison-Syndrom (1979) (4)
The value of SIO 0 immunostaining as a diagnostic tool in human malignant melanomas A comparative study using SIO 0 and neuron-specific enolase antibodies (2004) (3)
GUT-HORMONE PROFILE (1978) (3)
Live demo: Platform for closed loop neuromodulation based on dual mode biosignals (2017) (3)
Safety and efficacy of an extended‐release peptide YY analogue for obesity: A randomized, placebo‐controlled, phase 1 trial (2021) (3)
VIP nerves in Crohn's disease (1978) (3)
Gut hormones and Type 2 diabetes mellitus (2014) (3)
Atrial natriuretic peptide and glucagon release in experimental intestinal ischaemia and reperfusion (1994) (3)
Neuron specific enolase (NSE) immunostaining detection of endocrine cell hyperplasia in adult rats exposed to asbestos. (1982) (3)
Atrial Natriuretic Peptide (anp) Inhibits the Aldosterone Response to Angiotensin Ii in Man (1985) (3)
Membrane binding and biological activity of rat alpha-CGRP and beta-CGRP. Evidence for one class of high affinity receptor (1987) (3)
Proceedings: Characterization of the new gastrointestinal hormones. (1975) (3)
Autoantibodies to gut hormone secreting cells as markers of peptide deficiency. (1983) (3)
Cholera and Pancreatic Cholera: Is VIP the Common Pathophysiologic Factor? (2020) (3)
Peptide Histidine Isoleucine Inhibits Biliary but Not Pancreatic Secretion in Man (1983) (3)
Effect of food on porcine gut regulatory peptides in arterial and portal venous blood. (1985) (3)
The post-prandial secretion of Peptide YY1-36 and 3-36 in obesity is differentially increased after gastric bypass versus sleeve gastrectomy. (2022) (3)
Pancreatic polypeptide: a novel substrate for the endopeptidase neprilysin (2010) (3)
Renovascular distribution of NPY and its vasoconstrictor and natriuretic properties. (1984) (3)
Peptide histidine isoleucine (PHI) (1983) (3)
Secretin release in Children with Coeliac Disease (1978) (3)
Editorial: from gut to mind--hormonal satiety signals and anorexia nervosa. (2006) (3)
7B2, A New Protein Secreted by Human Functionless Pituitary Tumours, in vitro (1987) (3)
Proceedings: The interpretation of plasma gastrin results--an explanation. (1975) (3)
Subcellular localization of serotonin and motilin in the human jejunum. (1980) (3)
The Glucagonoma Syndrome (1990) (3)
Energy intake following infusion of glucagon and GLP-1: a double-blind crossover study (2013) (3)
Proceedings: Dual role for vasoactive intestinal peptide--peripheral hormone and neurotransmitter. (1976) (3)
Do Circulating Levels of Atrial Natriuretic Peptide (ANP) Mediate the Natriuretic Response to Water Immersion in Man (1985) (3)
Circulating concentrations of immunoreactive peptide 7B2 in certain pathophysiological conditions, and response to oral glucose load. (1988) (3)
Elevated levels of vasoactive intestinal peptide in the eye and urinary bladder of diabetic and prediabetic Chinese hamsters (1985) (3)
Pancreatic endocrine responses to stimulation via the sympathetic innervation. (1975) (3)
Distribution and Ontogeny of CGRP, a Major Skin Neuropeptide (1985) (3)
Proceedings: Simultaneous differentiation of gastrin, CCK, EG and VIP cells. (1976) (3)
The diffuse neuroendocrine system in gastroenterology. (1980) (3)
Hepatocyte cholesterol content modulates glucagon receptor signalling (2021) (3)
Identification of the hormone kisspeptin in amniotic fluid. (2010) (3)
Peptide tyrosine (PYY) is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas (1983) (3)
The release of gastrointestinal hormones following an oral water load and atropine in man (1978) (3)
Experimental colonic carcinogenesis: changes in faecal bile acids after promotion of intestinal tumours by small bowel resection in the rat. (1988) (3)
The novel neuropeptides 7B2 and neuromedin B are localised to the mammalian neurohypophyseal system and are expressed in specific cell types of the anterior pituitary (1986) (3)
Effect of Eating Guar and Glucose on Subsequent Glucose Tolerance (1979) (3)
Proceedings: Effect of somatostatin on pancreatic and biliary function. (1975) (3)
Learning curve of vessel cannulation in rats using cumulative sum analysis. (2015) (3)
Peptide YY (PYY) is increased in elderly patients with femoral neck fractures: a prospective cohort study. (2006) (3)
Other clinical studyInsulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7–36 amide] after oral glucose in cirrhosis☆ (1995) (3)
How to assess the physiological role of a new peptide hormone: pancreatic polypeptide infusion in man [proceedings]. (1979) (3)
DIFFERENCES IN ALIMENTARY HORMONE RESPONSES BETWEEN BREAST AND BOTTLE-FED INFANTS: 87 (1980) (3)
Age-related change in 7B2 (a novel pituitary polypeptide) concentrations in human cerebrospinal fluid (1988) (3)
Gut hormone profile in post-infective tropical malabsorption (acute tropical sprue) (1978) (3)
Binding Sites of Pituitary Adenylate Cyclase-Activating Polypeptide in Human Brain (1993) (3)
VASOACTIVE INTESTINAL POLYPEPTIDE DURING PENILE ERECTION (1986) (3)
Atrial Natuiuretic Peptide (ANP) Inhibits Plasma Renin Activity in Man (1986) (3)
Impact of N-terminally substituted glucagon family receptor agonists on signal bias, trafficking and downstream responses (2020) (3)
Proceedings: Pancreatic glucagon in diabetic ketoacidosis. (1975) (3)
Proceedings: The G cell population of the gastric antrum, plasma gastrin, and gastrin acid secretion. (1974) (3)
Effects of Elevating Colonic Propionate on Liver Fat Content in Adults with Non‐Alcoholic Fatty Liver Disease (2015) (3)
[Behavior of plasma insulin and GIP in obese patients subjected to biliopancreatic bypass]. (1980) (3)
Proceedings: Distribution of radioimmunoassayable gastrin, secretin, pancreozymin and enteroglucagon in rat, dog, and baboon gut. (1973) (3)
Treatment of Gut-Associated Neuroendocrine Tumors with the Long-Acting Somatostatin Analog, SMS 201-995 (1987) (3)
Pancreatic alpha cell function in the fetal and newborn pig. (1986) (3)
Mucosal enzyme activities, peptide hormone concentrations and hormone secretory granule properties in functioning proximal jejunum after shunt operation for obesity. (1982) (3)
Vasoactive intestinal polypeptide in the neurohypophysis [proceedings]. (1979) (3)
Endocrine Tumours: The Pathobiology of Regulatory Peptide-Producing Tumours (1985) (3)
Day profiles of glucose dependent insulinotropic polypeptide (GIP) in normal subjects. (1985) (3)
A unique apudoma producing the glucagonoma and gastrinoma syndromes. (1983) (3)
Plasma cholecystokinin response to food in healthy subjects (1984) (3)
10 Motilin and neurotensin (1979) (3)
Inhibition ofsecretin stimulated pancreatic secretion bypancreatic polypeptide (1978) (3)
Effect of Motilin on Human Colonic Activity (1980) (3)
Regulation of hepatic enzymes and insulin levels in offspring of rat dams fed a reduced-protein diet. (1997) (3)
Effect of soya bean oil on symptoms, gastric emptying and gut hormone release in patients with postvagotomy symptoms. (1986) (3)
Quantification of physiological changes in gut endocrine cells: immunocytochemical and radioimmunoassays of secretin cell function. (1975) (2)
Intramural distribution of neuron specific enolase (NSE) in the human gastrointestinal tract (1983) (2)
Investigation of the chronic effects of NPY by subcutaneous implantation of 6-23 cells producing NPY in WAG rats. (2004) (2)
Gut hormones in disease. (1983) (2)
MOTILIN ENHANCES GALLBLADDER PRESSURE IN THE PIG (1982) (2)
Adrenal responses to hypoxia and hypercapnia in the young calf (1977) (2)
Neuromedin U (NMU): Brain Peptide (2006) (2)
The effect of splanchnic nerve stimulation on the uptake of atrial natriuretic peptide by the adrenal gland in conscious calves (1990) (2)
Modulation of hypothalamic and anterior pituitary galanin expression by estrogen in the rat (1988) (2)
Presence of high concentration of 7B2 in pleural effusion. (1988) (2)
Neuropeptide content of purified rat brain cholinergic synaptosome subpopulations (1992) (2)
The effect of a synthetic enkephalin analogue on postprandial gastrointestinal and pancreatic hormone secretion. (1983) (2)
The effect of GLP-1(7-36)NH2 and its fragments on insulin release (1993) (2)
Gut hormones come of age (2005) (2)
Glucagon-like peptide-1 7–36, a new brain-gut hormone (1988) (2)
Measurement of gut hormones in plasma. (2013) (2)
Is VIP Really the Main Contributor to the Watery Diarrhoea in Patients with VIP-Secreting Tumours? (1988) (2)
Clinical and Pathological Manifestations of Pancreatic Endocrine Tumours (1984) (2)
The incretins – outdated terminology in man? (1999) (2)
Marked changes in the regulatory peptide system of the bowel in equine grass sickness (1982) (2)
Absent nerves and absent motilin. (1982) (2)
GUT HORMONES IN NEONATAL NESIDIOBLASTOSIS OF THE PANCREAS (1981) (2)
Plasma enteroglucagon and plasma-volume changes after oral hypertonic glucose--their relationship to the dumping syndrome. (1973) (2)
Vascular Distribution of a Potent Vasoconstrictor Peptide, Neuropeptide Y (NPY) (1984) (2)
Symptomatic Improvement with SMS 201-995 in Acromegaly (1986) (2)
Calcitonin-gene-related-peptide (GCRP) in the spinal cord of man and eight mammalian and non mammalian species (1983) (2)
Characterisation of gut hormones storage granules from normal human jejunum using metrizamide density gradients (1981) (2)
Simultaneous immunocytochemistry and in situ hybridisation of beta thyroid stimulating hormone and its messenger RNA in euthyroid and hypothyroid rat pituitaries (1989) (2)
Effects of vasoactive intestinal peptide on jejunal, ileal, and colonic fluid transport and cAMP levels in the rabbit (1979) (2)
Aspects of neurohormonal peptides. (1985) (2)
Effects of the autonomic system on insulin release in response to exogenous glucose in weaned lambs. (1982) (2)
27 – Vasoactive Intestinal Peptide (1978) (2)
36 – Clinical Syndromes of Gut Hormones (1990) (2)
Capsaicin Pre-Treatment Inhibits Axon Reflex Vasodilatation Caused by Somatostatin and VIP in Human Skin (1983) (2)
The effects of naloxone on circulating metabolites, glycoregulatory hormones and gut peptides during pelvic surgery. (1983) (2)
NPY immunoreactivity in experimental hypertension (aorta-ligated and doca treated rats) (1984) (2)
Proceedings: Secretin release in man after intra-duodenal acid. (1974) (2)
Chromatographic analysis of plasma motilin immunoreactivity in human disease using region specific antibodies. (1982) (2)
The continuing hormonal contamination of insulin (1985) (2)
Absence of mutations in the Gs alpha and Gi2 alpha genes in sporadic parathyroid adenomas and insulinomas. (1994) (2)
Thermal imaging as a novel non-invasive method to measure human brown adipose tissue activity in humans (2015) (2)
Hormonal response to first feeding in neonates. (1978) (2)
The Demonstration of Polyethylenimine Mediated Gene Transfer into the Rodent Hypothalamus Results in Persistent Over-Expression and Phenotypic Change (2004) (2)
In vivo Insulin Secretion in the Pig is not Inhibited by Pancreastatin 33–49 (1987) (2)
Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor and its functional interaction with plasma membrane nanodomains in pancreatic beta cells (2018) (2)
Gastrointestinal tract and appetite control (2014) (2)
Endorphin-like immunoreactivity in the human and rodent pituitary glands [proceedings]. (1977) (2)
Plasma Motilin and Biliary Output in Man (1982) (2)
Kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis in adult male rats following central and peripheral administration (2005) (2)
Neurotensin-secreting carcinoma of the bronchus. (1983) (2)
Immunocytochemical localisation of galanin in the porcine respiratory tract (1984) (2)
Measuring the Pharmacokinetic Properties of Drugs with a Novel Surgical Rat Model (2017) (2)
Glucagon-like peptide II (GLP-II) is trophic to the intestinal epithelium of intravenously and orally fed rats (1998) (2)
Responses to feeding in the conscious unweaned calf. (1975) (2)
RADIOIMMUNOASSAY OF CHOLECYSTOKININ-PANCREOZYMIN (1973) (2)
The ontogeny of the diffuse neuroendocrine system of the human gut (1985) (2)
Bromocriptine Treatment ofAcromegaly (1975) (2)
Intramural distribution ofregulatory peptides inthe sigmoid-recto-anal regionofthehumangut (1988) (2)
Classification of Neuroendocrine Tumors (2009) (2)
The effects of kisspeptin-54 administration on GH, prolactin, and TSH secretion in healthy women (2014) (2)
Chapter 157 – PYY (2013) (2)
Codeine phosphate abolishes the pancreatic polypeptide response to oral fat (1982) (2)
Proceedings: Hormonal changes after thermal injury. (1976) (2)
Bile acid mediated changes after bariatric surgery : what can we learn from mouse models ? (2019) (2)
At the heart of the benefits of bariatric surgery (2012) (2)
Vasoactive intestinal polypeptide innervation of the genital tract of women [proceedings]. (1979) (2)
PLASMA-V.I.P. IN ULCERATIVE COLITIS (1976) (2)
Elevated Plasma Neurotensin in Adults with Cystic Fibrosis (1983) (2)
Energy Expenditure After Roux-En-Y Gastric Bypass in Rats (2009) (2)
Bombesin-like immunoreactivity in female rat genito-urinary tract (1984) (2)
Gut hormones in thyrotoxicosis and anorexia nervosa [proceedings]. (1979) (2)
Increased pressor effect of repeated doses of rat or porcine endothelin in the anaesthetised rat. (1990) (2)
Effect of partial ileal bypass on the gut hormone responses to food in man. (1983) (2)
Proceedings: Plasma pancreatic glucagon, plasma insulin and blood glucose studies in the fetal rabbit. (1974) (2)
Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats (2016) (2)
Proceedings: Gastric inhibitory peptide, vasoactive intestinal peptide and motilin: physiological and pathophysiological alterations. (1976) (2)
Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss (2022) (2)
What Can We Learn From Mouse Models About Bile Acid-Mediated Changes After Bariatric Surgery? (2019) (2)
Bile diversion from the duodenum: its effect on gastric and pancreatic function. (1984) (2)
Neuropeptide Y and the Anterior Pituitary (1990) (2)
Pancreastatin, a novel neuropeptide, is widely distributed throughout porcine brain, pituitary, spinal cord and dorsal root ganglia (1987) (2)
The gastrointestinal tract and the regulation of appetite (2005) (2)
Solubilisation of CGRP and IAPP receptors from rat lung (1993) (2)
α-Calcitonin gene-related peptide (CGRP) gene transcripts are expressed in areas associated with sensory and motor functions in man and rat (1987) (2)
Platform for Closed Loop Neuromodulation Based on Dual Mode Biosignals (2017) (1)
Kisspeptin: a novel role in the regulation of reproductive function. (2009) (1)
Contrasting effects of kisspeptin-10 between men and women reveal sexual dimorphism in the hypothalamic regulation of human reproduction (2012) (1)
Distribution of adrenomedullin binding sites in rat tissues: Evidence for tissue specific receptor subtypes (1994) (1)
Distribution and postprandial release of porcine peptide YY (PYY) (1986) (1)
Letter: Plasma-V.I.P. in ulcerative colitis. (1976) (1)
Continuous administration of kisspeptin-54 leads to desensitisation of the hypothalamo-pituitary-gonadal axis and testicular degeneration (2006) (1)
Signal bias at glucagon family receptors: rationale and downstream impacts (2020) (1)
Targeted delivery of propionate to the colon stimulates the release of anorectic gut hormones and suppresses appetite in humans (2014) (1)
Assessment of neurological injury due to circulatory arrest during profound hypothermia: an experimental biochemical and endocrinological study (1993) (1)
Changes in gut hormones after Roux-en-Y gastric bypass for morbid obesity favour an anorectic state (2005) (1)
Neuromedin U receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (1)
Neuropeptide Y in neuroblastoma × glioma hybrid cells (1)
Regulatory peptides in the neuroendocrine system of guinea-pig gallbladder (1982) (1)
VIPomas and the watery diarrhoea syndrome. (1978) (1)
Effect of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) on 7B2 release in rat pituitary and hypothalamus (1990) (1)
Loss of axonal flow of substance P but not VIP in rat sciatic nerves after injury (1984) (1)
Tachycardia-Induced Natriuresis and ANP (1986) (1)
Localization and characterization of galanin immunoreactivity in the human, pig and cat adrenal: Molecular heterogeneity due to N- and C- terminal extension of the galanin molecule (1985) (1)
Molecular characterization of the human VIP prohormone (1983) (1)
Pancreatic polypeptide meal response may predict gastric band induced weight loss (2010) (1)
Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats. (1985) (1)
Leptin Improves Insulin Sensitivity of Skeletal Muscle in Obese‐diabetic ob/ob Mice (2000) (1)
Study of immunoreactive pancreatic glucagon in the newborn period. (1972) (1)
Leptinmodulates theT-cell immune responseand reversesstarvation-induced immunosuppression (1)
Infusion of a novel peptide, PHI, in man. Pharmacokinetics and effect on gastric secretion (1983) (1)
Characterisation of Galanin-like immunoreactivity in the common frog (Rana rana) (1994) (1)
L-Phenylalanine modulates gut hormone release, and suppresses food intake in rodents via the Calcium Sensing Receptor (2016) (1)
The presence of bombesin, a recently discovered gut and brain peptide, in human lung [proceedings]. (1978) (1)
Aspects of measurement and analysis of regulatory peptides (1987) (1)
Effect of 6-hydroxydopamine on concentrations of neuropeptide Y (NPY) in rat female genital tract (1984) (1)
Poor responsiveness after bariatric surgery: clinical and eating behaviour characteristics (2018) (1)
Secretin-VIP receptor interactions (1978) (1)
Cytochemical Techniques in Work with Gastrointestinal Hormones (1988) (1)
Proglucagon peptide secretion post Roux-en-Y gastric bypass: one year prospective study (2020) (1)
A new pituitary protein 7B2 is increased in patients with high alpha- or beta-hCG. (1989) (1)
Combined ketoconazole and LHRH producing objective responses in patients with prostatic cancer who have failed conventional treatment (1984) (1)
Plasma kisspeptin levels in hypertensive diseases of pregnancy and the identification of kisspeptin in amniotic fluid (2009) (1)
[Behavior of plasma gastrin in obese subjects subjected to biliopancreatic bypass]. (1980) (1)
Layer separation of the human bowel for the study of regulatory peptides (1982) (1)
Effects of fasting and refeeding on luteinising hormone pulses and on multiple indices of metabolic state in female rats (2006) (1)
Circulating Cocaine- and Amphetamine-regulated transcript (CART) peptide in subjects with abnormalities of the hypothalamo-pituitary axis (2003) (1)
The origin of peptidergic nerves in the rat urinary bladder: Evidence from retrograde tracing combined with immunocytochemistry (1984) (1)
PYY deficiency may reinforce obesity (2004) (1)
Expression of C-flanking peptide of human pro-bombesin in pulmonary and extra-pulmonary small cell carcinoma (1986) (1)
Regional distribution of a novel peptide (P7 of 1B236) immunoreactivity in the human central nervous system (1986) (1)
DEVELOPMENTAL EXPRESSION OE NEUROTENSIN AND GALANIN IN THE RAT GASTROINTESTINAL TRACT (1995) (1)
Dissociation of Camp-Stimulated Mitogenesis from Activation of the Mitogen-Activated Protein Kinase (MAPK) Cascade (1996) (1)
Effect of Biased GLP-1/Glucagon Receptor Co-agonists on Insulin Secretion (2018) (1)
Kisspeptin levels in high risk pregnancies related to chronic diseases: insulin dependent diabetes mellitus (IDDM) and arterial hypertension (H) (2010) (1)
Neuromedin U : an overview (1993) (1)
Techniques for the Determination of Tumour Neuroendocrine Differentiation and for the Localisation of Intracellular Organelles Involved in Peptide Synthesis, Storage and Release (1987) (1)
Using the body’s natural signals — gut hormones (2008) (1)
VIP and the WDHA syndrome. (1979) (1)
Pyroglutamyl-Glutamyl-Proline Amide (pGlu-Glu-Pro-NH2)-. Like Immunoreactivity in the Human Pituitary Gland (1995) (1)
Intra-duodenal ph, motilin and interdigestive migrating motor complex in man (1978) (1)
Who will benefit from bariatric surgery for diabetes? A protocol for an observational cohort study (2021) (1)
Anomalous elution of CCK-8 from gel chromatographic columns (1984) (1)
Lithium intoxication. (1991) (1)
Pre-analytical factors affecting measurement of plasma kisspeptin by radioimmunoassay (2008) (1)
Post-translational processing of proglucagon in man (1984) (1)
Enteroglucagon in disease states [proceedings]. (1979) (1)
Enteropancreatic axis. (1978) (1)
Elevated plasma glucagon caused by danazol (1987) (1)
Long term experience of lhrh analogue ici 118630 in advanced prostatic cancer (1984) (1)
Mode of action of the alpha glucosidase inhibitor acarbose bay 5421 in the small bowel a perfusion study in man (1985) (1)
Changes in plasma PYY concentrations in gastrointestinal diseases (1984) (1)
Localization of Neural and Endocrine Peptides (1986) (1)
Reply: Clinical trial registry alone is not adequate: on the perception of possible endpoint switching and P-hacking. (2018) (1)
Neurotensin and enteroglucagon in obesity (1978) (1)
supplemental oxygen . variables and response to haemodynamic and blood gas hypertension : relation to secondary pulmonary concentrations in hypoxic Atrial natriuretic peptide (1)
Gut hormones: the future for obesity therapy? (2006) (1)
Effect of Gastrin Releasing Peptide (GRP) on the Release of Pancreatic and Gut Hormones (1982) (1)
Over-expression of iodothyronine deiodinase III in the hypothalamic VMN as a potential model of local hypothyroidism (2011) (1)
Plasma enteroglucagon levels in the dumping syndrome. (1972) (1)
Glucagon: its Role in Physiology and Clinical Medicine (1978) (1)
Proceedings: Endocrine responses to hypoxia in the conscious calf. (1976) (1)
QRFP43 stimulates the hypothalamic-pituitary-gonadal axis via GnRH in rats Running title: QRFP43 stimulates the HPG axis via GnRH (2008) (1)
Targeting GLP-1 receptor traf ﬁ cking to improve agonist ef ﬁ cacy (2018) (1)
Distribution of calcitonin-gene-related-peptide (CGRP) containing nerves in motor end-plates, perivascular- intraganglionic- and intraepithelial nerve fibres of the oesophagus (1983) (1)
Clinical authorization: what is best for the patient? (2003) (1)
Neuropeptide content in rat hypothalami and their release in vitro from tissue (1982) (1)
Glucagon stimulation of the anterior pituitary. (1972) (1)
Plasma Atrial Natriuretic Factor and Ultrastructure of Atrial Specific Granules Following Chronic Hypoxia in Rats (1987) (1)
Localisation and Molecular Forms of Galanin in Phaeochromocytomas and Human Adrenals (1985) (1)
Targeted delivery of propionate to the human colon prevents body weight and intra-abdominal adipose tissue gain in overweight adults (2014) (1)
Arcuate nucleus glucokinase and dietary glucose intake (2015) (1)
The development of neuropeptide Y immunoreactivity in the rat brain (1983) (1)
Some aspects of neuroendocrine pathology. (1987) (1)
Proceedings: gastrin release in response to oral glucose in patients before and after gastric operations. (1973) (1)
Quantification of orexin a immunoreactivity and prepro-orexin mRNA in the CNS of Zucker rats (2000) (1)
What is enteroglucagon (1981) (1)
Renovascular Distribution of Npy and Its Vasoconstrictor and Natriuretic Properties (1984) (1)
Imaging amyloidosis in Still's disease. (1989) (1)
Endocrine and metabolic response in the human newborn to first feed of breast milk 293 (1)
Proceedings: The effect of vagotomy on gastrin release in response to insulin hypoglycaemia. (1974) (1)
Lack of effect of hpGRF on pancreatic exocrine secretion in the rat (1983) (1)
Gut hormones (1987) (1)
The actions of growth hormone release inhibiting hormone in man (1975) (1)
Oral chenodeoxycholic acid increases post-prandial anorectic gut hormone levels and increases indices of insulin sensitivity (2019) (1)
Changes in PHI in the rat brain during development (1983) (1)
Plasma motilin levels in duodenal ulcer and effect of a truncal vagotomy and hypoglycaemia (1978) (1)
Endocrine Tumors of the Gastrointestinal Tract (2003) (1)
The role of the autonomic nervous system in the control of glucagon release during insulin hypoglycaemia in the calf (2005) (1)
Hormone Expression in Endocrine Tumors of Pancreas and Intestine in Transgenic Mice (1989) (1)
Subcutaneous administration of ghrelin and its effects on food intake in man (2004) (1)
Central Nervous System Neuropeptides Involved in Obesity (2000) (1)
Elimination of secretin in the dog (1978) (1)
57-OR: Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Glycaemia and Body Weight in Obesity and Type 2 Diabetes: A Randomized, Single-Blinded Study (2019) (1)
Regulatory Peptides in the Autonomic and Sensory Nervous Systems (1987) (1)
How the brain controls appetite (2003) (1)
APPG secretion in a rat phaeochromocytoma cell line (PC12) (1984) (1)
Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Increases Forearm Blood Flow and causes Prolonged Skin Vasodilation in man (1991) (1)
Continuous subcutaneous administration of kisspeptin-54 causes testicular degeneration in rats (2006) (1)
Distribution of 125I-endothelin binding sites in rat gastrointestinal tract (1989) (1)
The pattern of green fluorescent protein (GFP) expression following intrahypothalamic injection of adeno-associated virus-GFP (2002) (1)
Is age of vaginal opening an indicator of leptin sensitivity in female Sprague Dawley rats (2011) (1)
Imperial Satiety Protocol: A new non‐surgical weight‐loss programme, delivered in a health care setting, produces improved clinical outcomes for people with obesity (2020) (1)
CGRP in the pituitary gland (1991) (1)
Influence of Somatostatin on Postprandial Hormone Release (1982) (1)
Motilin and neurotensin. (1979) (1)
The effect of endothelin on arterial blood pressure and heart rate in the anaesthetised rat (1988) (1)
Seventh Annual Meeting of the European Association for the Study Of Diabetes Southampton, England, September 15–17, 1971 Abstacts, Part 1 (1971) (1)
Effects of Duodenal Perfusion of Sodium Taurocholate on Biliary and Pancreatic Output and Gut Hormone Release in Man (1979) (1)
LHRH Analogue in Treatment of Advanced Prostatic Cancer: Preliminary Data (1983) (1)
OVERDIAGNOSIS OF ENDOCRINE GUT TUMOURS (1977) (1)
Gut Hormone Secretory Granule Abnormalities in Jejunal Mucosal Diseases (1982) (1)
Gastrointestinal peptides and food intake regulation (2009) (1)
Chapter 176 – Pancreatic Polypeptide (2013) (1)
Local application of capsaicin to one sciatic nerve induces profound changes in peptide-containing afferent fibres in the ipsilateral lumbar dorsal horn of the adult rat (1982) (1)
Effect of naloxone on the antral motor response to solid food in man (1987) (1)
Peptide histidine methionine (PHM) increases ileostomy output (1988) (1)
Session 29: Ovarian stimulation (2013) (1)
Pituitary protein 7B2 plasma levels in patients with liver disease: Comparisons with other hormones and neuropeptides (2013) (1)
Bombesin release in response to splanchnic nerve stimulation in the calf (1982) (1)
Calcitonin-gene-related-peptide (CGRP): A novel neuropeptide in the mammalian iris (1983) (1)
GUT HORMONES IN THE NEONATE: 72 (1980) (1)
Measurement offasting andpostprandial plasma VIPinman (1978) (1)
The Human and Rat Genitourinary Tract Contain Galanin-Immunoreactivity (1985) (1)
The glucose dependence of pancreatic endocrine responses to 2-deoxyglucose in the calf (1982) (1)
The Physiology of the Endocrine System (1993) (1)
Plasma Trypsin in Patients with Steatorrhoea Due to Chronic Pancreatitis (1978) (1)
Release of vasoactive intestinal peptide from the gastrointestinal tract in response to autonomic stimulation in the calf [proceedings]. (1979) (1)
Neuron specific enolase immunostaining: A reliable histological means for determination of the neuroendocrine nature of small cell carcinomas of lung (1982) (1)
IMMUNOREACTIVE MOTILINS? (1978) (1)
Kisspeptin potently increases reproductive hormone release in women with hypothalamic amenorrhoea: a potential novel therapy for infertility (2009) (1)
Effects of Dietary Protein on Renal Haemodynamics (1984) (1)
NPY-immunoreactivity in rat brain extracts differs from procine and human NPY (1985) (1)
Abundance of VIP in duodenal mucosa of coeliacs and duodenal ulcer patients (1984) (1)
Proceedings: Gastrointestinal apudosis in obese, hyperglycaemic (ob/ob) mice. (1975) (1)
Differential expression of α and β-CGRP in rat anterior pituitary (1991) (1)
Gastrointestinal and Hepatobiliary Cancer (1983) (1)
Augurin stimulates food intake in male Wistar rats (2013) (0)
The impact of subcutaneous infusions of three anorexigenic gut hormones glucagon-like peptide-1, oxyntomodulin and peptide YY (GOP) on the psychological health of obese diabetic patients (2019) (0)
ARR somatostatin (1984) (0)
Vip-Ergic Innervation of Human Eccrine Sweat Glands: Studies in Axillary Hyperhidrosis (1984) (0)
The effects of proton pump inhibitor therapy on neuroendocrine tumour biomarkers (2016) (0)
Adrenomedullin receptors in Rat-2 fibroblasts show adrenomedullin mediated desensitisation (2000) (0)
Increased NPY in BB diabetic rat pancreas (1991) (0)
The differential effects of weight loss by RYGB versus very-low calorie diet (VLCD) on gut hormone levels and appetite: potential contribution to sustained weight loss (2019) (0)
Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) binding sites in rat tissues (1990) (0)
[Peptic hormones in the digestive tract]. (1978) (0)
Proceedings: Duodenal ulceration, gastric emptying, enteroglucagon release and abnormal oral glucose tolerance. (1975) (0)
The mechanism of abnormal pancreatic beta cell response to food following acute hypoglycaemia in man. (1981) (0)
Case ReportNecrolytic migratory erythema: a classical cutaneous presentation of the glucagonoma syndrome (1997) (0)
Full Title : Agouti related protein ( AgRP ) is upregulated in Cushing ’ s syndrome (2007) (0)
Letter: Radioimmunoassay of cholecystokinin-pancreozymin. (1973) (0)
Gut Regulatory Peptide Profiles in Acute Gastroenteritis and Necrotising Enterocolitis in Infancy (1992) (0)
Effect of cytokines on endothelin release from bovine aortic and pulmonary arterial endothelial cells (1990) (0)
The role of the autonomic nervous system in mediating pancreatic endocrine responses to arginine in the calf (1986) (0)
The hyperphagic effect of ghrelin is inhibited by diets high in fat in mice (2010) (0)
News and notices (2005) (0)
Nitric oxide-related pancreatic endocrine responses to hyperglycaemia in the conscious calf (1994) (0)
Distribution of Neuropeptide Y in Post Mortem Human Brain from Normal and Schizophrenic Subjects (1983) (0)
SYNCOFE (1989) (0)
Prolactin Status Influences Pituitary Galanin Gene Expression (1990) (0)
Alimentary tract andpancreas Effect ofpeptide histidine isoleucine onwater and electrolyte transport inthehumanjejunum (2011) (0)
inflammatory bowel disease . biopsies from patients with immunocytochemical studies in rectal concentrations and Vasoactive intestinal peptide (2006) (0)
Endothelin production by and receptors on retinal endothelial cells and pericytes (1989) (0)
Soybean oil and complications after vagotomy effect on symptoms gastric emptying and gut hormone release (1984) (0)
Release ofmotilin byoral andintravenous nutrients inman (2011) (0)
Antibody responses following change-over to mixed species (porcine/bovine) insulins (1983) (0)
Kisspeptin- A 'key regulator' of reproductive physiology, integrating limbic circuits with the regulation of reproductive hormones (2015) (0)
New use of compounds beta3-adrenergic agonists (1995) (0)
The Role of Nutritional Peptides in the Control of the Hypothalamo-Pituitary (H-P) Axes (2001) (0)
Thyrotropin-releasing hormone (TRH) peptide concentrations in the rat anterior pituitary and hypothalamus: Effects of dexamethasone (1993) (0)
Gut hormone release by intraduodenal stimulation in duodenal ulcer patients. (1989) (0)
Supporting mothers to become clinician scientists (2013) (0)
Biased agonism alters GLP-1 receptor trafficking and glucose homeostasis (2016) (0)
Endocrine abnormalities in the pancreas and gut of the obese hyperglycaemic (ob/ob) mouse [proceedings]. (1979) (0)
Endocrine abnormalities in the pancreas and gut of the obese hyperglycaemic (ob/ob) mouse. Abstr. (1979) (0)
Glucagon‐ and Proglucagon‐derived Peptides (2002) (0)
L-cysteine reduces food intake and suppresses plasma ghrelin levels in rats (2013) (0)
Hormones and the gastrointestinal tract (2020) (0)
C-terminal flanking peptide of human progastrin is expressed in normal human gastroduodenal mucosa, antra with G cell hyperplasia and islet cell tumours producing gastrin (1986) (0)
The Gut Hormone Peptide YY3-36 (PYY3-36) Regulates Appetite in Normal and Overweight Volunteers (2003) (0)
Cardiodilatin Circulates in Man at a Much Higher Concentration than ANP and it Responds to a Physiological Stimulus (1987) (0)
Adrenal and circulating agouti related protein (AgRP) is upregulated in Cushing's syndrome suggesting a novel inhibitory paracrine role in the human adrenal gland (2004) (0)
GLP-1/Glucagon dual agonist affects amino acid metabolism (2019) (0)
Gastrointestinal responses to a panel of lectins in rats maintained on total parenteral nutrition. (1999) (0)
Theileal brakeinhibition ofjejunal motility after ileal fatperfusion inman (2011) (0)
Changes in Prolactin and Proopiomelanocortin Messenger RNA in Rat Pituitary as Shown by in Situ Hybridization (1989) (0)
Characterisation of the cDNA encoding the human NmU precursor (1993) (0)
Localization of Endothelin-1 Binding Sites in Mammalian Blood Vessels Using in vitro Autoradiography (1990) (0)
Is diarrhea complicating bolus nasogastric tube feeding caused by an abnormal PYY response (1998) (0)
Manganese-enhanced MRI demonstrates that oxyntomodulin and GLP-1 affect neuronal activity in distinct regions of the brain (2007) (0)
Contents, Vol. 21, 1972 (1972) (0)
The novel thyroid hormone derivative 3-iodothyronamine increases food intake via the hypothalamic arcuate nucleus (2007) (0)
Contents, Vol. 29, 1984 (1984) (0)
Constant intravenous infusion of kisspeptin-54 restores LH pulsatility in women with hypothalamic amenorrhoea (2014) (0)
Investigating the role of vagal Y2R in PYY3-36-mediated appetite suppression (2019) (0)
Gastroduodenal mucosal VIP levels in coeliac sprue and duodenal ulcer disease (1983) (0)
Insulinopenia in impaired glucose tolerance preservation of insulin response to i.v. arginine and tolbutamide (2007) (0)
[The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)]. (1982) (0)
Urinary kisspeptin as a novel marker of pregnancy (2014) (0)
Glucagon-like peptide 2 and epidermal growth factor, but not glutamine, have additive effects on intestinal growth (2000) (0)
Transfection of 6-23 A Rat Thyroid Carcinoma Cell Line, with the Neuropeptide Y cDNA (2005) (0)
Prepro-Vip Derived Peptides: Cardiovascular Actions and Pharmacokinetics in Man (1988) (0)
Pharmacokinetics ofpancreatic polypeptide inman (1978) (0)
Exogenous Administration of Subcutaneous Glucagon-Like Peptide-1 (7–36) Amide Causes Hypoglycaemia in Fasted Healthy Volunteers (1997) (0)
Prolactin releasing peptide does not have a significant role in the control of growth hormone secretion either in vitro or in vivo in freely moving male rats (2002) (0)
Does Kisspeptin signaling offer a new way to treat infertility (2009) (0)
eview hrelin and appetite control in humans — Potential application in the treatment f obesity (2011) (0)
Two doses of kisspeptin improve oocyte maturation and implantation rates compared to a single kisspeptin injection during IVF treatment (2016) (0)
The novel peptide prokineticin-2 potently inhibits food intake in rodents and is a potential novel anti-obesity therapy (2009) (0)
Subject Index Vol. 52, 1990 (1990) (0)
Galanin-like peptide interactions with leptin and GnRH (2003) (0)
Galanin and the control of growth hormone secretion in man (1991) (0)
Experience of the LHRH Analogue, ICI 118,430, in Carcinoma of the Prostate (1984) (0)
Enteroglucagon Correlation with Insulin Release (1974) (0)
History of Incretin Discovery and Clinical Application (2015) (0)
Optical control of the glucagon-like peptide-1 receptor allosteric site (2016) (0)
Gut glucagon and reactive hypoglycaemia. (1973) (0)
Glucose-Stimulated Neuropeptide Y Secretion from Pancreatic Islets is 7-Fold Increased by Prior Dexamethasone Treatment (1993) (0)
News and notices (2005) (0)
Subject Index, Vol. 29, 1984 (1984) (0)
Distribution of Somatostatin, MET-Enkephal in and VIP in Spinal Cords of 3 Species: Evidence of a Specific VIP-Ergic System in Human Sacral Cord (1983) (0)
Central and peripheral regulatory peptides (1981) (0)
The sedimentation coefficients of human jejunal gut hormone storage granules. (1982) (0)
Pathology of peptide-producing neuroendocrine tumours. (1985) (0)
Distribution of Neuron-Specific Enolase in Separated Layers of the Human Gut (1984) (0)
The Prosser-White Oration 1981. Regulatory peptides and the skin. (1983) (0)
Fibroblast growth factor 19 changes after metabolic surgery: the role of bile flow changes after Roux-en-Y gastric bypass (2010) (0)
Physiology of CGRP in the islet compared with that of amylin (1991) (0)
The role of thyroxine in the maintenance of a normal glycogenolytic response to splanchnic nerve stimulation in adrenalectomized calves (1974) (0)
Unaltered islet regulatory peptides in the islets of rats with dietary-induced obesity (1991) (0)
Endocrine and metabolic effects of deprivation of enteral feeding in sick pre-term infants (1980) (0)
Vasoactive intestinal polypeptide-, substance P- and Met-enkephalin-immunoreactive innervation of the human gastrointestinal mucosa (1984) (0)
Salt and water handling after gastric bypass surgery in rats (2010) (0)
Food preference after Roux-en-Y gastric bypass surgery (2009) (0)
Neuropeptide Y in the gastrointestinal tract distribution, chormatographic analysis and pharmacology (1984) (0)
Proceedings: Vasoactive intestinal peptide characteristics in human gut. (1975) (0)
Identification of elevated urine kisspeptin in pregnant women: a novel non-invasive biomarker of placental function? (2014) (0)
Neurotensin Synthesis in the Anterior Pituitary is Regulated by Oestrogen Status (1989) (0)
Amylin and Neuromedin U - Two Novel Regulatory Peptides of the Gastroenteropancreatic System (1993) (0)
Contents Vol. 61, 2000 (2000) (0)
Use of beta-3 adrenergic agonists (1995) (0)
Subject Index Vol. 61, 2000 (2000) (0)
Hypotensive effect of pituitary adenylate cyclase activating polypeptide in the anaesthetised rat (1990) (0)
Inhibition of lower esophageal sphincter pressure by vaso-active intestinal peptide: Mode of action (1978) (0)
Physiology of the porcine gastrointestinal regulatory peptides. (1981) (0)
A novel pituitary protein 7B2 in humanj pheochromocytoma : in vivo and in vitro study (1990) (0)
Panel discussion II (1987) (0)
The physiological response of Peptide YY following orlistat (2008) (0)
Contents, Vol. 22, 1985 (1985) (0)
Gamma1-MSH immunoreactivity in corticotrophs and ACTH-producing tumours (1982) (0)
Release of islet amyloid polypeptide from perifused rat isolated islets (1990) (0)
Clinical effects of kisspeptin on reproductive hormone secretion, LH pulsatility and oocyte maturation (2014) (0)
Water Immersion in Cirrhosis: The Atrial Natriuretic Peptide Response (1987) (0)
Genetic ablation of the AgRP neuron leads to a lean, hypophagic phenotype (2005) (0)
VIP but PHM or PHV Releases Cardiodilatin in Man (1988) (0)
Effect of the neuropeptide hpGRF on exocrine pancreatic secretion in the rat (1985) (0)
Developments in Digestive Diseases 3 (1981) (0)
Rebound Effect and Escape of Diarrhea Inhibition Using Sandostatin® in VIPoma Patients (1989) (0)
Diminished concentrations of regulatory peptides in colonic polyps (1988) (0)
Distribution of Regulatory Peptide-Containing Nerves (1984) (0)
Kisspeptin modulates resting brain activity to alter responses to negative stimuli in humans (2017) (0)
Twice-weekly administration of kisspeptin leads to long-term stimulation of reproductive hormone release in infertile women with hypothalamic amenorrhoea (2010) (0)
Effect of glucagon-like peptide 2 on functional and transcription factor gene expression in the small intestine (2000) (0)
Subject Index, Vol. 22, 1985 (1985) (0)
Peptide YY (PYY) and Neuromedin U (NMU): Effects on Ingestive Behavior (2006) (0)
Systemic role of regulatory peptids : Symposium Oosterbeek, Netherlands May 2nd -6th, 1982 (1982) (0)
Amylin a new gep hormone? (1992) (0)
Differential effects of guar and acarbose on intestinal neuropeptides in the rat (1983) (0)
Co-administration of the gut hormones PYY and GLP-1 to human volunteers reduces food intake and brain activation in appetite centres (2011) (0)
Patient Age Predicts the Delay before Survivors of Cancer Utilise Their Cryopreserved Sperm for Assisted Reproductive Technology (2015) (0)
Contents, Vol. 37, 1983 (1983) (0)
Is an abrnomal peptide YY response the cause of intragastric enteral feeding related diarrhoea (1995) (0)
Development of a high throughput UHPLC-MS/MS (SRM) method for the quantitation of 1 endogenous glucagon from human plasma 2 (2017) (0)
Hypothalamic neuropeptide Y messenger RNA in the hyperphagia of pregnancy and lactation and its regulation by food deprivation (1993) (0)
A comparison of the neuronal populations within the nucleus tractus solitarius activated by peripheral administration of glucagon, GLP-1 and oxyntomodulin (2012) (0)
The Peutz-Jeghers kinase LKB 1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage (2014) (0)
PP406 CONTRIBUTION OF CHANGES IN GASTROINTESTINAL HORMONES AND LEPTIN TO WEIGHT LOSS AFTER GASTRIC BYPASS SURGERY (2010) (0)
Natriuresis of Head-Out Water Immersion Is Associated with ANP Release in Man (1986) (0)
Plasma gastrin:somatostatin ratio is decreased in gastrinomas (2011) (0)
Alarin stimulates food intake and the hypothalamo-pituitary-gonadal axis in male rats (2010) (0)
Response to: "The incretins – outdated terminology in man? By C. M. B. Edwards and S. R. Bloom, London, UK" (1999) (0)
Further characterisation ofthe'ileal brake' reflex in man-effect ofileal infusion ofpartial digests offat, protein, andstarch onjejunal motility andrelease of neurotensin, enteroglucagon, andpeptide YY (1988) (0)
The differential release of amino acids and neuropeptides from purified subpopulations of mammalian GABAergic and cholinergic cerebrocortical synaptosomes (1993) (0)
Irish endocrine society (1995) (0)
Oligonucleotides as probes for hybridisation: Identification of two VIP mRNA's (1990) (0)
Vasoactive intestinal peptide-like immunoreactivity in salivary glands of the rat [proceedings]. (1979) (0)
I.v. and s.c. infusions of kisspeptin-54 stimulate gonadotrophin release similarly in healthy women (2015) (0)
Pre-pro-VIP derivatives in the enteric innervation (1985) (0)
Transient transfection of HIT-T15 cells using antisense oligodeoxyonucleotides — A methodological study (1993) (0)
M1266 Mechanisms Causing Normoglycaemia Following Metabolic Surgery (2009) (0)
intestine . stomach and proximal small peptides in biopsies from human Measurement of gut hormonal (2006) (0)
Intra-hypothalamic gene transfer of cocaine and amphetamine regulated-transcript results in increased food intake and weight gain (2003) (0)
Eighth annual meeting of the European Association for the Study of Diabetes (1973) (0)
PHI and NPY in the lung innervation (1983) (0)
Evolutionary perspectives of peptides from gut endocrine cells and nerves (2009) (0)
6.7 – Leptin, Starvation and the Mouse Gut (2000) (0)
Occurrence, distribution and origin of peptidergic nerves in the male genital system of the guinea pig and rat (1984) (0)
An immunocytochemical survey of 25 thyroid medullary carcinomas using antisera to regulatory peptides and general neuroendocrine markers (1984) (0)
Abnormalities of neural and hormonal peptides in Hirschsprung's disease (1980) (0)
Neuropeptide Y is present in the sympathetic nerves of the cardiovascular system (1985) (0)
ASN1-ARG98 Pro-ANP is the Circulating form of Cardiodilatin in Man (1988) (0)
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue (2004) (0)
Pancreatic endocrine function in cortisol‐treated thyroidectomized calves. (1981) (0)
Investigating the interaction between KNDy peptides on gonadotrophin release in humans - novel findings with therapeutic importance (2016) (0)
Physiological blockade of gut hormones increases food intake (2006) (0)
Short Report: Pathophysiology Hepcidin levels in diabetes mellitus and polycystic ovary syndrome (2013) (0)
Suppression of the hypothalamo-pituitary adrenal axis by long-term intra-arcuate Cocaine- and Amphetamine-regulated transcript (CART) peptide (2003) (0)
Atrial Natriuretic Peptide (ANP) and Renal Failure (1986) (0)
Peftidengic Inneration of Human Male Genital Tract (1982) (0)
Glucagon-like peptide 1 (GLP-1). (2019) (0)
Guest Lecture: Gastrointestinal hormones (1978) (0)
Raised Plasma Cardiodilatin in Patients with Congestive Cardiac Failure (1988) (0)
Book Review: Glucagon in Gastroenterology and Hepatology: Pharmacological, Clinical, and Therapeutic Implication (1983) (0)
Editorial (1983) (0)
Somatostatin in the human heart and comparison with guinea pig heart (1984) (0)
Untersuchung zum Energieumsatz nach Roux-en-Y Gastric Bypass in der Ratte (2010) (0)
Expression of General Neuroendocrine Markers and Hormones in Pancreatic Glucagonomas of Transgenic Mice (1990) (0)
Broichhagen et al-Angewandte Chemie International Edition.sup-1 (2015) (0)
Untersuchung zur Fettpräferenz nach Roux-en-Y Gastric Bypass in der Ratte (2010) (0)
The use of somatostatin in the diagnosis and treatment of neuroendocrine tumors (1995) (0)
Keine Induktion des braunen Fettgewebes – Andere Mechanismen vermittelten den gesteigerten Energieumsatz nach Roux-en-Y Magenbypass (2011) (0)
SF-082-1 Gastric bypass surgery modulates food choice and taste sensitivity : a translational study (2011) (0)
University of Birmingham agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist (2021) (0)
362-OR: The Role of Intraislet Glucagon in Pulsatile Insulin Secretion (2022) (0)
University of Birmingham Ligand-specific factors influencing GLP-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells (2020) (0)
Intestinal glucagon-like peptides in man and pig (1987) (0)
Subject Index, Vol 31, 1985 (1985) (0)
What's wrong with freedom? (1980) (0)
Modified PYY (3-36) peptides and their effects on the eating behavior (2006) (0)
The effects of an enkephalin analog on gastric function and the secretion of gastrointestinal hormones (1982) (0)
Carcinoid syndrome (2020) (0)
Physiology and Therapeutic Potential of Glucagon-Like Peptide-1 (1998) (0)
Inhibition by islet amyloid polypeptide of insulin release from isolated perifused rat islets (1992) (0)
Adipose Tissue, Appetite, and Obesity OBESITY TREATMENT: GUT HORMONES, DRUG THERAPY, BARIATRIC SURGERY AND DIET Severe Copper Deficiency Post-Bariatric Surgery with Serious Preventable Complications (2020) (0)
Commentary on “The road to reliable peptide assays is paved with good guidelines” (2023) (0)
Author response for "Safety and Efficacy of an Extended‐Release Peptide YY Analogue for Obesity: a Randomised, Placebo‐Controlled , Phase 1 Trial" (2021) (0)
Roux-en-Y gastric bypass increases glycaemic variability and time in hypoglycaemia in patients with obesity and pre-diabetes/type 2 diabetes mellitus: a prospective cohort study (2020) (0)
Letter: Vasoactive intestinal peptide in cirrhosis. (1975) (0)
The effects of a tripeptide hormonal infusion on sweet taste function and eating behaviour (2022) (0)
Targeting GLP-1 receptor trafficking to improve agonist efficacy (2018) (0)
Increased food intake with oxyntomodulin analogues 1 (2015) (0)
Glycaemic variability assessed by continuous glucose monitoring after Roux-en-Y gastric bypass vs. sleeve gastrectomy (2021) (0)
Appetite regulation during a 6-month military tour to Afghanistan (2013) (0)
Author response for "Imperial Satiety Protocol ‐ a new non‐surgical weight‐loss programme, delivered in a healthcare setting, produces improved clinical outcomes for people with obesity" (2020) (0)
Obese subjects have lower satiety (2005) (0)
Neuromedin U evokes contraction of rat stomach in vitro (1990) (0)
Acute effects of co-infusion of peptide YY (3[ndash]36) and glucagon-like peptide-1 on insulin secretion and insulin sensitivity (2013) (0)
Neuropeptide Y and Monoamine and Concentrations in Marmosets Treated with MPTP: A Model of System for Parkinson 7s Disease (1985) (0)
Alternative splicing of mRNA encoding the NmU precursor (1994) (0)
Novel substance P neural circuits in the ventral spinal cord of the upper lumbar level of the rat (1982) (0)
Autoantibodies toguthormone secreting cells as markers ofpeptide deficiency (1983) (0)
Chapter 114 – Neuromedin U (2013) (0)
Regional differences in regulatory peptide concentrations in the human colon (1987) (0)
Session 69: Clinical endocrinology (2013) (0)
Age changes in the noradrenergic innervation and neuropeptide Y content of rat brown fat: a study by condensation histochemistry, immunohistochemistry and radioimmunoassay (1991) (0)
The effect of phlorizin treatment on food intake and hypothalamic neuropeptide Y in normal and diabetic rats (1991) (0)
Ablation of Peptide YY cells in adult mice reveals a role in beta-cell maintenance (2012) (0)
Modifying the conditions of food intake and weight control by means of oxyntomodulin (2004) (0)
Investigation of a novel binding site for the calcitonin gene related peptide (CGRP) family of peptides in rat nucleus accumbens (1993) (0)
Subject Index, Vol. 30, 1984 (1984) (0)
High Dose Somatostatin Analogue Treatment Normalises Growth Hormone in Acromegaly (1988) (0)
Hypothalamic Appetite Regulating Peptides in the Hyperphagia of Pregnancy and Lactation (1991) (0)
Absence of detectable galanin synthesis in rat islets of Langerhans (1993) (0)
Letter: Rapid glucagon release in artificial fever. (1974) (0)
CENTRAL GLP-I 7-36NH2 AND ITS PEPTIDE ANTAGONIST EXENDIN (9-39) IN THE CONTROL OF TEMPERATURE AND FOOD INTAKE (1996) (0)
Pituitary adenylate cyclase activating peptide (PACAP) releases 7B2, a secretory granule protein, from clonal pituitary cell lines ATT20 and GH3 (1990) (0)
Localization of Insulinomas Using Selective Intraarterial Calcium Injection (1994) (0)
Mixedpancreatic apudoma withsymptoms ofexcess vasoactive intestinal polypeptide andinsulin: improvement ofdiarrhoea withmetoclopramide (1981) (0)
Specific binding sites for the novel vasodilator adrenomedullin are expressed in mammalian lung (1994) (0)
Gastrointestinal mediator of insulin action. (1980) (0)
Effect of pituitary adenylate cyclase activating polypeptide (PACAP) on substance P (SP) release in rat pituitary and hypothalamus (1990) (0)
Kisspeptin-54 injection stimulates activity of the human GnRH pulse generator in healthy women (2011) (0)
Pelvic nerve section induces a loss of vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) from cat sacral spinal cord. Tracer studies of VIP-containing pelvic pathways (1984) (0)
Mode of Action of the α-Glucosidase Inhibitor Acarbose in the Small Bowel: A Perfusion Study in Man (1988) (0)
PVN LHADMN VMN AgRP CART POMC NPY Blood Brain Barrier Hypothalamus AMPK CB 1 BDNF MCH Orexin CART (2009) (0)
The Role of GLP-1 7–36 in Control of Insulin Secretion Investigated Using the Receptor Antagonist, Exendin (9–39) (1995) (0)
Co-Release of Amylin and Insulin from Isolated Rat Islets (1990) (0)
A putative role for amino acids in appetite regulation (2012) (0)
Failure of Glucose-Dependent Insulinotropic Peptide (GIP) to Account for the Enhanced Release of Insulin after Oral Glucose in Man (1981) (0)
Increased plasma ANF levels and cardiac filling pressure after acute β-blockade in conscious hypertensive rats (1986) (0)
N europeptides . In the Brain (1985) (0)
Identification and characterisation of new specific binding sites for the novel hypothalamic peptide, pituitary adenylate cyclase activating peptide (PACAP) in human brain (1990) (0)
GLP-17-36NH2 in the control of food intake in the partially satiated rat (1994) (0)
282 Long acting LHRH analogue in patients with adenocarcinoma of the prostate (1983) (0)
Investigating the role of ventromedial hypothalamic glucose-sensing neurones in the response to hypoglycaemia (2010) (0)
APPG-distribution in rat spinal cord: Evidence of an APPG-containing ascending pathway (1984) (0)
Dexamethasone-induced increase in hypothalamic neuropeptide Y (NPY) is reversed by insulin (1991) (0)
The Role of Orexins in the Regulation of Appetite, Sleep and Arousal (2001) (0)
Thyrotropin releasing hormone-like immunoreactivity (TRH-LI) in cell lines derived from rodent B-cell tumours (1993) (0)
How many GI hormones are there (1980) (0)
Investigation into the presence of regulatory peptides in rat islets of Langerhans (1994) (0)
The effect of glucose on hypothalamic neuropeptide Y release investigated using static incubation of hypothalamic explants (2011) (0)
Subject Index, Vol. 46, Supplement 2, 1990 (1990) (0)
Proglucagon-derived peptides and exendin-4 do not increase acute exocrine secretion in vivo and in vitro in rat (2014) (0)
Differential effects of native Peptide YY and its long acting analogue (Y-59) on innate lymphocyte function and anti-tumour activity (2014) (0)
The distribution of GAWK-like immunoreactivity in endocrine cells of the human gut, pancreas, adrenal and pituitary glands and its co-existence with chromogranin B (1988) (0)
Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome 1–3 (2002) (0)
Localisation of calcitonin gene-related peptide immunoreactivity and messenger RNA in the rat anterior pituitary and the effect of gonadal steroid manipulations (1989) (0)
PYY3-36 inhibits food intake in both fed and fasted states (2005) (0)
Nesidioblastosis ofthepancreas:definition ofthe syndrome andthemanagement ofthesevereneonatal hyperinsulinaemi c hypoglycaemia (1981) (0)
Presence of immunoreactive endothelin in human saliva and in the salivary glands of rat (1990) (0)
Investigation and characterisation of specific binding sites for islet amyloid polypeptide (IAPP) in rat membranes (1991) (0)
Book reviews (1981) (0)
The role of the melanocortin 5 receptor in the hypothalamic regulation of appetite and pituitary function (2004) (0)
Neuropeptide tyrosine (NPY) is co-stored with noradrenaline in the mammalian adrenal gland (1983) (0)
OP014 THE IMPACT OF DUODENAL-JEJUNAL EXCLUSION ON SATIETY HORMONES (2013) (0)
The Role of Hormones in the Pathophysiology of Acute and Chronic Diarrhea (2006) (0)
Dynamic endocrinology of the pituitary; Combined use of in situ hybridisation and immunocytochemistry for the study of prolactin and proopiomelanocortin gene expression, synthesis and secretion (1987) (0)
Investigation of the binding characteristics of IAPP and CGRP in various mammalian species (1992) (0)
A possible role for the melanocortin 3 receptor in the control of the hypothalamo-pituitary gonadal axis (2002) (0)
Gastrointestinal Hormones in Disease (1988) (0)
Localisation of VIP and PHM binding sites in human gastrointestinal tract using in vitro autoradiography (1987) (0)
University of Birmingham Allosteric Optical Control of a Class B G-Protein-Coupled Receptor (2016) (0)
Contents, Vol 31, 1985 (1985) (0)
Appetite regulating hormones in constitutionally lean and anorexia nervosa subjects (2006) (0)
Dramatic plasma CCK elevation results from dietary enzyme inhibitor (1983) (0)
Gut hormone measurement in human biopsies [proceedings]. (1977) (0)
Presence of Glucagon-Like-Peptide-1 in Plasma of Patients with Glucagon-Secreting Tumours (1985) (0)
Weight Loss With a Novel Peptide YY Analogue for Obesity: A Randomised, Placebo-Controlled Phase I Trial (2021) (0)
EncephalomyelitisProgression of Autoimmune Requirement for Leptin in the Induction and (2001) (0)
Problematic development of an immunometric assay for cocaine and amphetamine regulated transcript (CART) (55-102) peptide fragment (2003) (0)
Bypass of the Proximal Gut Has Weight Loss Independent Effects on Glycemic Control (2011) (0)
Kisspeptin signaling in the amygdala modulates reproductive hormone secretion (2015) (0)
Investigating glucose responsive neuropeptide release using a static hypothalamic incubation system (2012) (0)
Gastrointestinal hormones. (1977) (0)
Impaired PP release in chronic pancreatitis with steatorrhoea Table Chronic pancreatitis (2006) (0)
Expression of neuromedin B in the human pituitary (1991) (0)
Localization of Gastroenteropancreatic Tumours using the Indium-Labelled Somatostatin Analogue, Pentetreotide (1993) (0)
Differential contractile effects of various neuromedin U fragments and analogues on the isolated rat uterus (1992) (0)
Pharmacological studies on C-flanking peptide of neuropeptide Y (CPON) (1985) (0)
Proceedings: Enteroglucagon correlation with insulin release. (1974) (0)
NEUROENDOCRINE RESPONSESTO STIMULATIONOF THE VAGUS NERVES INBURSTSINCONSCIOUSCALVES (1983) (0)
AGI March 41/3 (2000) (0)
Elevated hypothalamic neuropeptide-Y concentrations in rats fed a palatable diet — effect of d-fenfluramine (1990) (0)
Neuropeptide Y (NPY) Concentrations Are Elevated in the Substantia Innominata in Alzheimers Type Dementia (1984) (0)
VIP, BUT NOT PACAP, POTENTIATES THE RELEASE OF LH AFTER LHRH INJECTION IN MAN (1992) (0)
Neuromedin B synthesis in the rat anterior pituitary and its regulation by endocrine status (1991) (0)
Letter: Diabetes without glucagon. (1976) (0)
Hypothalamic Npy and Appetite: Npy Concentrations Respond to the Regulation of Nutrient Intake During Parenteral Nutrition in Rats (1990) (0)
Analytical subcellular fractionation: a new approach to the study of polypeptide hormone storage granules in gut endocrine cells [proceedings]. (1978) (0)
[Hormonal peptides and neuropeptides of the digestive system of man. Physiology and pathology]. (1983) (0)
Gastric inhibitory polypeptide does not normally inhibit gastric secretion (1980) (0)
Diazepam Binding Inhibitor - IR in the Human CNS and Peripheral Tissues (1988) (0)
Effects of a panel of lectins on gastrointestinal hormone release in rats maintained on total parental nutrition (1998) (0)
Proceedings: Provoking gastrin release--which stimulus? (1974) (0)
Graham Frank Joplin (2007) (0)
SAT-607 The Vagus Nerve and the Hypothalamus Mediate Different Aspects of the Anorectic Effects of PYY3-36 (2020) (0)
Proceedings: Growth hormone release inhibitory hormone and pancreatic polypeptide. (1976) (0)
Islet Amyloid Polypeptide: A Paracrine Regulator of Bone Metabolism? (1991) (0)
The effect of TRH and LHRH on substance P (SP) release in rat pituitary (1989) (0)
Sucralose ingestion does not elicit a GLP-1, PYY or appetite response in healthy, normal-weight volunteers. (2009) (0)
W1861 Fibroblast Growth Factor 19 as a Possible Cause and a Treatment Target for Obesity (2010) (0)
Oxyntomodulin for the prevention or treatment of overweight (2002) (0)
Reduced circulating levels of kisspeptin, human chorionic gonadotropin, placental-like growth factor, soluble fms-like tyrosine kinase-1 and soluble endoglin but not prokineticin-1 are associated with miscarriage risk (2015) (0)
Evaluation of the in-house radioimmunoassay method for peptide YY (PYY) (2004) (0)
Descriptive dietary profile of poor responders to bariatric surgery (2018) (0)
In vivo hepatic energy pertubations during alanine infusion using 31P-NMR spectroscopy. (1995) (0)
Oxyntomodulin Potential Treatment for Obesity (2006) (0)
Plasma kisspeptin is a novel tumour marker in patients with gestational trophoblastic neoplasia (2006) (0)
Long-term culture of galanin expressing encapsulated RIN 1056a cells in vitro. (1997) (0)
Molecular characterization of cDNA encoding a novel form of pituitary adenylate cyclase activating polypeptide (PACAP) in rat testis (1994) (0)
Heterogeneity of neurotransmitter receptors: A comparison of beta-adrenergic, muscarinic cholinergic, and VIP receptors (1982) (0)
Regulatory Gut Peptides in the Perinatal Transition Period (1992) (0)
Positive correlation between symptomsandcirculating motilin, pancreatic polypeptide andgastrin concentrations infunctional bowel disorders (1985) (0)
From Expert Review of Clinical Pharmacology Approaches to the Pharmacological Treatment of Obesity (2010) (0)
The effects of kisspeptin administration on the menstrual cycle in healthy women (2014) (0)
Orexins increase active behaviour and CNS orexin a immunoreactivity is significantly different between spontaneously hypertensive and Wistar-Kyoto rats (2000) (0)
Effect of Analogues of Somatostatin on Pancreatic and Gut Hormones and Growth Hormone in Man (1979) (0)
390-P: Changes in Glycaemic Variability after RYGB: A One-Year Prospective Study with Comparison to Patients with Post-bariatric Hypoglycaemia (2019) (0)
Proceedings: Secretin radioimmunoassay in the pig. (1975) (0)
The mechanism of long lasting feeding effect of agouti related peptide - an evidence supporting a role for the melanocortin 3 receptor (2000) (0)
Pathophysiological Aspects of Gut Peptide Hormones (1993) (0)
The glucagonoma syndrome. (1990) (0)
Chromatographic characterization of plasma and tumour neurotensin-like immunoreactivity in a hepatoma patient (1984) (0)
Response ofplasma pancreatic andgastrointestinal hormones andgrowth hormone tooraland intravenous glucose andinsulin hypoglycaemia in Chagas's disease (2011) (0)
Investigating the sites and mechanisms by which peripheral prokineticin 2 administration reduces food intake and body weight in mice (2012) (0)
Glucose mal absorption and hormonal responses during rapid intra duodenal infusion of glucose in normal man (1982) (0)
Bayliss & Starlings' gut hormones - curing the obesity pandemic (2014) (0)
Book reviews (2011) (0)
RAPID GLUCAGON RELEASE IN ARTIFICIAL FEVER (1974) (0)
C Plasma Atrial Natriuretic Factor in Chronically Hypoxaemic Patients with Pulmonary Hypertension (1987) (0)
Regulation of anterior pituitary galanin by oestrogen and prolactin status (1993) (0)
Systemic and Hypothalamic Actions of Ghrelin in Regulation of Food Intake, Body Weight and Pituitary Function (2001) (0)
Distribution and molecular forms of bombesin and glucagon-like immunoreactivities in human brain (1983) (0)
Neuropeptide Y content and expression in human pancreatic islets (1993) (0)
Alterations of the somatotrophic axis in the obese agouti (Ay/a) mouse (2004) (0)
Graded Dynamic Exertion Progressively Increases Plasma Concentrations of Atrial Natriuretic Peptide (ANP) in Normal Man (1987) (0)
Neuropeptide Y in the Human Circle of Willis and Its Effect on Cerebral Cortical Blood Flow (1984) (0)
Hormones from gut and pancreas in term neonates: response to fetal distress and different alimentary stimuli (1978) (0)
The Comparative Electrophysiological Properties of Somatostatin and Verapamil on Atrioventricular Conduction and Atrioventricular Reentry Tachycardia (1986) (0)
Adrenal agouti related protein (Agrp) expression is regulated by glucocorticoids and Agrp via the MC3-R or MC4-R may have an inhibitory paracrine role on corticosterone secretion (2002) (0)
Valosin Immunoreactivity in Central and Peripheral Tissues of Three Mammalian Species (1987) (0)
Subject Index Vol. 37, 1983 (1983) (0)
Acarbose-Induced Elevation of Plasma Enteroglucagon Does Not Inhibit Pentagastrin Stimulated Gastric Acid Secretion in the Rat (1984) (0)
Gastrointestinal Hormone Response to Sham Feeding (1983) (0)
IS A VILLOUS ADENOMA OF THE RECTUM AN ENDOCRINE TUMOUR? (1975) (0)
NEUROTENSIN AND RENAL-FUNCTION IN THE CONSCIOUS RABBIT (1982) (0)
Insulin and gastric inhibitory polypeptide in plasma of obese subjects after a biliopancreatic bypass. (1980) (0)
Feeding effects of the gut hormones ghrelin, peptide YY3-36 and oxyntomodulin in lean and obese mice (2005) (0)
[Coeliac sprue and gut hormones: pathophysiological and clinical aspects (author's transl)]. (1981) (0)
The Role of Leptin in the Cell-Mediated Immune Response and T Lymphocyte Development (1999) (0)
Obesity, gut hormones and knighthood (2013) (0)
Increased PCR specificity by RNA size fractionation (1993) (0)
and biliary pathways . cells of the guinea pig gall bladder Peptide immunoreactive nerves and (2006) (0)
VIP-Containing Nerves in the Bladder and Sacral Cord (1985) (0)
Ontogenic development of rat galanin and neurotensin immunoreactivity and mRNA in the gastrointestinal tract of the rat (1992) (0)
The effect of TRH on 7B2 release (1989) (0)
RAMP 2 and the glucagon receptor RAMP 2 influences glucagon receptor pharmacology via trafficking and signaling (2017) (0)
Atrial Natriuretic Peptide Levels in Right Ventricle and Right Atrium following Chronic Hypoxia in Rats (1988) (0)
Marked Depletion of Spinal Cord Substance P and Other Neuropeptides in the Shy-Drager Syndrome (1985) (0)
Atrial Natriuretic Peptide (Anp), Neuropeptide Y (Npy), And Calcitonin Gene-Related Peptide (Cgrp) In The Cardiovascular System Of Man And Animals * (2019) (0)
Localization and distribution of neurotensin in human intestine [proceedings]. (1978) (0)
Insights into the mechanisms underpinning the physiological effects of biased GLP-1 receptor agonists (2019) (0)
oxyntomodulin-like analogues in male Wistar rats (2015) (0)
A New Specific Assay for Cholecystokinin Octapeptide (1985) (0)
The effect of specific micronutrients on appetite (2012) (0)
The Physiologically Significant Molecular Form of Human Enteroglucagon (1983) (0)
Implantation of fibre encapsulated RIN 1056a cells transfected with NPY cDNA into the lateral ventricle of rats alters body weight (2005) (0)
A novel role for neuropeptide Y in the regulation of energy homeostasis (2010) (0)
The effect of environmental enrichment on food intake, body weight and the HPA axis in laboratory rats (2011) (0)
Marked changes in pancreatic polypeptide and motilin release in different T types of functional bowel disorder (1983) (0)
The Effect of Acetate on Glucose and Fatty Acid Metabolism (1990) (0)
Ghrelin in Cachexia Associated with End-Stage Renal Disease (2012) (0)
The pharmacokinetics of VIP in dog and pig (1982) (0)
The use of an elemental feed in the nutritional support of an unusual case of diarrhoea (1993) (0)
Expression in Human Lung Tumor Cell Lines Production of Neuromedin B and Neuromedin B Gene (2006) (0)
Fibre and patients with diabetes (1988) (0)
Kisspeptin-54 administration stimulates LH pulsatility in women with hypothalamic amenorrhoea (2013) (0)
Origin of SP-immunoreactive nerves in the rat bladder (1982) (0)
Gawk (chromogranin - B 420–493) in endocrine tumours (1988) (0)
The effect of L-cysteine on appetite in humans (2014) (0)
Combined use of vasopressin and synthetic hypothalamic releasing factors as test of anterior pituitary function (1986) (0)
NEUROMEDIN U: A NOVEL BRAIN-GUT PEPTIDE (1989) (0)
Neuropeptide Y in Mammalian Cardiac Tissue; Effects on Isolated Perfused Rabbit Heart (1983) (0)
Neuronal Abnormalities in Crohn’s Disease: Greater Density and Altered Morphology of Nerves Containing Derivatives of Pro-PHM/VIP (1989) (0)
Trophic effects of ileal hormones (1983) (0)
The effects of anabolic steroids on growth, composition, and metabolism in boys with renal failure on regular hemodialysis body chronic (1980) (0)
Post Partum Release of Atrial Natriuretic Peptide in Healty Pregnant Women (1987) (0)
VIP-, substance P- and enkephalin-immunoreactive innervation of the human gastrointestinal mucosa (1983) (0)
Water quality concerns – are they real ? What needs to be done ? (2004) (0)
Letter: Vasoactive intestinal polypeptide. (1976) (0)
Gastrointestinal disorders in diabetes mellitus (1986) (0)
THE DISCOVERY OF NEUROPEPTIDES AND RADIOIMMUNOASSAY OF PEPTIDE HORMONES (2011) (0)
Localisation and regulation of cocaine- and amphetamine-regulated transcript (CART) in the anterior pituitary gland (2003) (0)
Human preproglucagon component peptides are topographically segregated within the pancreatic alpha granule (1984) (0)
Cerebellin1 is a novel orexigenic factor which potently increases food intake via hypothalamic neuropeptide Y release (2009) (0)
New use of compounds agonists beta9-adrenergic (1995) (0)
[Apudoma of the stomach producing pancreatic polypeptide hormone]. (1982) (0)
PYY 336 produces an acute anorexigenic effect followed by a later orexigenic effect not seen with other anorexigenic peptides (2007) (0)
Presence of GAWK-like immunoreactivity (LI) in insulin-secreting clonal β-cell lines (1993) (0)
Enhanced production of “ectopic” VIP-like immunoreactivity in human pheochromocytoma cell cultures (1983) (0)
Metabolic changes post Roux-En-Y Gastric Bypass: one year prospective study (2019) (0)
Hormonal and Metabolic Studies in Patients with Circulating Glucagon-Cell and Somatostatin-Cell Antibodies (1980) (0)
Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones. (1983) (0)
VIP and the genitourinary system of man and animals (1983) (0)
Profiling the metabolic clearance and enzymatic degradation of the gut hormone Peptide YY as a tool to design long-acting PYY3-36 analogues in treating obesity (2010) (0)
Partial cloning of the cDNA encoding the hamster VIP receptor (1993) (0)
Partial Reversal of Protan and Tritan Colour Defects with Inhaled Oxygen in Insulin-Dependent Diabetic Subjects (1995) (0)
LKB1 restricts polyp development from entero-endocrine L cell precursors (2014) (0)
Inhibition of Plasma Renin Activity (PRA) by Physiological Plasma Concentrations of Atrial Natriuretic Peptide (ANP) in Man (1987) (0)
The combination of Peptide YY 3 – 36 with GLP-17 – 36 amide causes an increase in first-phase insulin secretion in response to IV glucose (2014) (0)
Mechanism of improved glycemic control after metabolic surgery (2010) (0)
Derivatives of pre-pro-hormone molecules in neuroendocrine tumours (1985) (0)
Development of gut hormone secretion in the pre-term neonate: Comparison of continuous intragastric infusions of human milk with intermittent boluses (1982) (0)
Plasma secretin andpancreatic bicarbonate response to exogenous secretin in man SECRETIN INFUSION (2006) (0)
THE ENDOCRINE RESPONSE TO THE FIRST FEED OF BREAST MILK IN THE HUMAN NEWBORN (1975) (0)
Is the Novel and Abundant Regulatory Peptide Adrenomedullin, a Circulating Hormone in Man? (1996) (0)
Hormonal and metabolic responses to intravenous glucose in children on regular (1978) (0)
Vasoactive Intestinal Peptide (VIP) (2002) (0)
Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels (2017) (0)
CGRP-alpha inhibits food intake via the paraventricular nucleus (PVN) of the hypothalamus partly through the CGRP-type 1 receptor (2002) (0)
Book Review: Developments in Digestive Diseases 3 (1981) (0)
Kisspeptin: new marker of placental dysfunction? (2011) (0)
Neuroendocrine Peptides in Puimonary Neoplasia (1982) (0)
Abnormalities of thyroid function in the POMC-null mouse (2003) (0)
Which test should the bariatric physician use to test for postprandial hypoglycaemia - prolonged oral glucose tolerance test versus mixed meal test? (2017) (0)
Interactions between glucagon and GLP-1 in neuronal pathways affecting food intake (2011) (0)
Renal Neuropeptide Y (NPY) Depletion in Surgically-Induced Hypertension (1984) (0)
Kisspeptin-54 potently stimulates luteinising hormone release during the preovulatory phase of the menstrual cycle in healthy human females (2007) (0)
Cardiodilatin, ANP and Autoregulation (1987) (0)
Neurohormonal Peptides in Chagas' Disease and the Shy-Drager Syndrome, a Study with Rectal Biopsies (1979) (0)
New use of agonist compounds 3-adrenergic. (1996) (0)
Kisspeptin-54 safely and effectively triggers oocyte maturation during IVF treatment in women at high risk of developing ovarian hyperstimulation syndrome (OHSS) (2015) (0)
Single molecule SNAP-GLP-1R tracking data (2019) (0)
Discovery of nitric oxide and cyclic GMP in cellular signaling and their role in drug development Mineralocorticoid receptor, salt-sensitive hypertension and Novel therapies for diabetes: Insulin and (2010) (0)
Endocrine andmetabolic responseinthehuman newborn tofirst feed ofbreast milk (1977) (0)
1798-P: Chronic Administration of a Long-Acting Glucagon Analogue Results in Enhanced Insulin Secretory Activity in a Directly-Observed Murine Model (2020) (0)
Contrasting Effects of TRH and EFP, a Newly Discovered TRH-Like Peptide, on Insulin Secretion from Perifused Islets (1993) (0)
Vasoactive intestinal polypeptide and its mRNA in the isolated rat islets of Langerhans : effect of dexamethasone treatment (1992) (0)
Immunoreactive 7B2 and P7 in Huntington's Disease (1987) (0)
Comparison of the pharmacological effects of VIP and related peptides and Gila monster venom on rabbit genitourinary smooth muscle (1985) (0)
Abnormal Insulin Secretory Response to Food after Acute Hypoglycaemia in Man: Evidence for β-Cell Glucopenia (1980) (0)
Changes in Renal Function during Sodium Loading Associated with Infusion of Calcitonin Gene-Related Peptide in the Dog (1985) (0)
Book Review: Substance P, Vol 2 (1980) (0)
Contents, Vol. 35, Supplement 1, 1986 (1986) (0)
The metabolic and endocrine responses of neonates to surgical stress (1984) (0)
The role of endothelin in Swiss 3T3 cells (1989) (0)
The early improvement of glycaemia following RYGB can be mimicked by a Very Low Calorie Diet in obese volunteers with diabetes (2017) (0)
Obesity, present and future therapies (2015) (0)
Gastro-Entero-Pancreatic Tumors: Somatostatin Analogues - Peptide Therapy in Action Symposium, Session 1, January 1989: Proceedings Perspectives in Gastroenterology Somatostatin Analogues - Peptide Therapy in Action Symposium, Session II, January 1989 (1990) (0)
NIA0003 The role of peptide YY (PYY) in the control of appetite (2006) (0)
Kisspeptin advances ovulation in healthy women (2013) (0)
Receptors to bombesin-like peptides demonstrated using a divalent ligand and colloidal gold probe electron immunocytochemistry (1984) (0)
Therapeutic relevance of the entero-endocrine system (2010) (0)
Gastrointestinal hormonal changes of acute hepatic failure in the pig. (1981) (0)
Peptides in isolated rat islets of langerhans: Lack of effect of mifepristone (RU486), a novel antiglucocorticoid (1992) (0)
Proglucagon peptide family responses after RYGB surgery in obese patients with type 2 diabetes (2019) (0)
A VIP-/PHI-ergic pathway links pelvic organs with the spinal cord. Evidence determined by retrograde tracing combined with immunocytochemistry (1985) (0)
Neurokinin 3 receptor antagonism is a highly effective, novel treatment for menopausal hot flushes with rapid onset: a phase 2, randomised, double-blind, placebo-controlled trial (2017) (0)
The topographic distribution of pudendal motor nuclei and their peptidergic connections in the rat using retrograde uptake combined with immunocytochemistry (1984) (0)
Production of A Novel Pituitary Protein by Tumours and its Diagnostic Value (1985) (0)
Neurobiology of Obesity: Introductory chapter (2008) (0)

This paper list is powered by the following services:

Other Resources About Stephen R. Bloom

en.wikipedia.org

What Schools Are Affiliated With Stephen R. Bloom?

Stephen R. Bloom is affiliated with the following schools:

Stephen R. Bloom's Academic­Influence.com Rankings